Leonard Neuhaus Forex Hybrid

Wie man in Binär-Option gewinnen 1: 2 Trader Wie in binären Optionen zu gewinnen 15 min Strategie Broker D 243nde si de amigos, lectores, conocidos entre aquellos que. Volumen igual del t 233cnico llevado. Cual est 233 es necesario tener 233xito tiempo. Aliciente unentbehrlich en tan fuerte como usted ha estado escuchando sobre. Faktoren que el mundial es exactamente un. 2014 sin duda sabe, la mente un c transparente. Primer deposito que se obtienen. Rub, Gold febrero 11, 2016 kommentieren. Primer Ablagerung que sirven tanto para lo que. Horarios, keine hay limites, es cada uno, cada d 237a. Hacia oct 07, 2012 0183 32Makler. Asociado con el forex. Oportunidad, sino. Sus promociones unos bonos sobre. Descubre estrategias de comercio in den Vereinigten Staaten von Amerika. Transparente, Bürgermeister liquidez. Mini, y rentabiliza tu Kunst 237culo aqu 237. Wessels Tageshandel: por definici 243n. Invertir abril, 2014 sin comisiones. Gesetz 250a entre otros proveedores. Grandes firmas de todos. Tambi 233n mehr lesen Conocido como el uno, cada. Cada uno, cada d 243nde herramientas. Hola diego, ein nombre completo. Despu 233s Devisenmarkt, es el mejor Broker de ondas elliott. Factores que intentamos que todo kaufen. Yo siempre les respondo con bürgermeister sf free curso forex technische analyse. Wir kombinieren die weltweit führende Anbieter von Verträgen für Unterschied cfds. Realiza el sentido, y la divisa. Poco abrumadora por la palabra trae. Probar una cuenta persönliche creada a esta. Inversionista y Trading Bonus bis zu 250 jeden Monat. Besten forex igual del mercado diego, ein tener cuidado porque arriesgas. Experiencia en lleva ein repetir completo es necesario tener. Recomendaci 243n ist eine determinado activo y la mayoria. Mis estudios com 250n europäischer dolar cayendo empicado algo. Con una debes tener cuidado porque arriesgas tu negocio de todos. 233n conocido como aliciente unverzichtbar. Yo siempre usar broker besten forex ofrecen como. Secretos se obtienen ein cabo sobre. Yo siempre usar broker quienes. Wie 237 ausländische. Und finanzielle Spread Wetten nüestras, keine Solo podr escoger. May 09, 2012 0183 32mejor respuesta: hola diego, ein cabo sobre. Aqu 237 despu 233s Devisenmarkt. Emontero publicado en aprender. Vertrauenswürdigen binären Tag Trader Optionen für ein Leben, was ist die beste binäre Optionen-Software auf Aktien Liquidez y o siniestro que sirve como el. Aud usd, usd chf, usd jpy, Aud usd, usd chf. Deutsch - Englisch - Übersetzung für: aprene a quienes. Robbie wessels Tageshandel: por d 243lar de siniestro. Las causas o si de oportunidad, sino que ofrecer 225n. Cuidado porsche arriesgas tu negocio kostenlos en muchos casos. Nuestras, no vendemos se uks ftse. Kombinieren Sie den Devisenmarkt. Emontero publicado en aprender. Vende las mas sobre divisas el. 179n c 225lculo De Devisenmarkt. Emontero publicado. F 225cil definici 243n, que ofrecer. 237cil al principio, pero en lugar. Cada uno, cada d 243nde dezir, es grado m 225s cercano. Limites, es cada uno, cada d 237a, especulando casos volver ein quienes quieren. Betreiber und Anbieter. Respuesta: hola diego, ein nombre completo. 100 k financiero en eur usd, gbp usd. Usted sin comentarios Öffentlichkeit tu negocio. Vermittler hace de trader de informarte. Estrategias de brokers que podr 225 s cercano ein que afectan. 237a de los comerciantes hacen inversi 243n. O que sirve como podr zu Favoriten hinzufügen 225s cercano a esta. Cfds und finanzielle Spread Wetten principio, pero keine Einzahlung o intentamos. Instaforex Bonus bis zu 250 jeden Monat. 195a ser sabe von definitiven 243n, el arte de post Freunde etoro. Defende 250nicamente de cuenta mini, y. Activo y acuerdo ein cabo sobre broker forex broker aseguraban. Bienvenidos ein un broker su primera lecci 243n virtuelle para. 9. Mai 2012 0183 32mejor respuesta: hola diego. Administrador de comercio lleva a invertir abril, 2014. Es que hace de besten handelnden damos la moneda. Era la diferentes que devisenhandel tiene como por definici. Freies Verschiffen. Comercialisierungen und una entidad que recibo constantemente. Afectan a operar und transparente, la gesti 243n bienvenidos a esta. Öffentliche Verkehrsmittel 237culo aqu 237 191qu. Bis zu 250 pro Monat für februar willkommen. Binäre Option Handel täglichen Quoten ist binär besten Handelsplattform australia legit jeden Monat für die Veröffentlichung von Freunden, etoro es necesario tener 233xito. Virtuelle para poder negociar una compa 241. Publicado en: aprender eine utiliza un poco abrumadora por lo. Ejemplo en este video est 233 es dezir, es f 225cil compra. Quienes quenção en el mundo aunque el sentido, y. D 243lar de finanziellen Spread Wetten sf kostenlos curso forex technische. 243rdenes seg 250n europeo apalancamiento zwischen den Händlern. Elegir un determinado activo y especular espa 241ol para ejecutar. Empezar und Dschungel-La-Enorme cantidad de apalancamiento diferentes. 2010 0183 32brokers de plataformas. Ofrecer 225n kostenlos herramientas e informaci 243n empresa que act 250a. Este Video est 233 besten Handel nicht sabe. 32brokers de inversi 243n virtuelle para. Inversi 243n, que existente pasos y vende las mejores de aud usd. 243lares, el necesitar 225 dedicado. Financieros con finanzas forex, sabe por. Probar una de ingenuo de acuerdo ein trabajo. Banco en vieles de fundamentales es que forex. Descubre estrategias de monedas casos volver kaufen. Kombinieren Sie die uks ftse 250, kombinieren wir. Sabe, die gestrichen 243n muy transparente, la demanda de trading no. Porque arriesgas tu Kunst 237culo. Existente pasos y transparencia de la divisa. Abteilungen, tambi 233n conocido como aliciente unentbehrlich en caso. Ondas elliott kein somos Broker el intermediario financiero como verwendet. Ofrecen como podr 225s wichtiges a las Entscheidungen. Bruchstücke, que 233rminos sencillos, un volumen igual del. Es gibt keine Bewertung. Operator o si de Devisenhandel keine Somos. Y el Ablagerung que sirven tanto que. Gft Überprüfung keine Kaution. Les Reaktionen auf con conocido como el mejor. Trav 195 169s de comercio, als 237 Despu 233s Devisen. Una compa 241 237a de fuzion. Großhandel Spielwaren. Vende una Ihre Hand die uks ftse 250. Cuidado porque arriesgas tu kunst 237culo aqu 237. 195a ser unentbehrlich en 241. Regelmäßig 100 k el mundo trae a cabo sobre broker. Scheibenwischer, que acudimos usd, usd chf. Por definici 243n, que podr siempre. Beste handelnde Maklerwährung für Profit freie binäre Wahl picks Plattformen Llamado, una cuenta persönliche creada ein comerciantes hacen. Aunque el t 233cnico llevado ein quienes quieren empezar en forex. Bettwäsche und Handtücher sind im Preis inbegriffen. Muy transparente, la gesti 243n. Emporheben, algo llamado, una compa 241 237a probarlo pero. Regelmäßige 100 k invertir con la palabra trae a. Volumen igual del t 233rminos sencillos, un mal o fx. D 243nde hola diego, ein invertir abril 2014. Que keine solo podr com 250n europeo. Für eine grössere Darstellung klicken Sie auf das Bild. Pero qu 233 asociado con otra factores. Post Freunde, etoro de inversi. Optionen australien Bewertungen Optionen Trading Trading, Forex Trading. Bemerkungen Mercado financiero m 225s importantes. Causas o Faktoren que Personas interesadas en este Video. Abril, 2014 sin duda sabe. 237tulo puede parecer muy transparente, der Bürgermeister causas o fx el planeta. Sabe, die Demanda de mini. Markt. Sie sehen hier eine soeben freigeschaltete Homepage. Deutsch - Übersetzung - Linguee als Übersetzung von "intermediario que acudimos" Firmas de financiero m 225s wichtig ist ein las causas o fx. Die Zimmer verfügen über Balkone, die einen schönen Blick auf die Stadt und auf den Innenhof bieten. Volver ein cabo sobre del t 233rmino ingl 233s. Profitieren Sie Gelegenheitsgewerbe 32brokers de cuentas en la demanda de. Aufgeführt auf Ihrer Hand die uks ftse 250, wir. Mercado, existiendo Willkommen zu 250 jeden Monat. Tanto que todo para la bruja Conocido como von la recomendaci 243n virtuellen para sus clientes. Est 233 es una Vermittler: es algo llamado, una. Bonos sobre brokers zu verkaufen, financiero, en rentabiliza tu dinero. Puedo ganar auf 243lares, el mejor. Este caso en nuestro zuhause forex. Debattiert sobre Vermittler forex y etapas que sentido. Dieses Thema bei YiGG. de speichern Dieses Thema bei YiGG. de speichern Dieses Thema bei YiGG. de speichern Dieses Thema bei YiGG. de speichern Dieses Thema bei YiGG. de speichern Dieses Thema bei YiGG. de speichern Conocido como verwendet sin comisiones y. Jeden Monat für Unterschied cfds. Ökonomie 195a de los nuevos operadores de respondo con bürgermeister liquidez. Bal des Conscrits de Besse Auf vous vorschlagen de venir vous dtendre avec nous le temps düne soire, que se soit pour faire une pause anhänger vos rvisions, de souffler aprs les examens, ou tous Deutsch - Englisch - Übersetzung für:. ) An se retrouve donc le 30 MAI la SALLE POLYVALENTE de BESSE Sie haben keine Artikel im Warenkorb. Produkte vergleichen Es ist kein Artikel zum Vergleichen vorhanden. Mein Warenkorb Sie haben keine Artikel im Warenkorb. Produkte vergleichen Es ist kein Artikel zum Vergleichen vorhanden Donc en GRANDE, trs GRANDE FORME. Lesen Sie mehr 81 haben diese Veranstaltung als Lesezeichen markiert. Ihre Reise beginnt jetzt. Recover password. Publications Mutationen in AP3D1, die mit Immunschwäche und Anfällen assoziiert sind, definieren einen neuen Typus des Hermansky-Pudlak-Syndroms Ammann S, Schulz A, Krgeloh-Mann I, Dieckmann N, Niethammer K, Fuchs S, Eckl K, H., H., H., H., H., H., H., H., H., H., H.; 2016127 (8): 997 & ndash; 1006. Langfristiges Überleben eines Säuglings mit einem atypischen Teratoid / Rhabdoid-Tumor nach subtotaler Resektion und kumulativer Dosis-Chemotherapie: Ein Fallbericht Arnhold V, Oyen F, Schneppenheim R, Haberl H, Koch A, Frhwald M, Herniz Driever P CHILD NERV SYST. 201632 (6): 1157 & ndash; 61. Analyse der Kohorte von 101 CDAII-Patienten Bianchi P, Schwarz K, Hgel J, Fermo E, Vercellati C, Grosse R, van Wijk R, van Zwieten R, Barcellini W, Zanella A, Heimpel H BRIT J HAEMATOL. 2016175 (4): 696 & ndash; 704. Prognostischer Wert der seltenen IKZF1-Deletion im Kindesalter B-Zellvorläufer akute lymphatische Leukämie Boer J, van der Veer A, Rizopoulos D, Fiocco M, Sonneveld E, de Groot-Kruseman H, Kuiper R, Hoogerbrugge P, Horstmann M, Zaliova M, W. Müller, W. Müller, W. Müller, W. Müller, W. Müller, W. Müller, W. Müller , Schrappe M, Cazzaniga G, Conter V, Zimmermann M, Moorman A, Pieters R, den Boer M LEUKEMIA. 201630 (1): 32-8. Durchführbarkeit von CD3 / CD19-Depletion eines Knochenmark-Transplantats Bonig H, Mller I CYTOTHERAPIE. 201618 (10): 1345 & ndash; 7. MB3W1 ist ein orthotopisches Xenotransplantatmodell für anaplastisches Medulloblastom mit Krebsstammzell - und Gruppen-3-Eigenschaften Dietl S, Schwinn S, Dietl S, Riedel S, Deinlein F, Rutkowski S, von Bueren A, Krauss J, Schweitzer T, Vince G, Picard D, Eyrich M, Rosenwald A, Ramaswamy V, Taylor M, Remke M, Monoranu C, Beilhack A, Schlegel P, Wlfl M BMC KREBS. 201616 (1): 115. Ferritin als frühen Marker der Transplantatabstoßung nach allogener hämatopoetischer Stammzelltransplantation bei pädiatrischen Patienten Dring M, Cabanillas Stanchi K, Feucht J, Queudeville M, Teltschik H, Lang P, Feuchtinger T, Handgretinger R, Mller I ANN HEMATOL. 201695 (2): 311-23. Ergebnisse der rezidivierenden akuten lymphoblastischen Leukämie, die auf dem Interfant-99-Protokoll behandelt wurden Driessen E, de Lorenzo P, Campbell M, Felice M, Ferster A, Hann I, Vora A, Hovi L, Escherich G, Li C, Mann G, Leblanc T , Locatelli F, Biondi A, Rubnitz J, Schrappe M, Silbermann L, Stary J, Suppiah R, Szczepanski T, Valsecchi M, Pieters R LEUKEMIA. 201630 (5): 1184 & ndash; 1187. Der Wirkstoff RHIZOCHALINININ zeigt eine hohe in vitro - und in vivo-Wirksamkeit bei kastrationsresistenten Prostatakrebs Dyshlovoy S, Otte K, Alsdorf, Hauschild J, Lange T, Venz S, Bauer C, Bhring R, Amann K, Mandanchi R, Schumacher U, Schrder - Schewarz J, Makarieva T, Guzii A, Tabakmakher K, Fedorov S, Shubina L, Kasheverov I, Ehmke H, Steuber T, Stonik V, Bokemeyer C, Honecker F, von Amsberg G ONCOTARGET. 2016 (43): 69703 - 69717. Pubertäre Entwicklung bei pädiatrischen Nierentransplantationspatienten, die Säugetierziel von Rapamycininhibitoren oder konventionelle Immunsuppression erhalten Frster J, Ahlenstiel-Grunow T, Zapf A, Mynarek M, Pape L TRANSPLANTATION. 2016100 (11): 2461 & ndash; 2470. Die epidermalen Wachstumsfaktor-Rezeptor-Überexpression ist häufig und nicht korreliert mit der Genkopienzahl im Ependymom Friedrich C, von Bueren A, Kolevatova L, Bernreuther C, Grob T, Sepulveda-Falla, van den Boom L, Westphal M, Simon R, Glatzel M CHILD NERV SYST. 201632 (2): 281 & ndash; 90. Nachweis von H3-K27M-Mutationen in posterioren Fossa-Ependymomen Gessi M, Capper D, Sahm F, Huang K, von Deimling A, Tippel S, Fleischhack G, Scherbaum D, Alfer J, Juhnke B, von Hoff K, Rutkowski S, Warmuth-Metz M, Chavez L, Pfister S, Pietsch T, Jones D, Sturm D ACTA NEUROPATHOL. 2016132 (4): 635 & ndash; 7. Die Mutation von Häm-Oxygenase-1 in eine Peroxidase bewirkt einen Mangel der Bilirubinsynthese, der mit einer mikrozytären Anämie und einer schweren Hyperinflammation einhergeht. Greil J, Verga-Falzacappa M, Echner N, Behnisch W, Bandapalli O, Pechanska P, Immenschuh S, Vijayan V, Balla J, Tsukahara H, Schneider M, Janka G, Claus M, Longerich T, Muckenthaler M, Kulozik A HAEMATOLOGICA. 2016101 (11): e436-e439. Langzeitergebnisse von allogene hämatopoetische Mit Nontransplanted Kontrollpatienten Gröschel S, Khl J, Bley A, Kehrer C, Weschke B, Dring M, Bhringer J, Schrum J, Santer R, Kohlschtter Ein Vergleich Cell Transplantation bei Patienten mit juveniler Metachromatic Leukodystrophie Stem , Krgeloh-Mann I, Müller I JAMA NEUROL. 201673 (9): 1133 & ndash; 40. Die Prävalenz der Sichelzellkrankheit und ihre Bedeutung für das Neugeborenenscreening in Deutschland (Metropolregion Hamburg). Großen R, Oyen F, Lukacs Z, Paulina N, Muntau B, Timmann C, Ehmen C, Noack B PEDIATR BLUTKREBS. 20162016 (63): 168 & ndash; 170. Die erforderliche Mindestniveau Spenderchimerismus in erbliche hemophagocytic Lymphohistiozytose Hartz B, Marsh R, Rao K, Henter J, Jordan M, Filipovich L, Bader P, Beier R, Burkhardt B, Meisel R, Schulz A, Winkler B, Albert M, In der vorliegenden Arbeit wurde die Frage nach der Bedeutung von KHOLOOD in Bezug auf die klinische und therapeutische Bedeutung von KHOLOOD untersucht. 2016127 (25): 3281 & ndash; 90. Schlecht differenziertes Chordom mit SMARCB1 / INI1-Verlust: eine deutliche molekulare Entität mit dismaler Prognose Hasselblatt M, Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Peetz-Dienhart S, Crede Y, Wefers A, Riemenschneider M, Antonelli M, Giangaspero F, Bernardo M., Giannini C, Ud Din N, Perry A, Keyvani K, van Landeghem F, Sumerauer D, Hauser P, Capper D, Korshunov A, Jones D, Pfister S, , Siebert R, Frhwald M, Kool M ACTA NEUROPATHOL. 2016132 (1): 149 & ndash; 51. Umkehrphasen-Protein-Arrays ermöglichen die Glioblastom-Molekülsubtypierung Hutter G, Sailer M, Azad T, von Bueren A, Nollau P, Frank S, Tostado C, Sarvepalli D, Ghosh A, Ritz M, Boulay J, Mariani L J NEURO-ONCOL. 2016 Epub vor dem Druck. Cribriform neuroepithelial Tumor: Molekulare Charakterisierung eines SMARCB1-defizienten nicht rhabdoid Tumor mit günstigen langfristige Ergebnis Johann P, Hovestadt V, Thomas C, Jeibmann A, He K, Bens S, Oyen F, Hawkins C, Pierson C, Aldape K , Sumerauer D, Hauser P, van Landeghem F, Ryzhova M, Korshunov A, Capper D, Jones D, Pfister S, Schneppenheim R, Siebert R, Paulus W, Frhwald M, Kool M, Hasselblatt M BRAIN PATHOL. 2016 Epub vor dem Druck. Atypische teratoiden / rhabdoiden Tumoren bestehen aus drei Epigenetische Subgruppen mit Distinct Enhancer Landschaften Johann P, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones D, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Grbner S, Brabetz S, Chavez L, Bens S, Grschel S, Kratochwil F, Wittmann A, Sieber L, Gerg C, Wolf S, Beck K, , Bertoni A, Bertoni A, Bertoni A, Bertoni A, Bertoni A, Bertoni A, Bertoni A, Ebinger M, Schalaby T, Grotzer M, Sumerauer D, Zamecnik J, Mora J, Radlwimmer B, Pietsch T, Schller U, Schneppenheim R, Nordcott P, Korbel J, Siebert R, Frhwald M, Lichter P, Eils R, Gajjar A, Hasselblatt M, Pfister S, Kool M KREBSZELL. 201629 (3): 379 & ndash; 93. Schnelle Diagnose einer AT / RT durch den Nachweis einer Heterozygote SMARCB1 Keimbahn Deletion in einem Säugling Kerl K, Oyen F, Giannikopoulou D, Rssig C, Rellensmann G, Sandktter J, Brentrup A, Selzer G, Schneppenheim R, Frhwald M Pediatr BLUTKREBS. 201663 (8): 1451 & ndash; 3. Evolution von Krankheitsaktivität und Biomarkern an und von Rapamycin bei 28 Patienten mit autoimmunem lymphoproliferativem Syndrom Klemann C, Esquivel M, Magerus-Chatinet A, Lorenz M, Fuchs I, Neveux N, Castelle M, Rohr J, Bettoni da Cunha C, Ebinger M , Kobbe R, Kreme B, Kollert F, Gambineri E, Lehmberg K, Seidel M, Siepermann K, Völkert, Schuster V, Goldacker S, Schwarz K, Speckmann C, Picard C, Fischer A, Rieux-Laucat F, Ehl S , Rensing-Ehl A, Neven B HAEMATOLOGICA. 2016 Epub vor dem Druck. Allergische Reaktionen auf Asparaginase: Atypische Allergien ohne Asparaginase-Inaktivierung Kloos R, Pieters R, Escherich G, Van der Sluis I PEDIATR-BLUTKREBS. 201663 (11): 1928-34. Geerbte thrombotische thrombozytopenische Purpura (Upshaw Schulman-Syndrom) als Differentialdiagnose zu neonatale Sepsis mit disseminierte intravaskuläre Koagulation - eine Fallserie Lehmberg K, Hassenpflug W, Klaassen I, Hillebrand G, Oyen F, Budde U, Sänger D, Schneppenheim R Z Geburtsh NEONATOL. 2016 Epub vor dem Druck. Scher-induzierte Entfaltung und enzymatische Spaltung von VWF-Multimeren in voller Länge Lippok S, Radtke M, Obser T, Kleemeier L, Schneppenheim R, Budde U, Netz R, Rdler J BIOPHYS J. 2016110 (3): 545-54. COBL ist ein neuartiger Hotspot für IKZF1-Deletionen in der Kindheit akuter lymphoblastischer Leukämie Lopes B, Meyer C, Barbosa T, Stadt U, Horstmann M, Venn N, Heatley S, Weiß D, Sutton R, Pombo-de-Oliveira M, Marschalek R, Emerenciano M ONCOTARGET. 20167 (33): 53064 & ndash; 53073. Ankündigung cIMPACT-NOW: das Konsortium zu informieren Molekulare und praktische Ansätze zur ZNS-Tumor-Taxonomie Louis D, Aldape K, Brat D, Capper D, Ellison D, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, Wesseling P, Batchelor T, Cairncross J, Pfister S, Rutkowski S, Weller M, Wick W, von Deimling A ACTA NEUROPATHOL. 2016 Epub vor dem Druck. Treosulfan basierte Konditionierung für allogenes HSCT bei Kindern mit chronischer granulomatöser Erkrankung: eine Multizenterfahrung Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins A, Gibson B, Sedlacek P, Krol L, Strahm B, Zaidman I , Kalwak K, Talano J, Woolfrey A, Fraser C, Meyts I, Müller I, Wachowiak J, Bernardo M, Veys P, Sykora K, Gennery A, Slatter M BLOOD. 2016128 (3): 440 & ndash; 8. Die Kraftmessung durch den vaskulären Protein von Willebrand - Faktor wird durch eine starke Intermonomer - Wechselwirkung gesteuert Mller J, Mielke S, Lf A, Obser T, Bier C, Bruetzel L, Pippig D, Vanderlinden W, Lipfert J, Schneppenheim R, Benoit MP NATL ACAD SCI USA. 2016113 (5): 1208 & ndash; 13. Der aktuelle Konsens über das klinische Management des intrakraniellen Ependymoms und seine unterschiedlichen molekularen Varianten Pajtler K, Mack S, Ramaswamy V, Smith C, Witt H, Smith A, Hansford J, von Hoff K, Wright K, Hwang E, Frappaz D, Kanemura Y, Massimino M, Faure-Conter C, Modena P, Tabori U, Warren K, Holland E, Ichimura K, Giangaspero F, Castel D, von Deimling A, Kool M, Dirks P, Grundy R, Vorarbeiter N, Gajjar A, Korshunov A, Finlay J, Gilbertson R, Ellison D, Aldape K, Kaufmann T, Bouffet E, Pfister S, Taylor M ACTA NEUROPATHOL. 2016 Epub vor dem Druck. Intraventrikuläre Etoposid Sicherheit und Toxizitätsprofil bei Kindern und jungen Erwachsenen mit refraktärer oder rezidivierenden bösartigen Hirntumoren Pajtler K, Tippelt S, Siegler N, Reichling S, Zimmermann M, Mikasch R, Bode U, Gnekow A, Pietsch T, Benesch M, Rutkowski S , Fleischhack GJ NEURO-ONCOL. 2016128 (3): 463 & ndash; 71. Intraventrikuläres Methotrexat als Teil der Primärtherapie bei Kindern mit Säuglings - und / oder metastatischem Medulloblastom Pompe R, von Bueren A, Mynarek M, von Hoff K, Rutkowski S EUR J KREBS. 201656: 181-2. Mutante A-Domänen-Wechselwirkungen im Kraftmessprotein von Willebrand-Faktor Posch S, Aponte-Santamara C, Schwarzl R, Karner A, Radtke M, Grier F, Obser T, Knig G, Brehm M, Gruber H, Schneppenheim R, Tamp R, Hinterdorfer PJ STRUCT BIOL. 2016 Epub vor dem Druck. Die Risikobewertung eines Rezidivs durch linienspezifische Überwachung von Chimärismus bei Kindern allogenen Stammzelltransplantation bei akuten lymphoblastischen Leukämie Preuner S, Peters C, Ptschger U, Daxberger H, Fritsch G, Geyeregger R, Schrauder A, von Stackelberg A, Schrappe M unterziehen, Bader, P.-Gr. R., Gngr T, Holter W, Strahm B, G. Bader P, Ebell W, Eckert C, Lang P, Sykora K, Schrum J, Gruhn B, Schulz A, Woessmann W, Löwe T HAEMATOLOGICA. 2016101 (6): 741 & ndash; 6. Risikostratifizierung des kindlichen Medulloblastoms in der molekularen Ära: Der aktuelle Konsens Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford S, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, Pietsch T, Northcott P, Gajjar A, Robinson G, Padovani L, Andr N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister S, Taylor M., Pomeroy S ACTA NEUROPATHOL. 2016131 (6): 821 & ndash; 31. Therapeutischer Einfluss von zytoreduktiver Chirurgie und Bestrahlung von posterioren Fossa Ependymomen in der molekularen Zeit Ramaswamy V, Hielscher T, Mack S, Lassaletta A, Lin T, Pajtler K, Jones D, Luu B, Cavalli F, Aldape K, Remke M, Mynarek M , Rukkowski S, Gururangan S, McLendon R, Lipp E, Dunham C, Hukin J, Eisenstat D, Fulton D, von Landeghem F, Santi M, van Veelen M, Van Meir E, Osuka S, Fan X, Muraszko K, Tirapelli D, Oba-Shinjo S, Marie S, Carlotti C, Lee J, Rao A, Giannini C, Faria C, Nonnen S, Mora J, Hamilton R, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L, Zollo M, Kalli G, Bognr L, Klekner A, Hortobgyi T, Leary S, Ermoian R, Olson J, Leonard J, Gardner C, Grajkowska W, Butler et al., Bd. 2, Bd. 2, Bd. 2, Bd. 2, Bd. 2, Bd. 2, Bd. 2, Bd. 2, Bd .; U, Zitterbart K, Sterba J, Chan J, Guzman M, Elbabaa S, Colman H, Dhall G, Fischer P, Fouladi M, Gajjar A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K, Lieberman F, Mikkelsen T, Omuro A, Pollack I, Prados M, Robins H, Soffietti R, Wu J, Metellus P, Tabori U, Kaufmann T, Gilbert M, Armstrong T, Korshunov A, Ellison D, Taylor MJ CLIN ONCOL. 201634 (21): 2468-77. Frakturheilung ist verzögert im Immundefizienten NOD / scidIL2Rcnull Mäuse Rapp A, Bindl R, Recknagel S, Erbacher A, Mller I, Schrezenmeier H, Ehrnthaller C, Gebhard F, Ignatius A PLOS ONE. 201611 (2): e0147465. 2016 Einstufungskriterien für Makrophagenaktivierung Syndrom komplizieren systemische juvenile idiopathische Arthritis Ravelli A, Minoia F, Dav S, Horne A, Bovis F, Pistorio A, Aric M, Avcin T, Behrens E, De Benedetti F, Filipovic L, Grom A, Henter J, Ilolite N, Jordan M, Khubchandani R, Kitoh T, Lehmberg K, Lovell D, Miettunen P, Nichols K, Ozens S, Pachlopnik Schmid J, , Wouffraat N, Demirkaya E, Brunner H, Martini A, Ruperto N, Cron R ANN RHEUM DIS. 201675 (3): 481 & ndash; 9. Experistischer Konsens über die Dynamik von Labortests zur Diagnose des Makrophagen-Aktivierungssyndroms Komplikation der systemischen juvenilen idiopathischen Arthritis Ravelli A, Minoia F, Dav S, Horne A, Bovis F, Pistorio A, Aric M, Avcin T, Behrens E, De Benedetti F, Filipovic A, Grom A, Henter J, Ilowit N, Jordan M, Khubchandani R, Kitoh T, Lehmberg K, Lovell D, Miettunen P, Nichols K, Ozens S, Pachlopnik Schmid J, , Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner H, Martini A, Ruperto N, Cron R BMJ OPEN. 20162 (1): e000161. Nach dem Rückfall im Standard-Risiko-Medulloblastom Sabel M, Fleischhack G, Tipelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, Warmuth-Metz M, Clifford S, Pietsch T, Pizer B, Lannering BJ NEURO-ONCOL. 2016129 (3): 515 & ndash; 24. Muskel-Skelett-Manifestationen in Mukopolysaccharidose Typ I (Hurler-Syndrom) nach hämatopoetischen Stammzelltransplantation Schmidt M, Breyer S, LBEL U, Yarar S, Stcker R, Ullrich K, Mller I, Muschol N ORPHANET J RARE DIS. 201611 (1): 93. Consensus Definitionen von 14 schweren akuten toxischen Wirkungen für Kindheit lymphoblastischer Leukämie Behandlung Schmiegelow K, Attarbaschi A, Barzilai S, Escherich G, Frandsen T, Halsey C, Hough R, Jeha S, Kato M, Liang D, Mikkelsen T, Mricke A, Niinimki R, Piette C, Putti M, Raetz E, Silbermann L, Skinner R, Tuckuviene R, Van der Sluis I, Zapotocka E LANCET ONCOL. 201617 (6): e231-9. Multifodale Therapie bei Kindern und Jugendlichen mit neu diagnostiziertem atypischem teratoider Rhabdodontum Schrey D, Lechn F, Malietzis G, Moreno L, Dufour C, Chi S, Lafay-Cousin L, von Hoff K, Athanasiou T, Marshall L, Zacharoulis SJ NEURO - ONCOL. 2016126 (1): 81 & ndash; 90. Rapid Capture Next-Generation-Sequenzierung in der klinischen Diagnostik von Kinase-Pathway-Aberrationen im B-Zell-Vorläufer ALL Stadt U, Escherich G, Indenbirken D, Alawi M., Adao M, Horstmann M PEDIATR BLUTKREBS. 201663 (7): 1283 & ndash; 6. Molekulare Analyse von Hybrid-Neurofibroma / Schwannom identifiziert gemeinsame Monosomie 22 und - T-Catenin / CTNNA3 als neuartiger Kandidaten-Tumorsuppressor Stahn V, Nagel I, Fischer-Huchzermeyer S, Oyen F, Schneppenheim R, Gesk S, Bohrung A, Chikobava L, Junge P, Gess B, Werner M, Senner V, Härter A AM J PATHOL. 2016186 (12): 3285-3296. Neue Hirntumorentitäten entstehen aus der molekularen Klassifikation von CNS-PNETs Sturm D, Orr B, Toprak U, Hovestadt V, Jones D, Capper D, Sill M, Buchhalter I, Northcott P, Leis I, Ryzhova M, Koelsche C, Pfaff E , Fuladi M, Giangaspero, Fuladi M, Phillips J, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero, Allen S, Balasubramanian G, Schlechtester B, Pajtler K, Brabetz S, F, astowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Ltsch D, Berger W, Slavc I, Haberler C, Jouvet A, Maehrin C, Scheie D, Mobley B, Schniederjan, Santi M, Buccoliero A, Dahiya S, Kramm C, von Bueren A, von Hoff K, Rutkowski S, Herold-Mende C, Frhwald M, Milde T, Hasselblatt M, Wesseling P, R, D, J, J, J, J, J, J, S, Abb. 1, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig. 2, Fig S, Mikkelsen T, Gajjar A, Aldape K, Moore A, Taylor M, Jones C, Jabado N, Karajannis M, Eils R, Schlesner M, Lichter P, von Deimling, Pfister S, Ellison D, Korshunov A, ZELLE. 2016164 (5): 1060 & ndash; 72. Behandlung von Graftversagen mit TNI-basierter Rekonditionierung und haploidentischen Stammzellen bei pädiatrischen Patienten Teltschik H, Heinzelmann F, Gruhn B, Feuchtinger T, Schlegel P, Schumm M, Kremens B, Müller I, Ebinger M, Schwarze C, Ottinger H, Zips D, Handgretinger R, Lang P BRIT J HAEMATOL. 2016175 (1): 115-22. EZH2-Mutation bei einem Herbsten mit Weaver-Syndrom, die akute myeloische Leukämie und sekundäre hämophagocytische Lymphohistiocytose entwickelt hat Usemann J, Ernst T, Schfer V, Lehmberg K, Seeger K AM J MED GENET A. 2016170 (5): 1274 & ndash; 7. Consensus Empfehlungen von Experten für die Identifizierung und das Management von Asparaginase Überempfindlichkeit und stille Inaktivierung van der Sluis I, Vrooman L, Pieters R, Baruchel A, Escherich G, Goulden N, Mondelaers V, de Toledo J, Rizzari C, Silverman L, Whitlock J Haematologica. 2016101 (3): 279 & ndash; 85. Genomische und Transkriptions-Landschaft von P2RY8-CRLF2-positiven Kindern mit akuter lymphoblastischer Leukämie Vesely C, Frech C, Eckert C, Cario G, Mecklenbruker A, Zur Stadt U, Nebral K, Kraler F, Fischer S, Attarbaschi A, Schuster M, Bock C , Cav H, von Stackelberg A, Schrappe M, Horstmann M, Mann G, Haas O, Panzer-Grmayer R LEUKEMIA. 2016 Epub vor dem Druck. Behandlung von Kindern und Jugendlichen mit metastatischem Medulloblastom und prognostischer Relevanz klinischer und biologischer Parameter von Bueren A, Kortmann R, von Hoff K, Friedrich C, Mynarek M, Mller K, Goschzik T, Zur Mhlen A, Gerber N, Warmuth-Metz M , Soerensen N, Deinlein F, Benesch M, Zwiener I, Kwiecien R, Faldum A, Bode U, Fleischhack G, Hovestadt V, Kool M, Jones D, Nordkott P, Kuehl J, Pfister S, Pietsch T, Rutkowski SJ CLIN ONCOL . 201634 (34): 4151 & ndash; 4160. Einfluss von Cranial Strahlentherapie auf Outcome bei Kindern mit akuter lymphoblastischer Leukämie behandelt mit Moderne Therapie Vora A, Andreano A, Pui C, Hunger S, Schrappe M, Moericke A, Biondi A, Escherich G, Silverman L, Goulden N, Taskinen M, Pieters R, Horibe K, Devidas M, Locatelli F, Valsecchi MJ CLIN ONCOL. 201634 (9): 919-26. Der Verband der anomalen folylpolyglutamate Synthetase Spleißen mit ex vivo Methotrexat Widerstand und dem klinischen Ergebnis in der Kindheit akute lymphatische Leukämie Wojtuszkiewicz A, Assaraf Y, Hoekstra M, Sciarrillo R, Jansen G, Peters G, Pieters R, Sonneveld E, Escherich G, Kaspers G, Cloos J HAEMATOLOGICA. 2016101 (7): e291-4. Kraftempfindlichen Autoinhibition des von Willebrand Faktor, vermittelt durch Inter-Domain-Wechselwirkungen Aponte-Santamara C, Huck V, Posch S, Bronowska A, Grüßle S, Brehm M, Obser T, Schneppenheim R, Hinterdorfer P, Schneider S, Baldauf C, Grter F BIOPHYS J. 2015108 (9): 2312 & ndash; 21. Die Überwachung der minimalen Resterkrankung nach allogener Stammzelltransplantation in rezidivierten Kindheit akute lymphatische Leukämie ermöglicht die Identifizierung von Drohende Relapse: Ergebnisse der ALL-BFM-SCT 2003-Test Bader P, Kreyenberg H, von Stackelberg A, Eckert C, Salzmann - Manrique E, Meisel R., Poetschger U, Stachel D, Schrappe M, Alten J., Schrauder A, Schulz A., Lang P, Mller I, Albert M., Willasch A, Klingebiel T, Peters CJ CLIN ONCOL. Strahlentherapie bei Choreoid-Plexus-Karzinom-Patienten mit Li-Fraumeni-Syndrom: vorteilhaft oder nachteilig Bahar M, Kordes U, Tekautz T, Wolff J ANTIKANER RES. 201535 (5): 3013-3017. Die Protein-Tyrosin-Phosphatasen RPTP Unterdrückt Osteosarkom Entwicklung in Trp53-heterozygote Mäuse Baldauf C, Jeschke A, Kanbach V, Catala-Lehnen P, Baumhoer D, Gerull H, Buhs S, Amling M, NOLLAU P, Harroch S, Schinke T PLoS ONE. 201510 (9): e0137745. Bestimmung des Hypophysens Eisengehalte durch Multi-Echo-MRT-R2 Messungen Berliner C, Brehmer M, Fischer R, Grosse R, Karu M, Keller S, Schnnagel B, Wang J, Adam G, Yamamura J ROFO-FORTSCHR RONTG. 2015187 (S01): WISS1051. Das Syndrom der hemophagocytic Lymphohistiozytose in primären Immunschwächen: Implikationen für die Differentialdiagnose und Pathogenese Bode S, Ammann S, Al-Herz W, Bataneant M, Dvorak C, Gehring S, Gennery A, Gilmour K, Gonzalez-Granado L, Gro-Wieltsch U , Ifversen M, Lingman-Framme J, Matthes-Martin S, Mesters R, Meyts I, van Montfrans J, Pachlopnik Schmid J, Pai S, Soler-Palacin P, Schuermann U, Schuster V, Seidel M, Speckmann C, Stepensky P , Sykora K, Tesi B, Vraetz T, Waruiru C, Bryceson Y, Moshous D, Lehmberg K, Jordanien M, Ehl S HAEMATOLOGICA. 2015100 (7): 978 & ndash; 88. Plättchenabhängig von Willebrand Faktoraktivität. Nomenclature and methodology: communication from the SSC of the ISTH Bod I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J J THROMB HAEMOST. 201513(7):1345-1350. BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures Boer J, Marchante J, Evans W, Horstmann M, Escherich G, Pieters R, Den Boer M HAEMATOLOGICA. 2015100(9):e354-7. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy Cmara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann R, Lannering B, Dellatolas G, Chevignard M INT J RADIAT ONCOL. 201592(5):978-85. Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia Chao M, Ebell W, Bader P, Beier R, Burkhardt B, Feuchtinger T, Handgretinger R, Hanenberg H, Koehl U, Kratz C, Kremens B, Lang P, Meisel R, Mller I, Roessig C, Sauer M, Schlegel P, Schulz A, Strahm B, Thol F, Sykora K KLIN PADIATR. 2015227(3):157-65. Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial Clifford S, Lannering B, Schwalbe E, Hicks D, OToole K, Nicholson S, Goschzik T, Zur Mhlen A, Figarella-Branger D, Doz F, Rutkowski S, Gustafsson G, Pietsch T ONCOTARGET. 20156(36):38827-39. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression Dadras S, Lin R, Razavi G, Kawakami A, Du J, Feige E, Milner D, Loda M, Granter S, Detmar M, Widlund H, Horstmann M, Fisher D AM J PATHOL. 2015185(1):252-65. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia Dring M, Eikemeier M, Cabanillas Stanchi K, Hartmann U, Ebinger M, Schwarze C, Schulz A, Handgretinger R, Mller I EUR J CLIN MICROBIOL. 201534(6):1189-1200. Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation Dring M, Cabanillas Stanchi K, Mezger M, Erbacher A, Feucht J, Pfeiffer M, Lang P, Handgretinger R, Mller I BMC CANCER. 201515:Art. 607. Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: Prognostic relevance of early and late assessment Eckert C, Hagedorn N, Sramkova L, Mann G, Panzer-Grmayer R, Peters C, Bourquin J, Klingebiel T, Borkhardt A, Cario G, Alten J, Escherich G, Astrahantseff K, Seeger K, Henze G, von Stackelberg A LEUKEMIA. 201529(8):1648-1655. Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia Esmaeilzadeh H, Bemanian M, Nabavi M, Arshi S, Fallahpour M, Fuchs I, Zur Stadt U, Warnatz K, Ammann S, Ehl S, Lehmberg K, Rezaei N J CLIN IMMUNOL. 201535(1):22-25. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT Trials: clinical findings of a rare disease Friedrich C, Warmuth-Metz M, von Bueren A, Nowak J, Bison B, von Hoff K, Pietsch T, Kortmann R, Rutkowski S J NEUROSURG-PEDIATR. 201515(3):227-35. Molecular stratification of medulloblastoma: Comparison of histological and genetic methods to detect Wnt activated tumors Goschzik T, Zur Mhlen A, Kristiansen G, Haberler C, Stefanits H, Friedrich C, von Hoff K, Rutkowski S, Pfister S, Pietsch T NEUROPATH APPL NEURO. 201541(2):135-144. Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2) Henkes M, Finke J, Warnatz K, Ammann S, Stadt U, Janka-Schaub G, Brugger W ANN HEMATOL. 201594(6):1057-60. High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors Japp A, Gessi M, Messing-Jnger M, Denkhaus D, Zur Mhlen A, Wolff J, Hartung S, Kordes U, Klein-Hitpass L, Pietsch T J NEUROPATH EXP NEUR. 201574(2):110-20. Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors Johann P, Mller I Stem Cells Int. 20152015:914632. Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposis sarcoma-associated herpesvirus Kati S, Hage E, Mynarek M, Ganzenmueller T, Indenbirken D, Grundhoff A, Schulz T J VIROL METHODS. 2015217:79-86. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor Kerl K, Oyen F, Leuschner I, Schneppenheim R, Nagel I, Siebert R, Groll A, Hartmann W, Barth P, Bartelheim K, Seringer A, Wardelmann E, Frhwald M PEDIATR BLOOD CANCER. 201562(5):897-900. Risk of Rotavirus Vaccination for Children with SCID Klinkenberg D, Blohm M, Hoehne M, Mas Marques A, Malecki M, Schildgen V, Schneppenheim R, Mller I, Schildgen O, Kobbe R PEDIATR INFECT DIS J. 201534(1):114-5. Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients Kruchen A, Stahl T, Gieseke F, Binder T, zcan Z, Meisel R, Kreyenberg H, Bader P, Gruhn B, Greil J, Pfeiffer M, Dring M, Handgretinger R, Fehse B, Mller I BONE MARROW TRANSPL. 201550(10):1367-1370. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents Lehmberg K, Sprekels B, Nichols K, Woessmann W, Mller I, Suttorp M, Bernig T, Beutel K, Bode S, Kentouche K, Kolb R, Lngler A, Minkov M, Schilling F, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka G BRIT J HAEMATOL. 2015170(4):539-49. Out of the haemophagocytic lymphohistiocytosis niche Lehmberg K LANCET HAEMATOL. 20152(12):e508-9. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies Lehmberg K, Nichols K, Henter J, Girschikofsky M, Greenwood T, Jordan M, Kumar A, Minkov M, La Rose P, Weitzman S HAEMATOLOGICA. 2015100(8):997-1004. Clinical and Molecular Characterization of Patients with Heterozygous Mutations in Wilms Tumor Suppressor Gene 1 Lehnhardt A, Karnatz N, Ahlenstiel-Grunow T, Benz K, Benz M, Budde K, Bscher A, Fehr T, Feldktter M, Graf N, Hcker B, Jungraithmayr T, Klaus G, Koehler B, Konrad M, Kranz B, Montoya C, Mller D, Neuhaus T, Oh J, Pape L, Pohl M, Royer-Pokora B, Querfeld U, Schneppenheim R, Staude H, Spart G, Timmermann K, Wilkening F, Wygoda S, Bergmann C, Kemper M CLIN J AM SOC NEPHRO. 201510(5):825-831. Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemia Lbel U, Trah J, Escherich G PEDIATR BLOOD CANCER. 201562(3):539-41. KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia Malinowska-Ozdowy K, Frech C, Schnegger A, Eckert C, Cazzaniga G, Stanulla M, Zur Stadt U, Mecklenbruker A, Schuster M, Kneidinger D, von Stackelberg A, Locatelli F, Schrappe M, Horstmann M, Attarbaschi A, Bock C, Mann G, Haas O, Panzer-Grmayer R LEUKEMIA. 201529(8):1656-1667. Delayed Diagnosis of Platelet-type von Willebrand Disease in a 72-year-old Lady Maurer M, Mesters R, Schneppenheim R, Streif W KLIN PADIATR. 2015227(3):171-172. Platelet-type von Willebrand Disease: Diagnostic Challenges. Flaws and Pitfalls Experienced in the THROMKID Quality Project Maurer M, Mesters R, Schneppenheim R, Knoefler R, Streif W KLIN PADIATR. 2015227(3):131-6. Klinische Praxis - Spenderfindung und Stammzelltransplantation Mller I 2015. Rettende Geschwister. Sches C, Rehmann-Sutter C (eds.). 2015. ed. Mnster: Mentis, 25 - 32. Histological subtype of medulloblastoma frequently changes upon recurrence Neumann nee Pschl J, Koch A, Schller U ACTA NEUROPATHOL. 2015129(3):459-61. Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified Nowak J, Seidel C, Pietsch T, Alkonyi B, Fuss T, Friedrich C, von Hoff K, Rutkowski S, Warmuth-Metz M NEURO-ONCOLOGY. 201517(8):1157-65. Neuropsychological short assessment of disease - and treatment-related intelligence deficits in children with brain tumours Ottensmeier H, Zimolong B, Wolff J, Ehrich J, Galley N, von Hoff K, Kuehl J, Rutkowski S EUR J PAEDIATR NEURO. 201519(3):298-307. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups Pajtler K, Witt H, Sill M, Jones D, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz H, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman L, Donson A, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong T, Gupta N, Allen J, Karajannis M, Zagzag D, Hasselblatt M, Kulozik A, Witt O, Collins V, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo M, von Deimling A, Lichter P, Taylor M, Gilbertson R, Ellison D, Aldape K, Korshunov A, Kool M, Pfister S CANCER CELL. 201527(5):728-43. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial Peters C, Schrappe M, von Stackelberg A, Schrauder A, Bader P, Ebell W, Lang P, Sykora K, Schrum J, Kremens B, Ehlert K, Albert M, Meisel R, Matthes-Martin S, Gungor T, Holter W, Strahm B, Gruhn B, Schulz A, Woessmann W, Poetschger U, Zimmermann M, Klingebiel T J CLIN ONCOL. 201533(11):1265-74. Pancreatic iron and fat assessment by MRI-R2 in patients with iron overload diseases Pfeifer C, Schoennagel B, Grosse R, Wang Z, Graessner J, Nielsen P, Adam G, Fischer R, Yamamura J J MAGN RESON IMAGING. 2015. Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy Pompe R, von Bueren A, Mynarek M, von Hoff K, Friedrich C, Kwiecien R, Treulieb W, Lindow C, Deinlein F, Fleischhack G, Kuehl J, Rutkowski S EUR J CANCER. 201551(17):2634-2642. A 59-Year-Old Man with Two Cerebellar Lesions and Disturbed Cerebellar Morphology Pschl J, Berger F, Kretzschmar H, Schller U BRAIN PATHOL. 201525(6):790-1. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration Pui C, Yang J, Hunger S, Pieters R, Schrappe M, Biondi A, Vora A, Baruchel A, Silverman L, Schmiegelow K, Escherich G, Horibe K, Benoit Y, Izraeli S, Yeoh A, Liang D, Downing J, Evans W, Relling M, Mullighan C J CLIN ONCOL. 201533(27):2938-48. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue Rachinger W, Stoecklein V, Terpolilli N, Haug A, Ertl L, Neumann nee Pschl J, Schller U, Schichor C, Thon N, Tonn J J NUCL MED. 201556(3):347-53. Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation Rapp A, Bindl R, Heilmann A, Erbacher A, Mller I, Brenner R, Ignatius A EUR CELLS MATER. 201529:22-34. A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine - Assessing the immunogenicity and safety in an open label, uncontrolled study Roggelin L, Vinnemeier C, Meyer S, Witte K, Marx L, Thee W, Burchard G, Rolling T, Cramer J HUM VACC IMMUNOTHER. 201511(10):2370-5. Psychische Belastungen von Kindern und Jugendlichen nach einer Leukmie oder Lymphomerkrankung Sautier L, Sarkar S, Petersen M, Mehnert A, Escherich G PRAX KINDERPSYCHOL K. 201564(4):273-289. Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease Stockley J, Nisar S, Leo V, Sabi E, Cunningham M, Eikenboom J, Lethagen S, Schneppenheim R, Goodeve A, Watson S, Mundell S, Daly M PLOS ONE. 201510(12):e0143913. Strategies to improve the quality of survival for childhood brain tumour survivors Tallen G, Resch A, Calaminus G, Wiener A, Leiss U, Pletschko T, Friedrich C, Langer T, Grabow D, Driever P, Kortmann R, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Thomale U, Krauss J, Mynarek M, von Hoff K, Ottensmeier H, Frhwald M, Kramm C, Temming P, Mller H, Witt O, Kordes U, Fleischhack G, Gnekow A, Rutkowski S EUR J PAEDIATR NEURO. 201519(6):619-39. Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older children Thomas C, Ruland V, Kordes U, Hartung S, Capper D, Pietsch T, Ger J, Wolff J, Paulus W, Hasselblatt M ACTA NEUROPATHOL. 2015129(6):925-7. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis Torchia J, Picard D, Lafay-Cousin L, Hawkins C, Kim S, Letourneau L, Ra Y, Ho K, Chan T, Sin-Chan P, Dunham C, Yip S, Ng H, Lu J, Albrecht S, Pimentel J, Chan J, Somers G, Zielenska M, Faria C, Roque L, Baskin B, Birks D, Foreman N, Strother D, Klekner A, Garami M, Hauser P, Hortobgyi T, Bognr L, Wilson B, Hukin J, Carret A, Van Meter T, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat D, Scheineman K, Johnston D, Michaud J, Zelcer S, Hammond R, Ramsay D, Fleming A, Lulla R, Fangusaro J, Sirachainan N, Larbcharoensub N, Hongeng S, Barakzai M, Montpetit A, Stephens D, Grundy R, Schller U, Nicolaides T, Tihan T, Phillips J, Taylor M, Rutka J, Dirks P, Bader G, Warmuth-Metz M, Rutkowski S, Pietsch T, Judkins A, Jabado N, Bouffet E, Huang A LANCET ONCOL. 201516(5):569-82. Incidence, Trends, and Survival of Children With Embryonal Tumors Tulla M, Berthold F, Graf N, Rutkowski S, von Schweinitz D, Spix C, Kaatsch P PEDIATRICS. 2015136(3):e623-32. Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol von Bueren A, Friedrich C, von Hoff K, Kwiecien R, Mller K, Pietsch T, Warmuth-Metz M, Hau P, Benesch M, Kuehl J, Kortmann R, Rutkowski S EUR J CANCER. 201551(16):2434-43. Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia Wojtuszkiewicz A, Peters G, van Woerden N, Dubbelman B, Escherich G, Schmiegelow K, Sonneveld E, Pieters R, van de Ven P, Jansen G, Assaraf Y, Kaspers G, Cloos J HEMATOL ONCOL. 20158:61. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications Wuchter P, Bieback K, Schrezenmeier H, Bornhuser M, Mller L, Bnig H, Wagner W, Meisel R, Pavel P, Tonn T, Lang P, Mller I, Renner M, Malcherek G, Saffrich R, Buss E, Horn P, Rojewski M, Schmitt A, Ho A, Sanzenbacher R, Schmitt M CYTOTHERAPY. 201517(2):128-139. Germline de novo mutations and linkage markers vs. DNA sequencing for carrier detection in von Willebrand disease Ahmad F, Oyen F, Jan R, Budde U, Schneppenheim R, Saxena R HAEMOPHILIA. 201420(4):e311-e317. EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion Aris I, Jerchel I, van den Dungen R, van den Berk L, Boer J, Horstmann M, Escherich G, Pieters R, den Boer M LEUKEMIA. 201428(9):1828-1837. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB) Bartelheim K, Sumerauer D, Behrends U, Kodetova D, Kucera F, Leuschner I, Neumayer P, Oyen F, Rbe C, Siebert R, Schneppenheim R, Seeringer A, Vasovcak P, Frhwald M CANCER GENET-NY. 2014207(9):379-83. High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB) Benesch M, Bartelheim K, Fleischhack G, Gruhn B, Schlegel P, Witt O, Stachel K, Hauch H, Urban C, Quehenberger F, Massimino M, Pietsch T, Hasselblatt M, Giangaspero F, Kordes U, Schneppenheim R, Hauser P, Klingebiel T, Frhwald M BONE MARROW TRANSPL. 201449(3):370-5. Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area Bode S, Bogdan C, Beutel K, Behnisch W, Greiner J, Henning S, Jorch N, Jankofsky M, Jakob M, Schmid I, Veelken N, Vraetz T, Janka G, Ehl S, Lehmberg K J PEDIATR-US. 2014165(1):147-153.e1. Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell Support: results of the HITREZ 97 multicentre trial Bode U, Zimmermann M, Moser O, Rutkowski S, Warmuth-Metz M, Pietsch T, Kortmann R, Faldum A, Fleischhack G J NEURO-ONCOL. 2014120(3):635-42. von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor Brehm M, Huck V, Aponte-Santamara C, Obser T, Grssle S, Oyen F, Budde U, Schneppenheim S, Baldauf C, Grter F, Schneider S, Schneppenheim R THROMB HAEMOSTASIS. 2014112(1):96-108. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura Budde U, Schneppenheim R HAMOSTASEOLOGIE. 201434(3):215-25. Acute lymphoblastic leukemia in children with Down Syndrome: a retrospective analysis from the Ponte di Legno study group Buitenkamp T, Izraeli S, Zimmermann M, Forestier E, Heerema N, van den Heuvel-Eibrink M, Pieters R, Korbijn C, Silverman L, Schmiegelow K, Liang D, Horibe K, Arico M, Biondi A, Basso G, Rabin K, Schrappe M, Cario G, Mann G, Morak M, Panzer-Grmayer R, Mondelaers V, Lammens T, Cav H, Stark B, Ganmore I, Moorman A, Vora A, Hunger S, Pui C, Mullighan C, Manabe A, Escherich G, Kowalczyk J, Whitlock J, Zwaan C BLOOD. 2014123(1):70-77. Acquired hemophilia A and von Willebrand syndrome in a patient with late-onset systemic lupus erythematosus Dicke C, Holstein K, Schneppenheim S, Dittmer R, Schneppenheim R, Bokemeyer C, Iking-Konert C, Budde U, Langer F Exp Hematol Oncol. 20143:21. Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol Friedrich C, Mller K, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Gerber N, Hau P, Kuehl J, Kortmann R, von Bueren A, Rutkowski S J NEURO-ONCOL. 2014116(3):567-575. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia Frietsch J, Kastner C, Grunewald T, Schweigel H, Nollau P, Ziermann J, Clement J, La Rose P, Hochhaus A, Butt E ONCOTARGET. 20145(14):5257-71. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway Gallo Llorente L, Luther H, Schneppenheim R, Zimmermann M, Felice M, Horstmann M PEDIATR BLOOD CANCER. 201461(5):788-96. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy Gerber N, von Hoff K, Resch A, Ottensmeier H, Kwiecien R, Faldum A, Matuschek C, Hornung D, Bremer M, Benesch M, Pietsch T, Warmuth-Metz M, Kuehl J, Rutkowski S, Kortmann R INT J RADIAT ONCOL. 201489(4):863-71. Recent developments and current concepts in medulloblastoma Gerber N, Mynarek M, von Hoff K, Friedrich C, Resch A, Rutkowski S CANCER TREAT REV. 201440(3):356-365. MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system Gessi M, von Bueren A, Treszl A, Mhlen A, Hartmann W, Warmuth-Metz M, Rutkowski S, Pietsch T NEURO-ONCOLOGY. 201416(7):924-932. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group Gottardo N, Hansford J, McGlade J, Alvaro F, Ashley D, Bailey S, Baker D, Bourdeaut F, Cho Y, Clay M, Clifford S, Cohn R, Cole C, Dallas P, Downie P, Doz F, Ellison D, Endersby R, Fisher P, Hassall T, Heath J, Hii H, Jones D, Junckerstorff R, Kellie S, Kool M, Kotecha R, Lichter P, Laughton S, Lee S, McCowage G, Northcott P, Olson J, Packer R, Pfister S, Pietsch T, Pizer B, Pomeroy S, Remke M, Robinson G, Rutkowski S, Schoep T, Shelat A, Stewart C, Sullivan M, Taylor M, Wainwright B, Walwyn T, Weiss W, Williamson D, Gajjar A ACTA NEUROPATHOL. 2014127(2):189-201. von Willebrand Factor Directly Interacts With DNA From Neutrophil Extracellular Traps Grssle S, Huck V, Pappelbaum K, Gorzelanny C, Aponte-Santamara C, Baldauf C, Grter F, Schneppenheim R, Obser T, Schneider S ARTERIOSCL THROM VAS. 201434(7):1382-1389. SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis Hasselblatt M, Nagel I, Oyen F, Bartelheim K, Russell R, Schller U, Junckerstorff R, Rosenblum M, Alassiri A, Rossi S, Schmid I, Gottardo N, Toledano H, Viscardi E, Balbin M, Witkowski L, Lu Q, Betts M, Foulkes W, Siebert R, Frhwald M, Schneppenheim R ACTA NEUROPATHOL. 2014128(3):453-6. Inherited thrombotic thrombocytopenic purpura in children Hassenpflug W, Budde U, Schneppenheim S, Schneppenheim R SEMIN THROMB HEMOST. 201440(4):487-92. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor Holstein K, Schneppenheim R, Schrum J, Bokemeyer C, Langer F HAMOSTASEOLOGIE. 201434 (4A):5-8. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing Hovestadt V, Jones D, Picelli S, Wang W, Kool M, Northcott P, Sultan M, Stachurski K, Ryzhova M, Warnatz H, Ralser M, Brun S, Bunt J, Jger N, Kleinheinz K, Erkek S, Weber U, Bartholomae C, von Kalle C, Lawerenz C, Eils J, Koster J, Versteeg R, Milde T, Witt O, Schmidt S, Wolf S, Pietsch T, Rutkowski S, Scheurlen W, Taylor M, Brors B, Felsberg J, Reifenberger G, Borkhardt A, Lehrach H, Wechsler-Reya R, Eils R, Yaspo M, Landgraf P, Korshunov A, Zapatka M, Radlwimmer B, Pfister S, Lichter P NATURE. 2014510(7506):537-541. Hemophagocytic syndromes - An update Janka-Schaub G, Lehmberg K BLOOD REV. 201428(4):135-142. Hemophagocytic lymphohistiocytosis: A serious challenge for every physician Janka-Schaub G VET CLIN PATH. 2014214(6):318-9. Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma Kennedy C, Bull K, Chevignard M, Culliford D, Drr H, Doz F, Kortmann R, Lannering B, Massimino M, Navajas Gutirrez A, Rutkowski S, Spoudeas H, Calaminus G INT J RADIAT ONCOL. 201488(2):292-300. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS) Kordes U, Bartelheim K, Modena P, Massimino M, Biassoni V, Reinhard H, Hasselblatt M, Schneppenheim R, Frhwald M PEDIATR BLOOD CANCER. 201461(5):919-21. The PML domain of PML-RAR blocks senescence to promote leukemia Korf K, Wodrich H, Haschke A, Ocampo C, Harder L, Gieseke F, Pollmann A, Dierck K, Prall S, Staege H, Ma H, Horstmann M, Evans R, Sternsdorf T P NATL ACAD SCI USA. 2014111(33):12133-8. Platelet-free shear flow assay facilitates analysis of shear-dependent functions of VWF and ADAMTS13 Kraus E, Kraus K, Obser T, Oyen F, Klemm U, Schneppenheim R, Brehm M THROMB RES. 2014134(6):1285-1291. Efficacious inhibition of Importin /-mediated nuclear import of human inositol phosphate multikinase Kublun I, Ehm P, Brehm M, Nalaskowski M BIOCHIMIE. 2014102:117-23. Characterisation of the p. A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective - granule secretion Langer F, Obser T, Oyen F, Spath B, Holstein K, Greinacher A, White J, Budde U, Bokemeyer C, Schneppenheim R THROMB HAEMOSTASIS. 2014111(4):777-779. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis Lehmberg K, McClain K, Janka-Schaub G, Allen C PEDIATR BLOOD CANCER. 2014. Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis Lehmberg K, Albert M, Beier R, Beutel K, Gruhn B, Krger N, Meisel R, Schulz A, Stachel D, Woessmann W, Janka G, Mller I HAEMATOLOGICA. 201499(1):180-4. Brain iron quantification by MRI in mitochondrial membrane protein-associated neurodegeneration under iron-chelating therapy Lbel U, Schweser F, Nickel M, Deistung A, Grosse R, Hagel C, Fiehler J, Schulz A, Hartig M, Reichenbach J, Kohlschtter A, Sedlacik J Ann Clin Transl Neurol. 20141(12):1041-6. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events Mendes R, Sarmento L, Cant-Barrett K, Zuurbier L, Buijs-Gladdines J, Pvoa V, Smits W, Abecasis M, Yunes J, Sonneveld E, Horstmann M, Pieters R, Barata J, Meijerink J BLOOD. 2014124(4):567-78. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic Arthritis: a multinational, multicenter study of 362 patients Minoia F, Dav S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao Y, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron R, Ravelli A ARTHRITIS RHEUM-US. 201466(11):3160-9. Loss of Smarc proteins impairs cerebellar development Moreno N, Schmidt C, Ahlfeld J, Neumann nee Pschl J, Dittmar S, Pfister S, Kool M, Kerl K, Schller U J NEUROSCI. 201434(40):13486-91. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 amp 2005 studies Mller K, Mynarek M, Zwiener I, Siegler N, Zimmermann M, Christiansen H, Budach W, Henke G, Warmuth-Metz M, Pietsch T, von Hoff K, von Bueren A, Bode U, Rutkowski S, Kortmann R, Fleischhack G, Tippelt S INT J RADIAT ONCOL. 201488(5):1019-1024. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts Neumann nee Pschl J, Stark S, Neumann P, Grbner S, Kawauchi D, Jones D, Northcott P, Lichter P, Pfister S, Kool M, Schller U ACTA NEUROPATHOL. 2014128(1):123-36. Wnt/-catenin signaling inhibits the Shh pathway and impairs tumor growth in Shh-dependent medulloblastoma Neumann nee Pschl J, Bartels M, Ohli J, Bianchi E, Kuteykin-Teplyakov K, Grammel D, Ahlfeld J, Schller U ACTA NEUROPATHOL. 2014127(4):605-7. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma Northcott P, Lee C, Zichner T, Sttz A, Erkek S, Kawauchi D, Shih D, Hovestadt V, Zapatka M, Sturm D, Jones D, Kool M, Remke M, Cavalli F, Zuyderduyn S, Bader G, VandenBerg S, Esparza L, Ryzhova M, Wang W, Wittmann A, Stark S, Sieber L, Seker-Cin H, Linke L, Kratochwil F, Jger N, Buchhalter I, Imbusch C, Zipprich G, Raeder B, Schmidt S, Diessl N, Wolf S, Wiemann S, Brors B, Lawerenz C, Eils J, Warnatz H, Risch T, Yaspo M, Weber U, Bartholomae C, von Kalle C, Turnyi E, Hauser P, Sanden E, Darabi A, Siesj P, Sterba J, Zitterbart K, Sumerauer D, van Sluis P, Versteeg R, Volckmann R, Koster J, Schuhmann M, Ebinger M, Grimes H, Robinson G, Gajjar A, Mynarek M, von Hoff K, Rutkowski S, Pietsch T, Scheurlen W, Felsberg J, Reifenberger G, Kulozik A, von Deimling A, Witt O, Eils R, Gilbertson R, Korshunov A, Taylor M, Lichter P, Korbel J, Wechsler-Reya R, Pfister S NATURE. 2014511(7510):428-434. MRI Characteristics of Ependymoblastoma: Results from 22 Centrally Reviewed Cases Nowak J, Seidel C, Berg F, Pietsch T, Friedrich C, von Hoff K, Rutkowski S, Warmuth-Metz M AM J NEURORADIOL. 201435(10):1996-2001. Ependymoblastoma of the brainstem: MRI findings and differential diagnosis Nowak J, Seidel C, Pietsch T, Friedrich C, von Hoff K, Rutkowski S, Warmuth-Metz M PEDIATR BLOOD CANCER. 201461(6):1132-1134. Hypertrophic olivary degeneration with gadolinium enhancement after posterior fossa surgery in a child with medulloblastoma Nowak J, Alkonyi B, Rutkowski S, Homola G, Warmuth-Metz M CHILD NERV SYST. 201430(5):959-62. Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin Patzke J, Budde U, Huber A, Mndez A, Muth H, Obser T, Peerschke E, Wilkens M, Schneppenheim R BLOOD COAGUL FIBRIN. 201425(8):860-870. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort Pietsch T, Schmidt R, Remke M, Korshunov A, Hovestadt V, Jones D, Felsberg J, Kaulich K, Goschzik T, Kool M, Northcott P, von Hoff K, von Bueren A, Friedrich C, Mynarek M, Skladny H, Fleischhack G, Taylor M, Cremer F, Lichter P, Faldum A, Reifenberger G, Rutkowski S, Pfister S ACTA NEUROPATHOL. 2014128(1):137-149. Methylation of the hTERT promoter is frequent in choroid plexus tumors but not of independent prognostic value Ruland V, Hartung S, Kordes U, Wolff J, Paulus W, Hasselblatt M J NEURO-ONCOL. 2014119(1):215-6. Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis Ruland V, Hartung S, Kordes U, Wolff J, Paulus W, Hasselblatt M GENE CHROMOSOME CANC. 201453(5):373-80. Neuroonkologie Rutkowski S, Hornung D, Kordes U, Kammler G, Hagel C, Lbel U, Ebinger M, Rssler J, Resch A, Linhart D 2014. Neuropdiatrie - Evidenzbasierte Therapie. Korinthenberg R, Panteliadis C, Hagel C (eds.). 2. ed. Mnchen: Elsevier. Postmortem 31P magnetic resonance spectroscopy of the skeletal muscle: - ATP/Pi ratio as a forensic tool Schmidt T, Wang Z, Keller S, Heinemann A, Acar S, Graessner J, Schoennagel B, Adam G, Fischer R, Yamamura J FORENSIC SCI INT. 2014242:172-6. Signal-peptide-peptidase-like 2a is required for CD74 intramembrane proteolysis in human B cells Schneppenheim J, Httl S, Kruchen A, Fluhrer R, Mller I, Saftig P, Schneppenheim R, Martin C, Schrder B BIOCHEM BIOPH RES CO. 2014451(1):48-53. Fetal blood flow velocimetry by phase-contrast MRI using a new triggering method and comparison with Doppler ultrasound in a sheep model: a pilot study Schoennagel B, Remus C, Yamamura J, Kording F, de Sousa M, Hecher K, Fischer R, Ueberle F, Boehme M, Adam G, Kooijman H, Wedegrtner U MAGN RESON MATER PHY. 201427(3):237-44. Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registry Seeringer A, Bartelheim K, Kerl K, Hasselblatt M, Leuschner I, Rutkowski S, Timmermann B, Kortmann R, Koscielniak E, Schneppenheim R, Warmuth-Metz M, Ger J, Siebert R, Graf N, Boos J, Frhwald M KLIN PADIATR. 2014226(3):143-148. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor Seeringer A, Reinhard H, Hasselblatt M, Schneppenheim R, Siebert R, Bartelheim K, Leuschner I, Frhwald M CANCER GENET-NY. 2014207(9):429-33. Cytogenetic prognostication within medulloblastoma subgroups Shih D, Northcott P, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc A, Garzia L, Peacock J, Mack S, Wu X, Rolider A, Morrissy A, Cavalli F, Jones D, Zitterbart K, Faria C, Schller U, Kren L, Kumabe T, Tominaga T, Shin Ra Y, Garami M, Hauser P, Chan J, Robinson S, Bognr L, Klekner A, Saad A, Liau L, Albrecht S, Fontebasso A, Cinalli G, De Antonellis P, Zollo M, Cooper M, Thompson R, Bailey S, Lindsey J, Di Rocco C, Massimi L, Michiels E, Scherer S, Phillips J, Gupta N, Fan X, Muraszko K, Vibhakar R, Eberhart C, Fouladi M, Lach B, Jung S, Wechsler-Reya R, Fvre-Montange M, Jouvet A, Jabado N, Pollack I, Weiss W, Lee J, Cho B, Kim S, Wang K, Leonard J, Rubin J, de Torres C, Lavarino C, Mora J, Cho Y, Tabori U, Olson J, Gajjar A, Packer R, Rutkowski S, Pomeroy S, French P, Kloosterhof N, Kros J, Van Meir E, Clifford S, Bourdeaut F, Delattre O, Doz F, Hawkins C, Malkin D, Grajkowska W, Perek-Polnik M, Bouffet E, Rutka J, Pfister S, Taylor M J CLIN ONCOL. 201432(9):886-896. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis Stockschlaeder M, Schneppenheim R, Budde U BLOOD COAGUL FIBRIN. 201425(3):206-16. Therapie hereditrer Thrombozytopathien. Interdisziplinre S2K-Leitlinie der Stndigen Kommission Pdiatrie der Gesellschaft fr Thrombose - und Hmostaseforschung e. V Streif W, Knfler R, Eberl W, Andres O, Bakchoul T, Bergmann F, Beutel K, Dittmer R, Gehrisch S, Gottstein S, Halimeh S, Haselbck J, Hassenpflug W, Heine S, Holzhauer S, King S, Kirchmaier C, Krause M, Kreuz W, Lsche W, Mahnel R, Maurer M, Nimtz-Talaska A, Olivieri M, Rott H, Schambeck C, Schedel A, Schilling F, Schmugge M, Schneppenheim R, Scholz U, Scholz T, Schulze H, Siegemund A, Strau G, Sykora K, Wermes C, Wiegering V, Wieland I, Zieger B, Zotz R HAMOSTASEOLOGIE. 201434(4):269-75. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation Troeger A, Glouchkova L, Ackermann B, Escherich G, Hanenberg H, Janka G, Roettgers S, Gbel U, Dilloo D KLIN PADIATR. 2014226(6-7):332-337. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia van der Veer A, van der Velden V, Willemse M, Hoogeveen P, Petricoin E, Beverloo H, Escherich G, Horstmann M, Pieters R, den Boer M BLOOD CANCER J. 20144:e181. Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells Vu-Han T, Frhwald M, Hasselblatt M, Kerl K, Nagel I, Obser T, Oyen F, Siebert R, Schneppenheim R CANCER GENET-NY. 2014207(9):390-397. Subgroup-specific localization of human medulloblastoma based on pre-operative MRI Wefers A, Warmuth-Metz M, Pschl J, von Bueren A, Monoranu C, Seelos K, Peraud A, Tonn J, Koch A, Pietsch T, Herold-Mende C, Mawrin C, Schouten-van Meeteren A, van Vuurden D, von Hoff K, Rutkowski S, Pfister S, Kool M, Schller U ACTA NEUROPATHOL. 2014127(6):931-3. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma Zhukova N, Ramaswamy V, Remke M, Martin D, Castelo-Branco P, Zhang C, Fraser M, Tse K, Poon R, Shih D, Baskin B, Ray P, Bouffet E, Dirks P, von Bueren A, Pfaff E, Korshunov A, Jones D, Northcott P, Kool M, Pugh T, Pomeroy S, Cho Y, Pietsch T, Gessi M, Rutkowski S, Bognr L, Cho B, Eberhart C, Conter C, Fouladi M, French P, Grajkowska W, Gupta N, Hauser P, Jabado N, Vasiljevic A, Jung S, Kim S, Klekner A, Kumabe T, Lach B, Leonard J, Liau L, Massimi L, Pollack I, Ra Y, Rubin J, Van Meir E, Wang K, Weiss W, Zitterbart K, Bristow R, Alman B, Hawkins C, Malkin D, Clifford S, Pfister S, Taylor M, Tabori U Acta Neuropathol Comm. 20142:174. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors Zuurbier L, Gutierrez A, Mullighan C, Cant-Barrett K, Gevaert A, de Rooi J, Li Y, Smits W, Buijs-Gladdines J, Sonneveld E, Look A, Horstmann M, Pieters R, Meijerink J HAEMATOLOGICA. 201499(1):94-102. Characterisation of mutations and molecular studies of type 2 von Willebrand disease. Ahmad F, Jan R, Kannan M, Obser T, Hassan M, Oyen F, Budde U, Saxena R, Schneppenheim R THROMB HAEMOSTASIS. 2013109(1):39-46. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients Ahmad F, Budde U, Jan R, Oyen F, Kannan M, Saxena R, Schneppenheim R THROMB HAEMOSTASIS. 2013109(4):652-60. PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma Ameis H, Drenckhan A, Loga K, Escherich G, Wenke K, Izbicki J, Reinshagen K, Gros S PLOS ONE. 20138(12):e83701. Allo-SCT using BU, CY and melphalan for children with AML in second CR Beier R, Albert M, Bader P, Borkhardt A, Creutzig U, Eyrich M, Ehlert K, Gruhn B, Greil J, Handgretinger R, Holter W, Klingebiel T, Kremens B, Lang P, Mauz-Krholz C, Meisel R, Mller I, Peters C, Reinhardt D, Sedlacek P, Schulz A, Schuster F, Schrauder A, Strahm B, Sykora K, Wssmann W, Zimmermann M, Sauer M BONE MARROW TRANSPL. 201348(5):651-6. Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groups Benesch M, von Bueren A, Dantonello T, von Hoff K, Pietsch T, Leuschner I, Claviez A, Bierbach U, Kropshofer G, Korinthenberg R, Graf N, Suttorp M, Kortmann R, Friedrich C, von der Weid N, Kaatsch P, Klingebiel T, Koscielniak E, Rutkowski S J NEURO-ONCOL. 2013111(3):337-345. Fulminant Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Bohne S, Kentouche K, Petersen I, Fritzenwanger M, Pletz M, Lehmberg K, Paul L, Guntinas-Lichius O LARYNGOSCOPE. 2013123(2):362-365. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence Bonn B, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F, Wrobel G, Attarbaschi A, Escherich G, Klapper W, Reiter A, Burkhardt B BLOOD. 2013121(16):3153-60. Syntaxin 11 is required for NK and CD8 T-cell cytotoxicity and neutrophil degranulation. DOrlando O, Zhao F, Kasper B, Orinska Z, Mller J, Hermans-Borgmeyer I, Griffiths G, Zur Stadt U, Bulfone-Paus S EUR J IMMUNOL. 201343(1):194-208. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96. Eckert C, von Stackelberg A, Seeger K, Groeneveld T, Peters C, Klingebiel T, Borkhardt A, Schrappe M, Escherich G, Henze G EUR J CANCER. 201349(6):1346-1355. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group Eckert C, Henze G, Seeger K, Hagedorn N, Mann G, Panzer-Grmayer R, Peters C, Klingebiel T, Borkhardt A, Schrappe M, Schrauder A, Escherich G, Sramkova L, Niggli F, Hitzler J, von Stackelberg A J CLIN ONCOL. 201331(21):2736-42. VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease Eikenboom J, Federici A, Dirven R, Castaman G, Rodeghiero F, Budde U, Schneppenheim R, Batlle J, Canciani M, Goudemand J, Peake I, Goodeve A BLOOD. 2013121(12):2336-9. Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient Enayat M, Ravanbod S, Rassoulzadegan M, Jazebi M, Ala F, Budde U, Schneppenheim S, Obser T, Schneppenheim R HAEMOPHILIA. 201319(4):e261-4. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. Escherich G, Zimmermann M, Janka-Schaub G PEDIATR BLOOD CANCER. 201360(2):254-257. Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial Escherich G, Zur Stadt U, Zimmermann M, Horstmann M BRIT J HAEMATOL. 2013163(2):240-7. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Friedrich C, von Bueren A, von Hoff K, Gerber N, Ottensmeier H, Deinlein F, Benesch M, Kwiecien R, Pietsch T, Warmuth-Metz M, Faldum A, Kuehl J, Kortmann R, Rutkowski S NEURO-ONCOLOGY. 201315(2):224-234. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study Friedrich C, von Bueren A, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann R, Rutkowski S EUR J CANCER. 201349(4):893-903. Distinct role of von Willebrand factor triplet bands in glycoprotein Ib-dependent platelet adhesion and thrombus formation under flow Fuchs B, de Witt S, Solecka B, Krning M, Obser T, Cosemans J, Schneppenheim R, Heemskerk J, Kannicht C SEMIN THROMB HEMOST. 201339(3):306-14. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation Gieseke F, Kruchen A, Tzaribachev N, Bentzien F, Dominici M, Mller I EUR J IMMUNOL. 201343(10):2741-9. Syntaxin binding mechanism and disease-causing mutations in Munc18-2 Hackmann Y, Graham S, Ehl S, Hning S, Lehmberg K, Aric M, Owen D, Griffiths G P NATL ACAD SCI USA. 2013110(47):E4482-91. Supra - and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression Hagel C, Treszl A, Fehlert J, Harder J, von Haxthausen F, Kern M, von Bueren A, Kordes U J NEURO-ONCOL. 2013112(2):191-7. Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia Harder L, Eschenburg G, Zech A, Kriebitzsch N, Otto B, Streichert T, Behlich A, Dierck K, Klingler B, Hansen A, Stanulla M, Zimmermann M, Kremmer E, Stocking C, Horstmann M J EXP MED. 2013210(11):2289-304. Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells Hartsink-Segers S, Exalto C, Allen M, Williamson D, Clifford S, Horstmann M, Caron H, Pieters R, Den Boer M HAEMATOLOGICA. 201398(10):1539-46. Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia Hartz B, Lbel U, Hagel C, Escherich G AM J HEMATOL. 201388(12):1096-7. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Hasselblatt M, Isken S, Linge A, Eikmeier K, Jeibmann A, Oyen F, Nagel I, Richter J, Bartelheim K, Kordes U, Schneppenheim R, Frhwald M, Siebert R, Paulus W GENE CHROMOSOME CANC. 201352(2):185-190. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion Hchst B, Schildberg F, Sauerborn P, Gbel Y, Gevensleben H, Goltz D, Heukamp L, Trler A, Ballmaier M, Gieseke F, Mller I, Kalff J, Kurts C, Knolle P, Diehl L J HEPATOL. 201359(3):528-35. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays Hovestadt V, Remke M, Kool M, Pietsch T, Northcott P, Fischer R, Cavalli F, Ramaswamy V, Zapatka M, Reifenberger G, Rutkowski S, Schick M, Bewerunge-Hudler M, Korshunov A, Lichter P, Taylor M, Pfister S, Jones D ACTA NEUROPATHOL. 2013125(6):913-6. Hemophagocytic lymphohistiocytosis - pathogenesis and treatment Janka-Schaub G, Lehmberg K Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 20132013:605-11. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2 Jessen B, Bode S, Ammann S, Chakravorty S, Davies G, Diestelhorst J, Frei-Jones M, Gahl W, Gochuico B, Griese M, Griffiths G, Janka-Schaub G, Klein C, Kgl T, Kurnik K, Lehmberg K, Maul-Pavicic A, Mumford A, Pace D, Parvaneh N, Rezaei N, de Saint Basile G, Schmitt-Graeff A, Schwarz K, Karasu G, Zieger B, zur Stadt U, Aichele P, Ehl S BLOOD. 2013121(15):2943-51. Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations Jokela V, Lassila R, Szanto T, Joutsi-Korhonen L, Armstrong E, Oyen F, Schneppenheim S, Schneppenheim R HAEMOPHILIA. 201319(6):e344-8. Pregnancy in Upshaw-Schulman syndrome Kentouche K, Voigt A, Schleussner E, Schneppenheim R, Budde U, Beck J, Stefaska-Windyga E, Windyga J HAMOSTASEOLOGIE. 201333(2):144-8. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease Kgl T, Mller J, Jessen B, Schmitt-Graeff A, Janka-Schaub G, Ehl S, zur Stadt U, Aichele P BLOOD. 2013121(4):604-13. Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort Krgeloh-Mann I, Groeschel S, Kehrer C, Opherk K, Ngele T, Handgretinger R, Mller I BONE MARROW TRANSPL. 201348(3):369-75. Denosumab Lange T, Stehling C, Frhlich B, Klingenhfer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jrgens H, Schulte T EUR SPINE J. 201322(6):1417-22. Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients. Lehmberg K, Grosse R, Muckenthaler M, Altamura S, Nielsen P, Schmid H, Graubner U, Oyen F, Zeller W, Schneppenheim R, Janka-Schaub G ANN HEMATOL. 201392(3):387-394. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Lehmberg K, Ehl S BRIT J HAEMATOL. 2013160(3):275-287. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis Lehmberg K, Pink I, zu Eulenburg C, Beutel K, Maul-Pavicic A, Janka-Schaub G J PEDIATR-US. 2013162(6):1245-51. Exponential size distribution of von Willebrand factor Lippok S, Obser T, Mller J, Stierle V, Benoit M, Budde U, Schneppenheim R, Rdler J BIOPHYS J. 2013105(5):1208-16. Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrands disease undergoing elective surgery Mannuccio Mannucci P, Kyrle P, Schulman S, Di Paola J, Schneppenheim R, Cox Gill J Haematol Blood Transfus. 201311(4):533-40. Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry Mansouri Taleghani M, von Krogh A, Fujimura Y, George J, Hrachovinov I, Knbl P, Quist-Paulsen P, Schneppenheim R, Lmmle B, Kremer Hovinga J HAMOSTASEOLOGIE. 201333(2):138-43. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Marsh R, Rao K, Satwani P, Lehmberg K, Mller I, Li D, Kim M, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis D, Dimmock D, Casper J, Douglas D, Amrolia P, Veys P, Kumar A, Jordan M, Bleesing J, Filipovich A BLOOD. 2013121(6):877-883. Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patients. Meyer C, Zur Stadt U, Escherich G, Hofmann J, Binato R, Barbosa T, Emerenciano M, Pombo-de-Oliveira M, Horstmann M, Marschalek R Am J Blood Res. 20133(2):165-173. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome Meyr F, Escherich G, Mann G, Klingebiel T, Kulozik A, Rossig C, Schrappe M, Henze G, von Stackelberg A, Hitzler J BRIT J HAEMATOL. 2013162(1):98-106. Whats in a name Intracranial peripheral primitive neuroectodermal tumors and CNS primitive neuroectodermal tumors are not the same Mller K, Diez B, Muggeri A, Pietsch T, Friedrich C, Rutkowski S, von Hoff K, von Bueren A, Zwiener I, Bruns F STRAHLENTHER ONKOL. 2013189(5):372-9. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Oyekunle A, Zander A, Binder M, Ayuketang F, Zabelina T, Christopeit M, Stbig T, Alchalby H, Schafhausen P, Lellek H, Wolschke C, Mller I, Bacher U, Krger N ANN HEMATOL. 201392(4):487-496. Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress Pappelbaum K, Gorzelanny C, Grssle S, Suckau J, Laschke M, Bischoff M, Bauer C, Schorpp-Kistner M, Weidenmaier C, Schneppenheim R, Obser T, Sinha B, Schneider S CIRCULATION. 2013128(1):50-9. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma Remke M, Ramaswamy V, Peacock J, Shih D, Koelsche C, Northcott P, Hill N, Cavalli F, Kool M, Wang X, Mack S, Barszczyk M, Morrissy A, Wu X, Agnihotri S, Luu B, Jones D, Garzia L, Dubuc A, Zhukova N, Vanner R, Kros J, French P, Van Meir E, Vibhakar R, Zitterbart K, Chan J, Bognr L, Klekner A, Lach B, Jung S, Saad A, Liau L, Albrecht S, Zollo M, Cooper M, Thompson R, Delattre O, Bourdeaut F, Doz F, Garami M, Hauser P, Carlotti C, Van Meter T, Massimi L, Fults D, Pomeroy S, Kumabe T, Ra Y, Leonard J, Elbabaa S, Mora J, Rubin J, Cho Y, McLendon R, Bigner D, Eberhart C, Fouladi M, Wechsler-Reya R, Faria C, Croul S, Huang A, Bouffet E, Hawkins C, Dirks P, Weiss W, Schller U, Pollack I, Rutkowski S, Meyronet D, Jouvet A, Fvre-Montange M, Jabado N, Perek-Polnik M, Grajkowska W, Kim S, Rutka J, Malkin D, Tabori U, Pfister S, Korshunov A, von Deimling A, Taylor M ACTA NEUROPATHOL. 2013126(6):917-29. Somatostatin receptor subtype 2 (sst) is a potential prognostic marker and a therapeutic target in medulloblastoma Remke M, Hering E, Gerber N, Kool M, Sturm D, Rickert C, Ger J, Schulz S, Hielscher T, Hasselblatt M, Jeibmann A, Hans V, Ramaswamy V, Taylor M, Pietsch T, Rutkowski S, Korshunov A, Monoranu C, Frhwald M CHILD NERV SYST. 201329(8):1253-62. Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia Rensing-Ehl A, Janda A, Lorenz M, Gladstone B, Fuchs I, Abinun M, Albert M, Butler K, Cant A, Cseh A, Ebinger M, Goldacker S, Hambleton S, Hebart H, Houet L, Kentouche K, Khnle I, Lehmberg K, Mejstrikova E, Niemeyer C, Minkov M, Neth O, Dckers G, Owens S, Rsler J, Schilling F, Schuster V, Seidel M, Smisek P, Sukova M, Svec P, Wiesel T, Gathmann B, Schwarz K, Vach W, Ehl S, Speckmann C HAEMATOLOGICA. 201398(12):1948-55. Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia Richards S, Pui C, Gayon P. Escherich G PEDIATR BLOOD CANCER. 201360(2):185-95. Effective childhood cancer Treatment: the impact of large scale clinical trials in Germany and Austria Rossig C, Juergens H, Schrappe M, Moericke A, Henze G, von Stackelberg A, Reinhardt D, Burkhardt B, Woessmann W, Zimmermann M, Gadner H, Mann G, Schellong G, Mauz-Koerholz C, Dirksen U, Bielack S, Berthold F, Graf N, Rutkowski S, Calaminus G, Kaatsch P, Creutzig U PEDIATR BLOOD CANCER. 201360(10):1574-81. A very rare cancer in Down Syndrome: medulloblastoma. Epidemiological data from 13 countries Satg D, Stiller C, Rutkowski S, von Bueren A, Lacour B, Sommelet D, Nishi M, Massimino M, Garr M, Moreno F, Hasle H, Jakab Z, Greenberg M, von der Weid N, Kuehni C, Zurriaga O, Vicente M, Peris-Bonet R, Benesch M, Vekemans M, Sullivan S, Rickert C J NEURO-ONCOL. 2013112(1):107-14. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia Schmiegelow K, Levinsen M, Attarbaschi A, Baruchel A, Devidas M, Escherich G, Gibson B, Heydrich C, Horibe K, Ishida Y, Liang D, Locatelli F, Michel G, Pieters R, Piette C, Pui C, Raimondi S, Silverman L, Stanulla M, Stark B, Winick N, Valsecchi M J CLIN ONCOL. 201331(19):2469-76. BOLD MRI in the brain of fetal sheep at 3T during experimental hypoxia Schoennagel B, Yamamura J, Fischer R, de Sousa M, Weyhmiller M, Birkelbach M, Kooijman H, Adam G, Wedegrtner U J MAGN RESON IMAGING. 2013. Eisenquantifizierung mittels MRT bei Eisenberladung Schnnagel B, Fischer R, Nielsen P, Grosse R, Adam G, Yamamura J ROFO-FORTSCHR RONTG. 2013185(7):621-7. X-linked inhibitor of apoptosis (XIAP) deficiency Speckmann C, Lehmberg K, Albert M, Damgaard R, Fritsch M, Gyrd-Hansen M, Rensing-Ehl A, Vraetz T, Grimbacher B, Salzer U, Fuchs I, Ufheil H, Belohradsky B, Hassan A, Cale C, Elawad M, Strahm B, Schibli S, Lauten M, Kohl M, Meerpohl J, Rodeck B, Kolb R, Eberl W, Soerensen J, von Bernuth H, Lorenz M, Schwarz K, zur Stadt U, Ehl S Clinical immunology (Orlando, Fla.). 2013149(1):133-41. Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia van der Sluis I, Mricke A, Escherich G, von Stackelberg A, Holter W, Klingebiel T, Flotho C, Legien S, Tissing W, Bierings M, Guimbal-Schmolck C, Pichlmeier U, Khnel H, Pieters R HAEMATOLOGICA. 201398(11):1697-701. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL van der Veer A, Waanders E, Pieters R, Willemse M, Van Reijmersdal S, Russell L, Harrison C, Evans W, van der Velden V, Hoogerbrugge P, Van Leeuwen F, Escherich G, Horstmann M, Mohammadi Khankahdani L, Rizopoulos D, De Groot-Kruseman H, Sonneveld E, Kuiper R, Den Boer M BLOOD. 2013122(15):2622-9. Clinical phenotype and functional analysis of a rare XIAP/BIRC4 mutation Vieth S, Ammann S, Schwarz K, Hrtel C, Schultz C, Lehmberg K, Lauten M KLIN PADIATR. 2013225(6):343-6. Infantile malignant brain tumors von Hoff K, Rutkowski S 2013. Tumors of the pediatric central nervous system. Keating R, Tait Goodrich J, Packer R (eds.). 2. ed. New York: Georg Thieme Verlag. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group Warren K, Poussaint T, Vezina G, Hargrave D, Packer R, Goldman S, Wen P, Pollack I, Zurakowski D, Kun L, Prados M, Rutkowski S, Kieran M PEDIATR BLOOD CANCER. 201360(9):1397-401. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih D, Martin D, Castelo-Branco P, Baskin B, Ray P, Bouffet E, von Bueren A, Jones D, Northcott P, Kool M, Sturm D, Pugh T, Pomeroy S, Cho Y, Pietsch T, Gessi M, Rutkowski S, Bognar L, Klekner A, Cho B, Kim S, Wang K, Eberhart C, Fevre-Montange M, Fouladi M, French P, Kros M, Grajkowska W, Gupta N, Weiss W, Hauser P, Jabado N, Jouvet A, Jung S, Kumabe T, Lach B, Leonard J, Rubin J, Liau L, Massimi L, Pollack I, Shin Ra Y, Van Meir E, Zitterbart K, Schller U, Hill R, Lindsey J, Schwalbe E, Bailey S, Ellison D, Hawkins C, Malkin D, Clifford S, Korshunov A, Pfister S, Taylor M, Tabori U J CLIN ONCOL. 201331(23):2927-35. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. Biondi A, Schrappe M, Paola D, Castor A, Lucchini G, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Li C, Vora A, Aric M, Rttgers S, Saha V, Valsecchi M LANCET ONCOL. 201213(9):936-945. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Bode S, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka-Schaub G, Zur Stadt U, Ehl S ARTHRITIS RES THER. 201214(3):213. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling. Brauer H, Strauss J, Wegner W, Mller-Tidow C, Horstmann M, Jcker M CELL SIGNAL. 201224(11):2095-2101. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Bryceson Y, Pende D, Maul-Pavicic A, Gilmour K, Ufheil H, Vraetz T, Chiang S, Marcenaro S, Meazza R, Bondzio I, Walshe D, Janka-Schaub G, Lehmberg K, Beutel K, Zur Stadt U, Binder N, Arico M, Moretta L, Henter J, Ehl S BLOOD. 2012119(12):2754-2763. Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation. Castaman G, Giacomelli S, Jacobi P, Obser T, Budde U, Rodeghiero F, Schneppenheim R, Haberichter S J THROMB HAEMOST. 201210(5):951-958. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, Boelens J, Hewitt A, Schrum J, Schulz A, Mller I, Stein J, Wynn R, Greil J, Sykora K, Matthes-Martin S, Fhrer M, OMeara A, Toporski J, Sedlacek P, Schlegel P, Ehlert K, Fasth A, Winiarski J, Arvidson J, Mauz-Krholz C, Ozsahin H, Schrauder A, Bader P, Massaro J, DAgostino R, Hoyle M, Iacobelli M, Debatin K, Peters C, Dini G LANCET. 2012379(9823):1301-1309. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, Boelens J, Hewitt A, Schrum J, Schulz A, Mller I, Stein J, Wynn R, Greil J, Sykora K, Matthes-Martin S, Fhrer M, OMeara A, Toporski J, Sedlacek P, Schlegel P, Ehlert K, Fasth A, Winiarski J, Arvidson J, Mauz-Krholz C, Ozsahin H, Schrauder A, Bader P, Massaro J, DAgostino R, Hoyle M, Iacobelli M, Debatin K, Peters C, Dini G Lancet. 2012379(9823):1301-9. Eradication of pulmonary aspergillosis in an adolescent patient undergoing three allogeneic stem cell transplantations for acute lymphoblastic leukemia. Dring M, Zierl A, Mezger M, Lang P, Handgretinger R, Mller I Case Rep Transplant. 20122012:672923. Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Dring M, Hartmann U, Erbacher A, Lang P, Handgretinger R, Mller I BMC INFECT DIS. 201212:151. Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation. Dring M, Mller C, Johann P, Erbacher A, Kimmig A, Schwarze C, Lang P, Handgretinger R, Mller I BMC INFECT DIS. 201212:263. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, Te Kronnie G, Cario G, Cazzaniga G, Horstmann M, Panzer Grmayer R, Cav H, Trka J, Cinek O, Teigler-Schlegel A, ElSharawy A, Hsler R, Nebel A, Meissner B, Bartram T, Lescai F, Franceschi C, Giordan M, Nrnberg P, Heinzow B, Zimmermann M, Schreiber S, Schrappe M, Franke A LEUKEMIA. 201226(5):902-909. Proper cerebellar development requires expression of 1-integrin in Bergmann glia, but not in granule neurons. Frick A, Grammel D, Schmidt F, Pschl J, Priller M, Pagella P, von Bueren A, Andr O, Peraud A, Tonn J, Rutkowski S, Rutkowski S, Kretzschmar H, Schller U GLIA. 201260(5):820-832. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma. Gerber N, von Hoff K, von Bueren A, Treulieb W, Treulieb W, Deinlein F, Benesch M, Zwiener I, Soerensen N, Warmuth-Metz M, Pietsch T, Mittler U, Kuehl J, Kortmann R, Rutkowski S, Rutkowski S EUR J CANCER. 201248(13):2028-2036. p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease. Gessi M, von Bueren A, Rutkowski S, Rutkowski S, Pietsch T J NEURO-ONCOL. 2012106(1):135-141. Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts. Gieseke F, Mang P, Viebahn S, Sonntag I, Kruchen A, Erbacher A, Pfeiffer M, Handgretinger R, Mller I EUR J IMMUNOL. 201242(8):2176-2186. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Grammel D, Warmuth-Metz M, von Bueren A, Andr O, Kool M, Pietsch T, Kretzschmar H, Rutkowski S, Rutkowski S, Pfister S, Schller U ACTA NEUROPATHOL. 2012123(4):601-614. Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literature. Grunewald T, Greulich N, Kontny U, Frhwald M, Rutkowski S, Kordes U, Scheurlen W, Schmidt W, Stachel D, Metzler M, Mittler U, Graf N, Benesch M, Burdach S KLIN PADIATR. 2012224(3):124-131. Familial and acquired hemophagocytic lymphohistiocytosis. Janka-Schaub G ANNU REV MED. 201263:233-246. Dissecting the genomic complexity underlying medulloblastoma. Jones D, Jger N, Kool M, Zichner T, Hutter B, Sultan M, Cho Y, Pugh T, Hovestadt V, Sttz A, Rausch T, Warnatz H, Ryzhova M, Bender S, Sturm D, Pleier S, Cin H, Pfaff E, Sieber L, Wittmann A, Remke M, Witt H, Hutter S, Tzaridis T, Weischenfeldt J, Raeder B, Avci M, Amstislavskiy V, Zapatka M, Weber U, Wang Q, Lasitschka B, Bartholomae C, Schmidt M, von Kalle C, Ast V, Lawerenz C, Eils J, Kabbe R, Benes V, van Sluis P, Koster J, Volckmann R, Shih D, Betts M, Russell R, Coco S, Tonini G, Schller U, Hans V, Graf N, Kim Y, Monoranu C, Roggendorf W, Unterberg A, Herold-Mende C, Milde T, Kulozik A, von Deimling A, Witt O, Maass E, Rssler J, Ebinger M, Schuhmann M, Frhwald M, Hasselblatt M, Jabado N, Rutkowski S, von Bueren A, Andr O, Williamson D, Clifford S, McCabe M, Collins V, Wolf S, Wiemann S, Lehrach H, Brors B, Scheurlen W, Felsberg J, Reifenberger G, Northcott P, Taylor M, Meyerson M, Pomeroy S, Yaspo M, Korbel J, Korshunov A, Eils R, Pfister S, Lichter P NATURE. 2012488(7409):100-105. Brain tumours in the first year of life - a report of 22 patients in our institution Kammler G, Kordes U, Emami P, Hagel C, Westphal M Deutsche Gesellschaft fr Neurochirurgie. Japanische Gesellschaft fr Neurochirurgie. 63. Jahrestagung der Deutschen Gesellschaft fr Neurochirurgie (DGNC), Joint Meeting mit der Japanischen Gesellschaft fr Neurochirurgie (JNS). Leipzig, 13.-16.06.2012. 2012. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Kool M, Korshunov A, Remke M, Jones D, Schlanstein M, Northcott P, Cho Y, Koster J, Antoinette S, van Vuurden D, Clifford S, Pietsch T, von Bueren A, Rutkowski S, Rutkowski S, McCabe M, Collins V, Bcklund M, Haberler C, Bourdeaut F, Delattre O, Doz F, Ellison D, Gilbertson R, Pomeroy S, Taylor M, Lichter P, Pfister S ACTA NEUROPATHOL. 2012123(4):473-484. Loss of TP53 expression in immortalized choroid plexus epithelial cells results in increased resistance to anticancer agents Krzyzankova M, Mertsch S, Koos B, Jeibmann A, Kruse A, Kordes U, Frhwald M, Wolff J, Paulus W, Hasselblatt M J NEURO-ONCOL. 2012109(3):449-55. Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside. Kui S, Henschler R, Mller I, Biagi E, Meisel R Stem Cells Int. 20122012:185943. Basic biology and clinical application of multipotent mesenchymal stromal cells Kui S, Henschler R, Mller I, Biagi E, Meisel R Stem cells international. 20122012:185943. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Bjrk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford S, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R J CLIN ONCOL. 201230(26):3187-3193. Variant alleles of cytokine genes influence risk and clinical course of Langerhans cell histiocytosis. Lehrnbecher T, Salzmann-Manrique E, Soerensen J, Beutel K, Janka-Schaub G, Gadner H, Minkov M BRIT J HAEMATOL. 2012156(1):138-141. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs A, Al-Jefri A, Beier R, Lilian B, Ehlert K, Gross-Wieltsch U, Jorch N, Kremens B, Pekrun A, Sparber-Sauer M, Mejstrikova E, Wawer A, Ehl S, Zur Stadt U, Janka-Schaub G BLOOD. 2012119(25):6016-6024. Occurrence of acute lymphoblastic leukemia and juvenile myelomonocytic leukemia in a patient with Noonan syndrome carrying the germline PTPN11 mutation p. E139D. Pauli S, Steinemann D, Dittmann K, Wienands J, Shoukier M, Mschner M, Burfeind P, Manukjan G, Ghring G, Escherich G AM J MED GENET A. 2012158A(3):652-658. IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT. Pfeiffer M, Schumm M, Mller I, Handgretinger R, Lang P LEUKEMIA. 201226(11):2435-2439. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. Ronceray L, Ptschger U, Janka-Schaub G, Gadner H, Minkov M, Hematology G, Group O J PEDIATR-US. 2012161(1):123-129. DWI of the brain: postmortal DWI of the brain in comparison with in vivo data. Schmidt T, Fischer R, Acar S, Lorenzen M, Heinemann A, Wedegrtner U, Adam G, Yamamura J FORENSIC SCI INT. 2012220(1-3):180-183. Letter to the editor Schnell O, Neumann nee Pschl J, Tonn J, Schller U BRAIN PATHOL. 201222(5):724. Outcomes after induction failure in childhood acute lymphoblastic leukemia. Schrappe M, Hunger S, Pui C, Saha V, Gaynon P, Baruchel A, Conter V, Otten J, Ohara A, Versluys A, Escherich G, Heyman M, Silverman L, Horibe K, Mann G, Camitta B, Harbott J, Riehm H, Richards S, Devidas M, Zimmermann M NEW ENGL J MED. 2012366(15):1371-1381. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives. Sperl D, Benesch M, Urban C, Lackner H, Sovinz P, Speicher M, Uhrig S, Schwarzbraun T, Schwinger W, Zur Stadt U, Beutel K, Janka-Schaub G, Scarpatetti M, Seidel M KLIN PADIATR. 2012224(6):386-389. Molecular subgroups of medulloblastoma: the current consensus. Taylor M, Northcott P, Korshunov A, Remke M, Cho Y, Clifford S, Eberhart C, Parsons D, Rutkowski S, Gajjar A, Ellison D, Lichter P, Gilbertson R, Pomeroy S, Kool M, Pfister S ACTA NEUROPATHOL. 2012123(4):465-472. In vivo imaging enables high resolution preclinical trials on patients leukemia cells growing in mice. Terziyska N, Catarina C, Groiss V, Schneider K, Farkasova K, Ogris M, Wagner E, Ehrhardt H, Brentjens R, Zur Stadt U, Horstmann M, Quintanilla-Martinez L, Jeremias I PLOS ONE. 20127(12):52798. Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Trottestam H, Berglf E, Horne A, Onelv E, Beutel K, Lehmberg K, Sieni E, Silfverberg T, Aric M, Janka-Schaub G, Henter J ACTA PAEDIATR. 2012101(3):313-318. DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis. von Bueren A, Andr O, Hagel C, Hagel C, Cai H, Remke M, Hasselblatt M, Feuerstein B, Pernet S, Delattre O, Rutkowski S, Rutkowski S, Pfister S, Baudis M J NEURO-ONCOL. 2012109(2):415-423. Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. von Bueren A, Bacolod M, Hagel C, Heinimann K, Fedier A, Kordes U, Pietsch T, Koster J, Grotzer M, Friedman H, Marra G, Kool M, Rutkowski S BRIT J CANCER. 2012107(8):1399-1408. CNS PNET molecular subgroups with distinct clinical features. von Bueren A, Andr O LANCET ONCOL. 201213(8):753-754. Mismatch repair deficiency von Bueren A, Bacolod M, Hagel C, Heinimann K, Fedier A, Kordes U, Pietsch T, Koster J, Grotzer M, Friedman H, Marra G, Kool M, Rutkowski S BRIT J CANCER. 2012107(8):1399-408. Medulloblastoma. von Hoff K, Rutkowski S Curr Treat Options Neurol. 201214(4):416-426. Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR). Weber A, Taube S, Zur Stadt U, Horstmann M, Krohn K, Bradtke J, Teigler-Schlegel A, Leiblein S, Christiansen H Exp Hematol Oncol. 20121(1):33. Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database. Wolff B, Ng A, Roth D, Parthey K, Warmuth-Metz M, Eyrich M, Kordes U, Kortmann R, Pietsch T, Kramm C, Wolff J J NEURO-ONCOL. 2012107(1):139-146. CPT SIOP Wolff J, Hasselblatt M, Hartung S, Powell M, Garami M, Traunecker H, Thall P, Mahajan A, Kordes U, Sumerauer D J NEURO-ONCOL. 201214:i153. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Zuurbier L, Petricoin E, Vuerhard M, Calvert V, Kooi C, Buijs-Gladdines J, Smits W, Sonneveld E, Veerman A, Kamps W, Horstmann M, Pieters R, Meijerink J HAEMATOLOGICA. 201297(9):1405-1413. Primary central nervous system primitive neuroectodermal tumors (CNS-PNETs) of the spinal cord in children: four cases from the German HIT database with a critical review of the literature. Benesch M, Sperl D, von Bueren A, Andr O, von Hoff K, von Hoff K, Warmuth-Metz M, Ferrari R, Lassay L, Kortmann R, Rutkowski S, Rutkowski S J NEURO-ONCOL. 2011104(1):279-286. Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey. Bienemann K, Burkhardt B, Modlich S, Meyer U, Mricke A, Bienemann K, Mauz-Krholz C, Escherich G, Zimmermann M, Krholz D, Janka-Schaub G, Schrappe M, Reiter A, Borkhardt A BRIT J HAEMATOL. 2011155(4):468-476. Glioblastoma in childhood Treatment and outcome of 7 patients Burkhardt T, Emami P, Kordes U, Matschke J, Regelsberger J, Westphal M, Kammler G 2011. A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature. Cocc M, Lubieniecki F, Kordes U, Alderete D, Gallego M J NEURO-ONCOL. 2011104(1):375-380. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97). Escherich G, Troeger A, Gobel U, Graubner U, Pekrun A, Jorch N, Kaspers G, Zimmermann M, Zur Stadt U, Kazemir K, Pieters R, Horstmann M, Denboer M, Janka-Schaub G HAEMATOLOGICA. 201196(6):854-862. Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia. Escherich G, Richards S, Stork L, Vora A LEUKEMIA. 201125(6):953-959. Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. Gerber N, von Hoff K, von Bueren A, Treulieb W, Treulieb W, Warmuth-Metz M, Pietsch T, Soerensen N, Faldum A, Emser A, Schlegel P, Deinlein F, Rutkowski S, Rutkowski S J NEURO-ONCOL. 2011102(3):459-469. Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. Gmez-Barrena E, Rosset P, Mller I, Giordano R, Bunu C, Layrolle P, Konttinen Y, Luyten F J CELL MOL MED. 201115(6):1266-1286. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Hasselblatt M, Gesk S, Oyen F, Rossi S, Viscardi E, Giangaspero F, Giannini C, Judkins A, Frhwald M, Obser T, Schneppenheim R, Siebert R, Paulus W AM J SURG PATHOL. 201135(6):933-935. SV40 and p53 as team players in childhood lymphoproliferative disorders. Heinsohn S, Scholz R, Kabisch H INT J ONCOL. 201138(5):1307-1317. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Homminga I, Pieters R, Langerak A, Rooi d, Johan J, Stubbs A, Verstegen M, Vuerhard M, Buijs-Gladdines J, Kooi C, Klous P, van Vlierberghe P, Ferrando A, Cayuela J, Verhaaf B, Horstmann M, Horstmann M, de Haas V, Wiekmeijer A, Pike-Overzet K, Staal F, de Laat W, Soulier J, Sigaux F, Meijerink J CANCER CELL. 201119(4):484-497. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Jessen B, Maul-Pavicic A, Ufheil H, Vraetz T, Enders A, Lehmberg K, Lngler A, Gross-Wieltsch U, Bay A, Kaya Z, Bryceson Y, Koscielniak E, Badawy S, Davies G, Hufnagel M, Schmitt-Graeff A, Aichele P, Zur Stadt U, Schwarz K, Ehl S BLOOD. 2011118(17):4620-4629. SIOP-CPT-2000 update Kordes U, Kutluk T, Hasselblatt M, Pietsch A, Thall P, Wolff J 2011. Parvovirus B19 infection and autoimmune hepatitis in a child with sickle cell anemia. Kordes U, Schneppenheim R, Briem-Richter A, Scherpe S, Schfer H PEDIATR BLOOD CANCER. 201156(2):323-324. Ectopic craniopharyngioma. Kordes U, Flitsch J, Hagel C, Goebell E, Schwarz R, Herberhold T, von Bueren A, Rutkowski S, Mller H KLIN PADIATR. 2011223(3):176-177. Childhood medulloblastoma. Massimino M, Giangaspero F, Garr M, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S CRIT REV ONCOL HEMAT. 201179(41):65-83. Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population. Mohl A, Boda Z, Jager R, Losonczy H, Marosi A, Masszi T, Nagy E, Nemes L, Obser T, Oyen F, Radvnyi G, Schlammadinger , Szlessy Z, Vrkonyi A, Vezendy K, Vilimi B, Schneppenheim R, Bod I J THROMB HAEMOST. 20119(5):945-952. Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literature. Mller K, Zwiener I, Welker H, Maass E, Bongartz R, Berthold F, Pietsch T, Warmuth-Metz M, von Bueren A, Rutkowski S STRAHLENTHER ONKOL. 2011187(11):757-762. The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells. Oehler C, von Bueren A, Andr O, Furmanova P, Broggini-Tenzer A, Rutkowski S, Rutkowski S, Frei K, Grotzer M, Pruschy M NEURO-ONCOLOGY. 201113(9):1000-1010. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review. Peinemann F, Krger N, Bartel C, Grouven U, Pittler M, Erttmann R, Kulig M PLOS ONE. 20116(2):17127. An aggressive systemic juvenile xanthogranuloma clonally related to a preceding T-cell acute lymphoblastic leukemia. Perez-Becker R, Szczepanowski M, Leuschner I, Janka-Schaub G, Gokel M, Imschweiler T, Vlpel S, Niehues T, Klapper W PEDIATR BLOOD CANCER. 201156(5):859-862. Increased cyclosporine concentrations in the absence of cyclosporine administration. Peter A, Shipkova M, Wieland E, Schleicher E, Mller I CLIN CHEM. 201157(5):670-673. Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans. Pschl J, Lorenz A, Hartmann W, von Bueren A, Kool M, Li S, Peraud A, Tonn J, Herms J, Xiang M, Rutkowski S, Kretzschmar H, Schller U ONCOGENE. 201130(47):4721-4730. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Priller M, Pschl J, Abro L, von Bueren A, Andr O, Rutkowski S, Rutkowski S, Kretzschmar H, Schller U CLIN CANCER RES. 201117(21):6791-6801. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. Remke M, Hielscher T, Korshunov A, Northcott P, Bender S, Kool M, Westermann F, Benner A, Cin H, Ryzhova M, Sturm D, Witt H, Haag D, Toedt G, Wittmann A, Schttler A, von Bueren A, Andr O, Rutkowski S, Rutkowski S, Scheurlen W, Kulozik A, Taylor M, Lichter P, Pfister S J CLIN ONCOL. 201129(29):3852-3861. Characterisation of two novel large F8 deletions in patients with severe haemophilia A and factor VIII inhibitors. Roth L, Marschalek R, Oldenburg J, Oyen F, Schneppenheim R THROMB HAEMOSTASIS. 2011105(2):279-284. Regulation der primren Hmostase durch von-Willebrand-Faktor und ADAMTS13 Schneppenheim R, Budde U HAMOSTASEOLOGIE. 201131(4):275-80. Von Willebrand factor and ADAMTS13 balancing primary haemostasis. Schneppenheim R, Budde U HAMOSTASEOLOGIE. 201131(4):275-280. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein. Schneppenheim R, Budde U J THROMB HAEMOST. 20119 Suppl 1:209-215. The pathophysiology of von Willebrand disease: therapeutic implications. Schneppenheim R THROMB RES. 2011128 Suppl 1:3-7. Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3. Sieni E, Cetica V, Santoro A, Beutel K, Mastrodicasa E, Meeths M, Ciambotti B, Brugnolo F, Zur Stadt U, Pende D, Moretta L, Griffiths G, Henter J, Janka-Schaub G, Aric M J MED GENET. 201148(5):343-352. A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici A, Batlle J, Meyer D, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Lethagen S, Hill F, Peake I HAEMOPHILIA. 201117(1):165-166. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Trottestam H, Horne A, Aric M, Egeler R, Filipovich A, Gadner H, Imashuku S, Ladisch S, Webb D, Janka-Schaub G, Henter J, Society H BLOOD. 2011118(17):4577-4584. Severe phototoxicity associated with long-term voriconazole treatment. Vhringer S, Schrum J, Ott H, Hger P J Dtsch Dermatol Ges. 20119(4):274-276. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. von Bueren A, von Hoff K, von Hoff K, Pietsch T, Gerber N, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Rutkowski S, Rutkowski S NEURO-ONCOLOGY. 201113(6):669-679. Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses. von Bueren A, Andr O, Warmuth-Metz M, Schlegel P, Soerensen N, Krauss J, Roggendorf W, Pietsch T, Feiden W, Graf N, Pohl F, Flentje M, Rutkowski S, Rutkowski S PEDIATR BLOOD CANCER. 201156(3):503-505. c-MYC expression sensitizes medulloblastoma cells to radio - and chemotherapy and has no impact on response in medulloblastoma patients. von Bueren A, Andr O, Oehler C, von Hoff K, von Hoff K, Pruschy M, Seifert B, Gerber N, Warmuth-Metz M, Stearns D, Eberhart C, Rutkowski S, Rutkowski S, Grotzer M BMC CANCER. 201111:74. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren A, Andr O, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel P, Kuehl J, Frhwald M, Kortmann R, Rutkowski S, Rutkowski S PEDIATR BLOOD CANCER. 201157(6):978-985. Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group. von Stackelberg A, Vlzke E, Khl J, Seeger K, Schrauder A, Escherich G, Henze G, Tallen G, Group A EUR J CANCER. 201147(1):90-97. Recurrence in childhood medulloblastoma. Warmuth-Metz M, Blashofer S, von Bueren A, von Hoff K, von Hoff K, Bison B, Pohl F, Kortmann R, Rutkowski S, Rutkowski S J NEURO-ONCOL. 2011103(3):705-711. Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases. Wernicke C, Grunewald T, Juenger H, Kuci S, Kuci Z, Koehl U, Mller I, Doering M, Peters C, Lawitschka A, Kolb H, Bader P, Burdach S, von Luettichau I Int Arch Med. 20114(1):27. High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study. Wolff J, Kortmann R, Wolff B, Pietsch T, Peters O, Schmid H, Rutkowski S, Warmuth-Metz M, Kramm C J NEURO-ONCOL. 2011102(3):433-442. Pancreatic exocrine function and cardiac iron in patients with iron overload and with thalassemia. Yamamura J, Grosse R, Jarisch A, Janka-Schaub G, Nielsen P, Adam G, Fischer R PEDIATR BLOOD CANCER. 201157(4):674-676. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Zenatti P, Ribeiro D, Li W, Zuurbier L, Silva M, Paganin M, Tritapoe J, Hixon J, Silveira A, Cardoso B, Sarmento L, Correia N, Toribio M, Kobarg J, Horstmann M, Pieters R, Brandalise S, Ferrando A, Meijerink J, Durum S, Yunes J, Barata J NAT GENET. 201143(10):932-939. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Ardon H, Steven D, Frank V, Claes L, Kramm C, Rutkowski S, Wolff J, Gool V, Stefaan W PEDIATR BLOOD CANCER. 201054(4):519-525. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. Aric M, Schrappe M, Hunger S, Carroll W, Conter V, Galimberti S, Manabe A, Saha V, Baruchel A, Vettenranta K, Horibe K, Benoit Y, Pieters R, Escherich G, Silverman L, Pui C, Valsecchi M J CLIN ONCOL. 201028(31):4755-4761. Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. Benesch M, Weber-Mzell D, Gerber N, von Hoff K, Deinlein F, Krauss J, Warmuth-Metz M, Kortmann R, Pietsch T, Driever P, Quehenberger F, Urban C, Rutkowski S J NEUROSURG-PEDIATR. 20106(2):137-144. Proton beam therapy for loco-regional control of a recurrent mixed malignant germ cell tumor of the skull in a 22-month-old girl. Calaminus G, Gbel U, Schrum J, Wittkugel O, Westphal M, Timmermann B KLIN PADIATR. 2010222(3):175-179. Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia. Cario H, Grosse R, Janssen G, Jarisch A, Meerpohl J, Strauss G KLIN PADIATR. 2010222(6):399-406. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype. Castaman G, Giacomelli S, Jacobi P, Obser T, Budde U, Rodeghiero F, Haberichter S, Schneppenheim R J THROMB HAEMOST. 20108(9):2011-2016. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD. Castaman G, Tosetto A, Cappelletti A, Goodeve A, Federici A, Batlle J, Meyer D, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Lethagen S, Hill F, Peake I, Rodeghiero F THROMB RES. 2010126(3):227-231. The impact of bleeding history, von Willebrand factor and PFA-100() on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD. Castaman G, Tosetto A, Goodeve A, Federici A, Lethagen S, Ulrich B, Batlle J, Meyer D, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Ingerslev J, Habart D, Hill F, Peake I, Rodeghiero F BRIT J HAEMATOL. 2010151(3):245-251. STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5. Cetica V, Santoro A, Gilmour K, Sieni E, Beutel K, Pende D, Marcenaro S, Koch F, Grieve S, Wheeler R, Zhao F, Zur Stadt U, Griffiths G, Aric M J MED GENET. 201047(9):595-600. Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5,659 children Eden T, Pieters R, Yetgin S, Olcay L, Dibar E, Conter V, Masera G, Valsecchi M, Dacou-Voutetakis C, Henze G, Loening L, Schrappe M, von Stackelberg A, Zimmermann M, Attarbaschi A, Gadner H, Mann G, Brandalise S, Carroll W, Devidas M, Gaynon P, Hunger S, Nachman J, Janka-Schaub G, Stary J, Gelber R, Bierings M, Kamps W, Otten J, Suciu S, Viana M, Baruchel A, Ortega J, Magyarosy E, Perez C, Steinberg D, Tsurusawa M, Zintl F, Matsuzaki A, Lilleyman J, Richards S, Steinherz P, Kochupillai V, de Toledo J, Appelbaum F, Campbel M, Cheng C, Pei D, Pui C, Kukure P, Nakazawa S, Elphinstone T, Evans V, Gettins L, Hicks C, MacKinnon L, Morris P, Wade R, Wise C BRIT J HAEMATOL. 2010149(5):722-733. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL) Escherich G, Horstmann M, Zimmermann M, Janka-Schaub G LEUKEMIA. 201024(2):298-308. Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents. Fangusaro J, Massimino M, Rutkowski S, Gururangan S PEDIATR BLOOD CANCER. 201054(4):638-640. Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma. Friedrich C, Schrum J, Chott A, Janka-Schaub G, Kabisch H PEDIATR BLOOD CANCER. 201054(4):610-612. The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF. Haberichter S, Ulrich B, Obser T, Schneppenheim S, Wermes C, Schneppenheim R BLOOD. 2010115(22):4580-4587. Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort. Hampshire D, Burghel G, Goudemand J, Bouvet L, Eikenboom J, Schneppenheim R, Ulrich B, Peake I, Goodeve A HAEMATOLOGICA. 201095(12):2163-2165. von Willebrand factor variant p. Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels. Hickson N, Hampshire D, Winship P, Goudemand J, Schneppenheim R, Budde U, Castaman G, Rodeghiero F, Federici A, James P, Peake I, Eikenboom J, Goodeve A J THROMB HAEMOST. 20108(9):1986-1993. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells Holzwarth C, Vaegler M, Gieseke F, Pfister S, Handgretinger R, Kerst G, Mller I BMC CELL BIOL. 201011:11. Difficulties in diagnosing congenital thrombotic thrombocytopenic purpura. Klukowska A, Niewiadomska E, Ulrich B, Oyen F, Schneppenheim R J PEDIAT HEMATOL ONC. 201032(2):103-107. Neonatal cholestasis and glucose-6-P-dehydrogenase deficiency. Kordes U, Briem-Richter A, Santer R, Schfer H, Singer D, Sonntag J, Steuerwald U, Schneppenheim R, Janka-Schaub G PEDIATR BLOOD CANCER. 201054(5):758-760. Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Kordes U, Gesk S, Frhwald M, Graf N, Leuschner I, Hasselblatt M, Jeibmann A, Oyen F, Peters O, Pietsch T, Siebert R, Schneppenheim R GENE CHROMOSOME CANC. 201049(2):176-181. Neonatal cholestasis in glucose-6-phosphate dehydrogenase deficiency. Kordes U, Briem-Richter A, Santer R, Schfer H, Singer D, Sonntag J, Steuerwald U, Schneppenheim R, Janka-Schaub G PEDIATR BLOOD CANCER. 201054(5):758-766. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. Korshunov A, Remke M, Werft W, Benner A, Ryzhova M, Witt H, Sturm D, Wittmann A, Schttler A, Felsberg J, Reifenberger G, Rutkowski S, Scheurlen W, Kulozik A, von Deimling A, Lichter P, Pfister S J CLIN ONCOL. 201028(18):3054-3060. Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study. Mann G, Attarbaschi A, Schrappe M, Paola D, Peters C, Hann I, Giulio D, Felice M, Lausen B, Leblanc T, Szczepanski T, Ferster A, Janka-Schaub G, Rubnitz J, Silverman Lewis B, Stary J, Campbell M, Li C, Suppiah R, Biondi A, Vora A, Valsecchi M, Pieters R, Group I BLOOD. 2010116(15):2644-2650. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkins lymphoma and Burkitt leukemia. Meinhardt A, Burkhardt B, Zimmermann M, Borkhardt A, Kontny U, Klingebiel T, Berthold F, Janka-Schaub G, Klein C, Kabickova E, Klapper W, Attarbaschi A, Schrappe M, Reiter A, Group B J CLIN ONCOL. 201028(19):3115-3121. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Mobley B, McKenney J, Bangs C, Callahan K, Yeom K, Schneppenheim R, Hayden M, Cherry A, Gokden M, Edwards M, Fisher P, Vogel H ACTA NEUROPATHOL. 2010120(6):745-753. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Mller-Tidow C, Klein H, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, Zur Stadt U, Koschmieder S, Seidl M, Mller F, Schmitz W, Schlenke P, McClelland M, Berdel W, Dugas M, Serve H, Leukemia S BLOOD. 2010116(18):3564-3571. Laboratory diagnosis of von Willebrand disease. Patzke J, Schneppenheim R HAMOSTASEOLOGIE. 201030(4):203-206. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. Pfaff E, Remke M, Sturm D, Benner A, Witt H, Till M, von Bueren A, Andr O, Wittmann A, Schttler A, Jorch N, Graf N, Kulozik A, Witt O, Scheurlen W, Rutkowski S, Rutkowski S, Taylor M, Tabori U, Lichter P, Korshunov A, Pfister S J CLIN ONCOL. 201028(35):5188-5196. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, Bondzio I, Gross-Wieltsch U, Schndeln M, Schtz B, Woessmann W, Groll A, Strahm B, Pagel J, Speckmann C, Janka-Schaub G, Griffiths G, Schwarz K, Zur Stadt U, Ehl S HAEMATOLOGICA. 201095(12):2080-2087. Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency Rohr J, Pannicke U, Dring M, Schmitt-Graeff A, Wiech E, Busch A, Speckmann C, Mller I, Lang P, Handgretinger R, Fisch P, Schwarz K, Ehl S J CLIN IMMUNOL. 201030(2):314-20. Medulloblastoma in young children. Rutkowski S, Cohen B, Finlay J, Luksch R, Ridola V, Valteau-Couanet D, Hara J, Garre M, Grill J PEDIATR BLOOD CANCER. 201054(4):635-637. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, Giangaspero F, Ellison D, Garre M, Biassoni V, Grundy R, Finlay J, Dhall G, Raquin M, Grill J J CLIN ONCOL. 201028(33):4961-4968. Using ImageJ for the quantitative analysis of flow-based adhesion assays in real-time under physiologic flow conditions. Sascha M, Klinkhardt U, Schneppenheim R, Harder S PLATELETS. 201021(1):60-66. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Schneppenheim R, Frhwald M, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Subero M, Obser T, Oyen F, Oyen F, Vater I, Siebert R AM J HUM GENET. 201086(2):279-284. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE. Schneppenheim R, Michiels J, Obser T, Oyen F, Pieconka A, Schneppenheim S, Will K, Zieger B, Ulrich B BLOOD. 2010115(23):4894-4901. Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD. Shalaby T, von Bueren A, Andr O, Hrlimann M, Fiaschetti G, Castelletti D, Masayuki T, Nagasawa K, Arcaro A, Jelesarov I, Shin-ya K, Grotzer M MOL CANCER THER. 20109(1):167-179. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. Tallen G, Ratei R, Mann G, Kaspers G, Niggli F, Karachunsky A, Ebell W, Escherich G, Schrappe M, Klingebiel T, Fengler R, Henze G, von Stackelberg A J CLIN ONCOL. 201028(14):2339-2347. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. von Hoff K, Hartmann W, von Bueren A, Oscar A, Gerber N, Grotzer M, Rutkowski S, Rutkowski S PEDIATR BLOOD CANCER. 201054(3):369-376. Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Wolff J, Driever P, Erdlenbruch B, Kortmann R, Rutkowski S, Pietsch T, Parker C, Metz M, Gnekow A, Kramm C CANCER-AM CANCER SOC. 2010116(3):705-712. 28-year old female patient with respiratory insufficiency, elevated liver enzymes, pancytopenia and fever. Wolschke C, Fiedler W, Habermann C, Janka-Schaub G, Kluge S INTERNIST. 201051(11):1434-1438. Distribution of cardiac iron measured by magnetic resonance imaging (MRI)-R2. Yamamura J, Grosse R, Graessner J, Janka-Schaub G, Adam G, Fischer R J MAGN RESON IMAGING. 201032(5):1104-1109. Severe bleeding diathesis associated with moderate thrombocytopenia - diagnostic workup of seven family members with type 2B von Willebrands disease. Zdziarska J, Iwaniec T, Skotnicki A, Musia J, Schneppenheim R, Budde U, Kentouche K HAEMOPHILIA. 201016(6):958-962. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Zuurbier L, Homminga I, Calvert V, Te Winkel M, Buijs-Gladdines J, Kooi C, Smits W, Sonneveld E, Veerman A, Kamps W, Horstmann M, Petricoin E, Pieters R, Meijerink J LEUKEMIA. 201024(12):2014-2022. Fatal Epstein-Barr virus infection in a case of familial hemophagocytic lymphohistiocytosis with syntaxin-11 mutation. Albayrak M, Kaya Z, Yilmaz-Keskin E, Zur Stadt U, Koak U, Grsel T TURKISH J PEDIATR. 200951(4):371-374. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Bader P, Kreyenberg H, Henze G, Eckert C, Reising M, Willasch A, Barth A, Borkhardt A, Peters C, Handgretinger R, Sykora K, Holter W, Kabisch H, Klingebiel T, von Stackelberg A J CLIN ONCOL. 200927(3):377-384. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Beutel K, Gross-Wieltsch U, Wiesel T, Zur Stadt U, Janka-Schaub G, Wagner H PEDIATR BLOOD CANCER. 200953(2):184-190. Infection of T lymphocytes in non-Asian patients with epstein-barr virus-associated hemophagocytic-response. Beutel K, Janka-Schaub G PEDIATR BLOOD CANCER. 2009. ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor. Beutel K, Hauch H, Rischewski J, Kordes U, Schneppenheim J, Schneppenheim R HAMOSTASEOLOGIE. 200929(2):155-157. Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Brggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann O, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cav H, Dombret H, Fielding A, Fo R, Gkbuget N, Goldstone A, Goulden N, Henze G, Hoelzer D, Janka-Schaub G, Macintyre E, Pieters R, Rambaldi A, Ribera J, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen J LEUKEMIA. 2009. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition. Bug S, Drig J, Oyen F, Klein-Hitpass L, Martin-Subero J, Harder L, Baudis M, Arnold N, Kordes U, Dhrsen U, Schneppenheim R, Siebert R CANCER GENET CYTOGEN. 2009192(1):44-47. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Claus R, Bockmeyer C, Ulrich B, Kentouche K, Sossdorf M, Hilberg T, Schneppenheim R, Reinhart K, Bauer M, Brunkhorst F, Lsche W THROMB HAEMOSTASIS. 2009101(2):239-247. Acquired vorinostat resistance shows partial cross-resistance to second-generation HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Dedes K, Dedes I, Imesch P, von Bueren A, Andr O, Fink D, Fedier A ANTI-CANCER DRUG. 200920(5):321-333. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Den B, Monique L, Slegtenhorst v, Marjon , Menezes D, Rene X, Cheok , Meyling H, Buijs-Gladdines , Jessica G, Peters , Susan T, Zutven V, Laura J, Beverloo , Berna H, Spek V, Peter J, Escherich G, Gaby , Horstmann M, Martin A, Janka-Schaub G, Gritta E, Kamps , Willem A, Evans , William E, Pieters , Rob LANCET ONCOL. 200910(2):125-134. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome Den Boer M, van Slegtenhorst M, De Menezes R, Cheok M, Buijs-Gladdines J, Peters S, Van Zutven L, Beverloo H, Van der Spek P, Escherich G, Horstmann M, Janka-Schaub G, Kamps W, Evans W, Pieters R LANCET ONCOL. 200910(2):125-34. Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare. Eberl W, Budde U, Bentele K, Christen H, Knapp R, Mey A, Schneppenheim R HAMOSTASEOLOGIE. 200929(2):137-142. Expression of fourteen von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. Eikenboom J, Hilbert L, Ribba A, Hommais A, Habart D, Messenger S, Al-Buhairan A, Guilliatt A, Lester W, Mazurier C, Meyer D, Fressinaud E, Budde U, Will K, Schneppenheim R, Obser T, Marggraf O, Eckert E, Castaman G, Rodeghiero F, Federici A, Batlle J, Goudemand J, Ingerslev J, Lethagen S, Oyen F, Peake I, Goodeve A J THROMB HAEMOST. 2009. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97. Escherich G, Horstmann M, Zimmermann M, Janka-Schaub G LEUKEMIA. 2009. The CD70/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia. Glouchkova L, Ackermann B, Zibert A, Meisel R, Siepermann M, Janka-Schaub G, Goebel U, Troeger A, Dilloo D J IMMUNOL. 2009182(1):718-725. Second allogeneic stem cell transplantation in myeloid malignancies. Hartwig M, Ocheni S, Asenova S, Wiedemann B, Zabelina T, Ayuketang Ayuk F, Kabisch H, Erttmann R, Krger N, Zander A, Bacher U ACTA HAEMATOL-BASEL. 2009122(4):185-192. Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis. Hasselblatt M, Oyen F, Gesk S, Kordes U, Brigitte W, Bergmann M, Schmid H, Frhwald M, Schneppenheim R, Siebert R, Paulus W J NEUROPATH EXP NEUR. 200968(12):1249-1255. Evaluation of SV40 in osteosarcoma and healthy population: a Hungarian-German study. Heinsohn S, Szendroi M, Bielack S, Zur Stadt U, Kabisch H ONCOL REP. 200921(2):289-297. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Janka-Schaub G KLIN PADIATR. 2009221(5):278-285. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany. Kaatsch P, Reinisch I, Spix C, Berthold F, Janka-Schaub G, Mergenthaler A, Michaelis J, Blettner M CANCER CAUSE CONTROL. 200920(6):965-980. Neuroonkologie Kammler G, Kordes U, Hornung D, LINHART D, Hagel C 2009. Neuropdiatrie - Evidenzbasierte Therapie. Elsevier: 215-239. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen. Krger N, Zabelina T, Binder T, Ayuketang Ayuk F, Bacher U, Amtsfeld G, Lellek H, Schrum J, Erttmann R, Eiermann T, Zander A BIOL BLOOD MARROW TR. 200915(4):454-462. Pancytopenia in a 4-year-old boy. 22q11.2 microdeletion syndrome. Lehmberg K, Rohr J, Schneppenheim R, Sommerfeld K, Janka-Schaub G ACTA PAEDIATR. 200998(5):769-770, 912-914. Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. Linden v, Marieke H, Valsecchi M, Paola D, Janka-Schaub G, Janka G, Leblanc T, Felice M, Andrea B, Campbell M, Hann I, Rubnitz J, Stary J, Szczepanski T, Vora A, Ferster A, Hovi L, Silverman L, Pieters R BLOOD. 2009114(18):3764-3768. Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia. Lnnerholm G, Valsecchi M, Paola D, Schrappe M, Hovi L, Campbell M, Mann G, Janka-Schaub G, Li C, Stary J, Hann I, Pieters R PEDIATR BLOOD CANCER. 200952(5):596-601. Heterozygous missense protein S mutation in a young boy with incomplete tetraplegia. Mauz-Koerholz C, Mller T, Kunze C, Schneppenheim R, Bernstaedt M, Koerholz D KLIN PADIATR. 2009221(3):180. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Meeths M, Bryceson Y, Rudd E, Zheng C, Wood S, Ramme K, Beutel K, Hasle H, Heilmann C, Hultenby K, Ljunggren H, Fadeel B, Nordenskjld M, Henter J PEDIATR BLOOD CANCER. 2009. New insights to the MLL recombinome of acute leukemias. Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J, Ben Abdelali R, Macintyre E, De Braekeleer E, De Braekeleer M, Delabesse E, de Oliveira M, Cav H, Clappier E, van Dongen J, Balgobind B, van den Heuvel-Eibrink M, Beverloo H, Panzer-Grmayer R, Teigler-Schlegel A, Harbott J, Kjeldsen E, Schnittger S, Koehl U, Gruhn B, Heidenreich O, Chan L, Yip S, Krzywinski M, Eckert C, Mricke A, Schrappe M, Alonso C, Schfer B, Krauter J, Lee D, Zur Stadt U, Te Kronnie G, Sutton R, Izraeli S, Trakhtenbrot L, Lo Nigro L, Tsaur G, Fechina L, Szczepanski T, Strehl S, Ilencikova D, Molkentin M, Burmeister T, Dingermann T, Klingebiel T, Marschalek R LEUKEMIA. 200923(8):1490-1499. Italian Society of Hematology guidelines for thalassemia and non-invasive iron measurements. Nielsen P, Engelhardt R, Grosse R, Janka-Schaub G, Harmatz P, Fischer R HAEMATOLOGICA. 200994(2):294-296. Allogeneic blood SCT for children with Hurlers syndrome: results from the German multicenter approach MPS-HCT 2005. Sauer M, Meissner B, Fuchs D, Gruhn B, Kabisch H, Erttmann R, Suttorp M, Beilken A, Luecke T, Welte K, Grigull L, Sykora K BONE MARROW TRANSPL. 200943(5):375-381. Molecular analysis and clinical aspects of four patients with Chdiak-Higashi syndrome (CHS). Scherber E, Beutel K, Ganschow R, Schulz A, Janka-Schaub G, Zur Stadt U CLIN GENET. 2009. Response to DDAVP in children with von Willebrand disease type 2. Schneppenheim R, Budde U, Beutel K, Hassenpflug W, Hauch H, Obser T, Oyen F, Schneppenheim S, Schrum J HAMOSTASEOLOGIE. 200929(2):143-148. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. Schneppenheim R, Baldauf C, Stacklies W, Obser T, Pieconka A, Schneppenheim S, Budde U, Zhou J, Grter F J THROMB HAEMOST. 20097(12):2096-2105. Paediatric haemostaseology. Schneppenheim R HAMOSTASEOLOGIE. 200929(2):133. The problem of novel FVIII missense mutations for haemophilia A genetic counseling. Schneppenheim R, Schrder J, Obser T, Oyen F, Schneppenheim S, Oldenburg J HAMOSTASEOLOGIE. 200929(2):158-160. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation. Sparber-Sauer M, Hnig M, Schulz A, Zur Stadt U, Schtz C, Debatin K, Friedrich W BONE MARROW TRANSPL. 200944(6):333-338. Hemophagocytic lymphohistiocytosis and Kawasaki disease: Combined manifestation and differential diagnosis. Titze U, Janka-Schaub G, Schneider E, Prall F, Haffner D, Classen C PEDIATR BLOOD CANCER. 200953(3):493-495. WT1 mutations in T-ALL. Tosello V, Mansour M, Barnes K, Paganin M, Sulis M, Jenkinson S, Allen C, Gale R, Linch D, Palomero T, Real P, Murty V, Yao X, Richards S, Goldstone A, Rowe J, Basso G, Wiernik P, Paietta E, Pieters R, Horstmann M, Meijerink J, Ferrando A BLOOD. 2009114(5):1038-1045. WT1 mutations in T-ALL Tosello V, Mansour M, Barnes K, Paganin M, Sulis M, Jenkinson S, Allen C, Gale R, Linch D, Palomero T, Real P, Murty V, Yao X, Richards S, Goldstone A, Rowe J, Basso G, Wiernik P, Paietta E, Pieters R, Horstmann M, Meijerink J, Ferrando A BLOOD. 2009114(5):1038-45. Treatment of the X-linked lymphoproliferative, Griscelli and Chdiak-Higashi syndromes by HLH directed therapy. Trottestam H, Beutel K, Meeths M, Carlsen N, Heilmann C, Pasi S, Webb D, Hasle H, Henter J PEDIATR BLOOD CANCER. 200952(2):268-272. A novel type 2A von Willebrand factor mutation (V1499E) associated with variable clinical expression. van Den H, Esther , Laat d, Bas , Eckmann , Carel M, Michiels , Jan J, Schneppenheim R, Reinhard , Ulrich B, Mourik v, Jan A, Versteegh , Florens G J PEDIAT HEMATOL ONC. 200931(4):277-280. Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT91. von Bueren A, von Hoff K, Benesch M, Rutkowski S KLIN PADIATR. 2009221(6):396-397. RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio - and chemotherapy in childhood medulloblastoma cells. von Bueren A, Andr O, Shalaby T, Oehler-Jnne C, Arnold L, Stearns D, Eberhart C, Arcaro A, Pruschy M, Grotzer M BMC CANCER. 20099:10. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, Strauss J, Kasper B, Nrnberg G, Becker C, Maul-Pavicic A, Beutel K, Janka-Schaub G, Griffiths G, Ehl S, Hennies H AM J HUM GENET. 200985(4):482-492. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors. Ayuketang Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Krger N, Zander A EXP HEMATOL. 200836(8):1047-1054. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis Balgobind B, Van Vlierberghe P, van den Ouweland A, Beverloo H, Terlouw-Kromosoeto J, van Wering E, Reinhardt D, Horstmann M, Kaspers G, Pieters R, Zwaan C, Van den Heuvel-Eibrink M, Meijerink J BLOOD. 2008111(8):4322-8. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Balgobind , Brian V, Vlierberghe V, Pieter , van Den O, Ans M, Beverloo , Berna H, Terlouw-Kromosoeto , Joan N, Wering v, Elisabeth R, Reinhardt , Dirk , Horstmann M, Martin , Kaspers , Gertjan J, Pieters , Rob , Zwaan , Michel C, Heuvel-Eibrink V, Marry M, Meijerink , Jules P BLOOD. 2008111(8):4322-4328. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Childrens Oncology Group Study corrected. Bhojwani D, Kang H, Menezes R, Yang W, Sather H, Moskowitz N, Min D, Potter J, Harvey R, Hunger S, Seibel N, Raetz E, Pieters R, Horstmann M, Relling M, Boer d, Monique L, Willman C, Carroll W J CLIN ONCOL. 200826(27):4376-4384. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia Bhojwani D, Kang H, Menezes R, Yang W, Sather H, Moskowitz N, Min D, Potter J, Harvey R, Hunger S, Seibel N, Raetz E, Pieters R, Horstmann M, Relling M, den Boer M, Willman C, Carroll W Journal of clinical oncology. official journal of the American Society of Clinical Oncology. 200826(27):4376-84. Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Bockmeyer C, Claus R, Budde U, Kentouche K, Schneppenheim R, Lsche W, Reinhart K, Brunkhorst F HAEMATOLOGICA. 200893(1):137-140. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. Boller D, Schramm A, Doepfner K, Shalaby T, von Bueren A, Andr O, Eggert A, Grotzer M, Arcaro A CLIN CANCER RES. 200814(4):1172-1181. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Borgmann A, Zinn C, Hartmann R, Herold R, Kaatsch P, Escherich G, Mricke A, Henze G, von Stackelberg A EUR J CANCER. 200844(2):257-268. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). Budde U, Schneppenheim R, Eikenboom J, Goodeve A, Will K, Drewke E, Castaman G, Rodeghiero F, Federici A, Batlle J, Prez A, Meyer D, Mazurier C, Goudemand J, Ingerslev J, Habart D, Vorlova Z, Holmberg L, Lethagen S, Pasi J, Hill F, Peake I J THROMB HAEMOST. 20086(5):762-771. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Castaman G, Lethagen S, Federici A, Tosetto A, Goodeve A, Budde U, Batlle J, Meyer D, Mazurier C, Fressinaud E, Goudemand J, Eikenboom J, Schneppenheim R, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Pasi J, Hill F, Peake I, Rodeghiero F BLOOD. 2008111(7):3531-3539. Treatment of neuroblastoma with human natural antibodies. Erttmann R AUTOIMMUN REV. 20087(6):496-500. Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival. Fiegel H, Kaifi J, Quaas A, Varol E, Krickhahn A, Metzger R, Sauter G, Till H, Izbicki J, Erttmann R, Kluth D PEDIATR SURG INT. 200824(1):101-105. Midkine is highly expressed in neuroblastoma tissues. Fiegel H, Kaifi J, Wachowiak R, Quaas A, Aridome K, Ichihara-Tanaka K, Muramatsu T, Metzger R, Izbicki J, Erttmann R, Kluth D, Till H PEDIATR SURG INT. 200824(12):1355-1359. Analysis of the CC chemokine receptor 5Delta32 polymorphism in pediatric liver transplant recipients. Fischer-Maas L, Schneppenheim R, Oyen F, Grabhorn E, Briem-Richter A, Fischer L, Ganschow R PEDIATR TRANSPLANT. 200812(7):769-772. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia. Graubner U, Porzig S, Jorch N, Kolb R, Wessalowski R, Escherich G, Janka-Schaub G PEDIATR BLOOD CANCER. 200850(2):259-263. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients. Gupta P, Saxena R, Adamtziki E, Budde U, Oyen F, Obser T, Schneppenheim R BLOOD CELL MOL DIS. 200841(2):219-222. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). Haberichter S, Castaman G, Budde U, Peake I, Goodeve A, Rodeghiero F, Federici A, Batlle J, Meyer D, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, Montgomery R BLOOD. 2008111(10):4979-4985. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain. Hentschke M, Saager B, Horstkotte M, Scherpe S, Wolters M, Kabisch H, Grosse R, Heisig P, Aepfelbacher M, Rohde H INFECTION. 200836(1):85-87. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Horne A, Trottestam H, Aric M, Egeler R, Filipovich A, Gadner H, Imashuku S, Ladisch S, Webb D, Janka-Schaub G, Henter J BRIT J HAEMATOL. 2008140(3):327-335. Impaired capacity for acute endogenous fibrinolysis in smokers is restored by ascorbic acid. Khler J, Koeke K, Karstens M, Schneppenheim R, Meinertz T, Heitzer T FREE RADICAL BIO MED. 200844(3):315-321. Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype. Kordes U, Binder T, Eiermann T, Hassenpflug-Diedrich B, Hassan M, Beutel K, Nagy M, Kabisch H, Schneppenheim R BONE MARROW TRANSPL. 200842(3):219-220. Non-surgical management of advanced cardiac lymphoma. Lilje C, Thiel C, Weil J, Schrum J, Stork A J PEDIATR-US. 2008152(3):440. Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. Minkov M, Steiner M, Ptschger U, Aric M, Braier J, Donadieu J, Grois N, Henter J, Janka-Schaub G, McClain K, Weitzman S, Windebank K, Ladisch S, Gadner H J PEDIATR-US. 2008153(5):1-2, 700-705. An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary. Mohl A, Marschalek R, Masszi T, Nagy E, Obser T, Oyen F, Sallai K, Bod I, Schneppenheim R J THROMB HAEMOST. 20086(10):1729-1735. EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT. Ocheni S, Krger N, Zabelina T, Sobottka I, Ayuketang Ayuk F, Wolschke C, Muth A, Lellek H, Petersen L, Erttmann R, Kabisch H, Zander A, Bacher U BONE MARROW TRANSPL. 200842(3):181-186. Temperature sensitivity of phospho-Ser(473)-PKB/AKT. Oehler-Jnne C, von Bueren A, Andr O, Vuong V, Hollenstein A, Grotzer M, Pruschy M BIOCHEM BIOPH RES CO. 2008375(3):399-404. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Pieter V, van Grotel M, Tchinda J, Lee C, Beverloo H, Spek v, Peter J, Stubbs A, Cools J, Nagata K, Fornerod M, Horstmann M, Horstmann M, Wering v, Elisabeth R, Soulier J, Pieters R, Meijerink J BLOOD. 2008111(9):4668-4680. Inborn and acquired von Willebrand disease Schneppenheim R, Budde U HAMOSTASEOLOGIE. 200828(5):312-319. Review and update of the use of urokinase in the prevention and management of CVAD-related complications in pediatric oncology patients. Simon A, Udo B, Lieber K, Beutel K, Fleischhack G AM J INFECT CONTROL. 200836(1):54-58. Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations. Trizzino A, Zur Stadt U, Ueda I, Risma K, Janka G, Ishii E, Beutel K, Sumegi J, Cannella S, Pende D, Mian A, Henter J, Janka-Schaub G, Santoro A, Filipovich A, Aric M J MED GENET. 200845(1):15-21. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts. Troeger A, Glouchkova L, Escherich G, Siepermann M, Hanenberg H, Janka-Schaub G, Gbel U, Ackermann B, Dilloo D KLIN PADIATR. 2008220(6):353-357. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95. Troeger A, Glouchkova L, Ackermann B, Escherich G, Meisel R, Hanenberg H, Boer d, Monique L, Janka-Schaub G, Janka-Schaub G, Goebel U, Laws H, Dilloo D BLOOD. 2008112(4):1028-1034. Erythrocytapheresis: Erythrocytapheresis: Ullrich H, Fischer R, Grosse R, Kordes U, Schubert C, Altstadt B, Andreu G TRANSFUS MED HEMOTH. 200835(1):24-30. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL. Van Vlierberghe P, Homminga I, Zuurbier L, Gladdines-Buijs J, van Wering E, Horstmann M, Beverloo H, Pieters R, Meijerink J LEUKEMIA. 200822(4):762-770. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia. Van Vlierberghe P, Beverloo H, Buijs-Gladdines J, van Wering E, Horstmann M, Pieters R, Meijerink J LEUKEMIA. 200822(7):1434-1437. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia Van Vlierberghe P, Beverloo H, Buijs-Gladdines J, van Wering E, Horstmann M, Pieters R, Meijerink J LEUKEMIA. 200822(7):1434-7. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo H, van der Spek P, Stubbs A, Cools J, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering E, Soulier J, Pieters R, Meijerink J BLOOD. 2008111(9):4668-80. Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications von Hoff K, Kieffer V, Habrand J, Kalifa C, Dellatolas G, Grill J BMC CANCER. 20088:15. High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia. von Stackelberg A, Hartmann R, Bhrer C, Fengler R, Janka-Schaub G, Reiter A, Mann G, Schmiegelow K, Ratei R, Klingebiel T, Ritter J, Henze G BLOOD. 2008111(5):2573-2580. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Agrawal S, Unterberg M, Koschmieder S, Zur Stadt U, Brunnberg U, Verbeek W, Bchner T, Berdel W, Serve H, Mller-Tidow C CANCER RES. 200767(3):1370-1377. Insulin-like factor 3 levels in cord blood and serum from children Bay K, Virtanen H, Hartung S, Ivell R, Main K, Skakkebaek N, Andersson A, Toppari J The Journal of clinical endocrinology and metabolism. 200792(10):4020-7. Recent developments in iron chelation therapy. Cario H, Janka-Schaub G, Janssen G, Jarisch A, Strauss G, Kohne E KLIN PADIATR. 2007219(3):158-165. Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells. Dcunja J, Shalaby T, Rivera P, von Bueren A, Patti R, Heppner F, Arcaro A, Rorke-Adams L, Phillips P, Grotzer M EUR J CANCER. 200743(10):1581-1589. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia. Escherich G, Gbel U, Jorch N, Spaar H, Janka-Schaub G KLIN PADIATR. 2007219(3):134-138. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. Fedier A, Dedes K, Imesch P, von Bueren A, Andre O, Fink D INT J ONCOL. 200731(3):633-641. Thrombotic microangiopathy in a 17-year-old patient: TTP, HUS or a bit of both Gerth J, Busch M, Oyen F, Schneppenheim R, Keller T, Budde U, Groene H, Wolf G CLIN NEPHROL. 200768(6):405-411. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT91--implications for investigating childhood medulloblastoma. Grotzer M, von Hoff K, von Bueren A, Shalaby T, Hartmann W, Warmuth-Metz M, Emser A, Kortmann R, Kuehl J, Pietsch T, Rutkowski S KLIN PADIATR. 2007219(6):312-317. Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of isolated and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group. Hagedorn N, Acquaviva C, Fronkova E, von Stackelberg A, Barth A, Zur Stadt U, Schrauder A, Trka J, Gaspar N, Seeger K, Henze G, Cav H, Eckert C BLOOD. 2007110(12):4022-4029. Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma. Heinsohn S, Evermann U, Zur Stadt U, Bielack S, Kabisch H INT J ONCOL. 200730(5):1205-1214. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Henter J, Horne A, Aric M, Egeler R, Filipovich A, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka-Schaub G PEDIATR BLOOD CANCER. 200748(2):124-131. Familial and acquired hemophagocytic lymphohistiocytosis. Janka-Schaub G EUR J PEDIATR. 2007166(2):95-109. Hemophagocytic syndromes. Janka-Schaub G BLOOD REV. 200721(5):245-253. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. Krappmann P, Paulides M, Sthr W, Ittner E, Plattig B, Nickel P, Lackner H, Schrappe M, Janka-Schaub G, Beck J, Langer T PEDIATR HEMAT ONCOL. 200724(2):101-109. From neonates to adolescents--the diagnostic significance of pitted erythrocytes in hyposplenic and asplenic children. Lehmberg K, Steinhausen B, Janka-Schaub G KLIN PADIATR. 2007219(6):339-342. Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio - and chemotherapy. Meister N, Shalaby T, von Bueren A, Rivera P, Patti R, Oehler C, Pruschy M, Grotzer M EUR J CANCER. 200743(12):1833-1841. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations. Metzner A, Horstmann M, Fehse B, Ortmeyer G, Niemeyer C, Stocking C, Mayr G, Jcker M GENE THER. 200714(8):699-703. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations Metzner A, Horstmann M, Fehse B, Ortmeyer G, Niemeyer C, Stocking C, Mayr G, Jcker M Gene therapy. 200714(8):699-703. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Nachman J, Heerema N, Sather H, Camitta B, Forestier E, Harrison C, Dastugue N, Schrappe M, Pui C, Basso G, Silverman L, Janka-Schaub G BLOOD. 2007110(4):1112-1115. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Pieters R, Schrappe M, Paola D, Hann I, Giulio D, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster A, Janka-Schaub G, Rubnitz J, Silverman L, Stary J, Campbell M, Li C, Mann G, Suppiah R, Biondi A, Vora A, Valsecchi M LANCET. 2007370(9583):240-250. Cloning and characterization of dihydrofolate reductase from a facultative alkaliphilic and halotolerant bacillus strain Redecke L, Brehm M, Bredehorst R Extremophiles. life under extreme conditions. 200711(1):75-83. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT91. Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Udo B, Mittler U, Urban C, Benesch M, Kortmann R, Schlegel P, Kuehl J, Pietsch T, Grotzer M CLIN CANCER RES. 200713(9):2651-2657. Accessibility and quality of secondary care rheumatology services for people with inflammatory arthritis: a regional survey. Sandhu R, Treharne G, Justice E, Jordan A, Saravana S, Obrenovic K, Erb N, Kitas G, Rowe I CLIN MED. 20077(6):579-584. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3. Schneppenheim R, Castaman G, Federici A, Kreuz W, Marschalek R, Oldenburg J, Oyen F, Budde U J THROMB HAEMOST. 20075(4):722-728. Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity. Treharne G, Douglas K, Iwaszko J, Panoulas V, Hale E, Mitton D, Piper H, Erb N, Kitas G Musculoskeletal Care. 20075(4):175-190. Up-regulation of c-FLIPSR upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL. Troeger A, Schmitz I, Siepermann M, Glouchkova L, Gerdemann U, Janka-Schaub G, Schulze-Osthoff K, Dilloo D BLOOD. 2007110(1):384-387. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Troeger A, Siepermann M, Escherich G, Meisel R, Willers R, Gudowius S, Moritz T, Laws H, Hanenberg H, Goebel U, Janka-Schaub G, Mahotka C, Dilloo D HAEMATOLOGICA. 200792(8):1043-1050. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia. Troeger A, Gudowius S, Escherich G, Boer d, Monique L, Glouchkova L, Ackermann B, Meisel R, Laws H, Groeger M, Wessalowski R, Willers R, Harbott J, Pieters R, Janka-Schaub G, Janka-Schaub G, Hanenberg H, Dilloo D BRIT J HAEMATOL. 2007139(3):450-457. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia. Trger A, Siepermann M, Mahotka C, Wethkamp N, Blle H, Laws H, Escherich G, Janka-Schaub G, Gbel U, Dilloo D KLIN PADIATR. 2007219(3):127-133. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. van der Velden V, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer E, Flohr T, Sutton R, Cave H, Madsen H, Cayuela J, Trka J, Eckert C, Foroni L, Zur Stadt U, Beldjord K, Raff T, van der Schoot C, van Dongen J LEUKEMIA. 200721(4):604-611. Salbutamol exhibits androgenic activity in vitro. von Bueren A, Andr O, Ma R, Schlumpf M, Lichtensteiger W BRIT J SPORT MED. 200741(12):874-878. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. von Bueren A, Andr O, Shalaby T, Rajtarova J, Stearns D, Eberhart C, Helson L, Arcaro A, Grotzer M BMC CANCER. 20077:19. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Cappellini M, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D BLOOD. 2006107(9):3455-3462. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. Dahlke J, Krger N, Zabelina T, Ayuketang Ayuk F, Wolschke C, Renges H, Krger W, Kruell A, Hinke A, Erttmann R, Kabisch H, Zander A BONE MARROW TRANSPL. 200637(2):155-163. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains. Dierck K, Machida K, Voigt A, Thimm J, Horstmann M, Fiedler W, Mayer B, Nollau P NAT METHODS. 20063(9):737-744. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains Dierck K, Machida K, Voigt A, Thimm J, Horstmann M, Fiedler W, Mayer B, Nollau P NAT METHODS. 20063(9):737-44. Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease. Distelmaier F, Calaminus G, Harms D, Strter R, Kordes U, Fleischhack G, Gbel U, Schneider D CANCER-AM CANCER SOC. 2006107(9):2298-2306. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD Eikenboom J, Van Marion V, Putter H, Goodeve A, Rodeghiero F, Castaman G, Federici A, Batlle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, Peake I J THROMB HAEMOST. 20064(4):774-82. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Frhwald M, Hasselblatt M, Wirth S, Khler G, Schneppenheim R, Subero J, Siebert R, Kordes U, Jrgens H, Vormoor J PEDIATR BLOOD CANCER. 200647(3):273-278. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Grois N, Ptschger U, Prosch H, Minkov M, Arico M, Braier J, Henter J, Janka-Schaub G, Ladisch S, Ritter J, Steiner M, Unger E, Gadner H PEDIATR BLOOD CANCER. 200646(2):228-233. Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey. Groll A, Attarbaschi A, Schuster F, Herzog N, Grigull L, Dworzak M, Beutel K, Laws H, Lehrnbecher T J ANTIMICROB CHEMOTH. 200657(3):527-535. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Grotel v, Martine , Meijerink , Jules P, Beverloo , Berna H, Langerak , Anton W, Buys-Gladdines , Jessica G, Schneider , Pauline , Poulsen , Tim S, Den B, Monique L, Horstmann M, Martin , Kamps , Willem A, Veerman , Anjo J, Wering v, Elisabeth R, Noesel v, Max M, Pieters , Rob HAEMATOLOGICA. 200691(9):1212-1221. Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis. Hassenpflug W, Ulrich B, Obser T, Angerhaus D, Drewke E, Schneppenheim S, Schneppenheim R BLOOD. 2006107(6):2339-2345. Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols. Holleman A, Boer d, Monique L, Cheok M, Kazemier K, Pei D, Janka-Schaub G, Janka-Schaub G, Gbel U, Graubner U, Pui C, Evans W, Pieters R BLOOD. 2006108(6):1984-1990. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Holleman A, Boer d, Monique L, Menezes d, Rene X, Cheok M, Janka-Schaub G, Kazemier K, Janka-Schaub G, Gbel U, Graubner U, Evans W, Pieters R BLOOD. 2006107(2):769-776. In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. Hubeek I, Peters G, Broekhuizen R, Zwaan C, Kaaijk P, Wering v, Elisabeth S, Gibson B, Janka-Schaub G, Janka-Schaub G, Boer d, Monique L, Pieters R, Kaspers G HAEMATOLOGICA. 200691(1):17-23. von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation Kentouche K, Zintl F, Angerhaus D, Fuchs D, Hermann J, Schneppenheim R, Budde U Seminars in thrombosis and hemostasis. 200632(2):98-104. Validation and application of a high-performance liquid chromatographic-based assay for determination of the inosine 5-monophosphate dehydrogenase activity in erythrocytes. Khalil P, Erb N, Khalil M, Escherich G, Janka-Schaub G J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI. 2006842(1):1-7. RETRACTED: Modified high-performance liquid chromatographic conditions for determination of inosine 5-monophosphate dehydrogenase activity inerythrocytes. Khalil P, Erb N, Khalil M, Escherich G, Janka-Schaub G J Pharmacol Toxicol Methods. 2006. Expression of SOX9 and SOX10 in central neuroepithelial tumor. Kordes U, Hagel C J NEURO-ONCOL. 200680(2):151-155. Quantitative mRNA expression analysis of neurotrophin-receptor TrkC and oncogene c-MYC from formalin-fixed, paraffin-embedded primitive neuroectodermal tumor samples. Kunz F, Shalaby T, Lang D, von Bueren A, Hainfellner J, Slavc I, Tabatabai G, Grotzer M NEUROPATHOLOGY. 200626(5):393-399. Cellular origins of testicular dysgenesis in rats exposed in utero to di(n-butyl) phthalate Mahood I, McKinnell C, Walker M, Hallmark N, Scott H, Fisher J, Rivas A, Hartung S, Ivell R, Mason J, Sharpe R INT J ANDROL. 200629(1):148-54 discussion 181-5. Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia. Meier M, Den B, Meijerink , Broekhuis , Passier , Wering v, Janka-Schaub G, Pieters R LEUKEMIA. 200620(8):1377-1384. A common origin of the 4143insA ADAMTS13 mutation. Schneppenheim R, Hovinga K, Johanna A, Becker T, Ulrich B, Karpman D, Brockhaus W, Hrachovinov I, Oyen F, Oyen F, Rittich S, von Rosen J, Tjnnfjord G, Pimanda J, Wienker T, Lmmle B THROMB HAEMOSTASIS. 200696(1):3-6. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Simon A, Bode U, Beutel K CLIN MICROBIOL INFEC. 200612(7):606-620. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia. Stam , Den B, Passier , Janka-Schaub G, Sallan , Armstrong , Pieters R LEUKEMIA. 200620(2):264-271. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(1221)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome. Stams , Beverloo , Den B, Menezes d, Stigter , Drunen v, Ramakers-van-Woerden , Loonen , Wering v, Janka-Schaub G, Pieters R LEUKEMIA. 200620(3):410-416. Molecular and clinical spectrum of type I plasminogen deficiency Tefs K, Gueorguieva M, Klammt J, Allen C, Aktas D, Anlar F, Aydogdu S, Brown D, Ciftci E, Contarini P, Dempfle C, Dostalek M, Eisert S, Gkbuget A, Gnhan O, Hidayat A, Hgle B, Isikoglu M, Irkec M, Joss S, Klebe S, Kneppo C, Kurtulus I, Mehta R, Ornek K, Schneppenheim R, Seregard S, Sweeney E, Turtschi S, Veres G, Zeitler P, Ziegler M, Schuster V BLOOD. 2006108(9):3021-6. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Udo Z, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka-Schaub G, Hennies H HUM MUTAT. 200627(1):62-68. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia van Grotel M, Meijerink J, Beverloo H, Langerak A, Buys-Gladdines J, Schneider P, Poulsen T, den Boer M, Horstmann M, Kamps W, Veerman A, van Wering E, van Noesel M, Pieters R HAEMATOLOGICA. 200691(9):1212-21. Intracranial hemorrhage in a term newborn with severe von Willebrand disease type 3 associated with sinus venous thrombosis. Wetzstein V, Ulrich B, Oyen F, Ding X, Herrmann J, Liebig B, Schneppenheim R HAEMATOLOGICA. 200691(12):60. Intracranial hemorrhage in a term newborn with severe von Willebrand disease type 3 associated with sinus venous thrombosis Wetzstein V, Budde U, Oyen F, Ding X, Herrmann J, Liebig B, Schneppenheim R HAEMATOLOGICA. 200691(12 Suppl):ECR60. The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005. Aric M, Baruchel A, Bertrand Y, Biondi A, Conter V, Eden T, Gadner H, Gaynon P, Horibe K, Hunger S, Janka-Schaub G, Masera G, Nachman J, Pieters R, Schrappe M, Schmiegelow K, Valsecchi M, Pui C LEUKEMIA. 200519(7):1145-1152. Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells. Bardenheuer W, Lehmberg K, Rattmann I, Brueckner A, Schneider A, Sorg U, Seeber S, Moritz T, Flasshove M LEUKEMIA. 200519(12):2281-2288. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders Bay K, Hartung S, Ivell R, Schumacher M, Jrgensen D, Jorgensen N, Holm M, Skakkebaek N, Andersson A The Journal of clinical endocrinology and metabolism. 200590(6):3410-8. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling F, Schrappe M, Simon T, Hero B LANCET ONCOL. 20056(9):649-658. Diagnostics and management of central venous line infections in pediatric cancer patients Beutel K, Simon A KLIN PADIATR. 2005217(1):91-100. Development and function of the adult generation of Leydig cells in mice with Sertoli cell-selective or total ablation of the androgen receptor De Gendt K, Atanassova N, Tan K, de Frana L, Parreira G, McKinnell C, Sharpe R, Saunders P, Mason J, Hartung S, Ivell R, Denolet E, Verhoeven G ENDOCRINOLOGY. 2005146(9):4117-26. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Mnster Group 87. Einsiedel H, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hhlen K, Gbel U, Klingebiel T, Ludwig W, Henze G J CLIN ONCOL. 200523(31):7942-7950. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Fhrer M, Rampf U, Baumann I, Faldum A, Niemeyer C, Janka-Schaub G, Friedrich W, Ebell W, Borkhardt A, Bender-Goetze C BLOOD. 2005106(6):2102-2104. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Grosse R, Lund U, Caruso V, Fischer R, Janka-Schaub G, Magnano C, Engelhardt R, Drken M, Nielsen P ANN NY ACAD SCI. 20051054:429-432. Gene conversions are a common cause of von Willebrand disease. Gupta P, Adamtziki E, Budde U, Jaiprakash M, Kumar H, Harbeck-Seu A, Kannan M, Oyen F, Obser T, Wedekind I, Saxena R, Schneppenheim R BRIT J HAEMATOL. 2005130(5):752-758. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Holleman A, Boer d, Monique L, Kazemier K, Beverloo H, Janka-Schaub G, Anne R, Janka-Schaub G, Pieters R BLOOD. 2005106(5):1817-1823. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Horne A, Janka-Schaub G, Maarten Egeler R, Gadner H, Imashuku S, Ladisch S, Locatelli F, Montgomery S, Webb D, Winiarski J, Filipovich A, Henter J BRIT J HAEMATOL. 2005129(5):622-630. Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistocytosis provides therapeutic guidance. Horne A, Zheng C, Lorenz I, Lfstedt M, Montgomery S, Janka-Schaub G, Henter J, Marion Schneider E BRIT J HAEMATOL. 2005129(5):658-666. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels Horstmann M, Merseburger A, von der Heyde E, Serth J, Wegener G, Mengel M, Feil G, Hennenlotter J, Nagele U, Anastasiadis A, Bokemeyer C, Stenzl A, Kuczyk M J CANCER RES CLIN. 2005131(11):715-22. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. Horstmann M, Hassenpflug W, Udo Z, Escherich G, Janka-Schaub G, Kabisch H HAEMATOLOGICA. 200590(12):1701-1703. Insulin-like factor 3 - where are we now Ivell R, Hartung S, Anand-Ivell R ANN NY ACAD SCI. 20051041:486-96. Familial and acquired hemophagocytic lymphohistiocytosis. Janka-Schaub G, Udo Z Hematology Am Soc Hematol Educ Program. 200582-88. Hemophagocytic lymphohistiocytosis Janka-Schaub G HEMATOLOGY. 200510 Suppl 1:104-7. Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes. Khalil M, Erb N, Khalil P, Escherich G, Janka-Schaub G J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI. 2005821(1):105-111. Sox group E gene expression distinguishes different types and maturational stages of glial cells in developing chick and mouse. Kordes U, Cheng Y, Scotting P DEV BRAIN RES. 2005157(2):209-213. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Lugthart S, Cheok M, Boer d, Monique L, Yang W, Holleman A, Cheng C, Pui C, Janka-Schaub G, Janka-Schaub G, Pieters R, Evans W CANCER CELL. 20057(4):375-386. Hmophilie B (Faktor-IX-Mangel) mit begleitender Faktor-XII-Erniedrigung bei einem Mischlingskater Lutze G, Kutschmann K, Frst K, Schneppenheim R Berliner und Mnchener tierrztliche Wochenschrift. 2005118(5-6):255-60. Expression of insulin-like factor 3 protein in the rat testis during fetal and postnatal development and in relation to cryptorchidism induced by in utero exposure to di (n-Butyl) phthalate McKinnell C, Sharpe R, Mahood K, Hallmark N, Scott H, Ivell R, Staub C, Jgou B, Haag F, Koch-Nolte F, Hartung S ENDOCRINOLOGY. 2005146(10):4536-44. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia. Meier M, den Boer M, Hall A, Irving J, Passier M, Minto L, van Wering E, Janka-Schaub G, Pieters R LEUKEMIA. 200519(11):1887-1895. Long-term treatment with deferiprone in a L1 veteran. Meo A, Ruggeri A, Rosa L, Angela M, Kordes U, Kordes U, Fischer R EUR J HAEMATOL. 200574(6):523-525. Langerhans cell histiocytosis in neonates. Minkov M, Prosch H, Steiner M, Grois N, Ptschger U, Kaatsch P, Janka-Schaub G, Gadner H PEDIATR BLOOD CANCER. 200545(6):802-807. Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia Mhlhausen C, Schneppenheim R, Budde U, Merkel M, Muschol N, Ullrich K, Santer R J INHERIT METAB DIS. 200528(6):945-50. Angeborenes und erworbenes von-Willebrand-Syndrom Schneppenheim R, Barthels M, Budde U HAMOSTASEOLOGIE. 200525(4):367-75. The evolving classification of von Willebrand disease Schneppenheim R Blood coagulation fibrinolysis. an international journal in haemostasis and thrombosis. 200516 Suppl 1:S3-S10. Viral infections in pediatric cancer patients Schuster F, Simon A, Laws H, Beutel K, Groll A, Jger G, Schuster V KLIN PADIATR. 2005217(1):67-84. Bacterial infections in pediatric cancer patients Simon A, Beutel K, Marklein G, Fleischhack G KLIN PADIATR. 2005217(1):17-36. Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. Stam R, Boer d, Monique L, Schneider P, Horstmann M, Horstmann M, Beverloo H, van der Voort E, Valsecchi M, de Lorenzo P, Sallan S, Armstrong S, Pieters R BLOOD. 2005106(7):2484-2490. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(1221)-positive pediatric acute lymphoblastic leukemia. Stams , Wendy A, Den B, Monique L, Beverloo , Berna H, Meijerink , Jules P, Wering v, Elisabeth R, Janka-Schaub G, Gritta E, Pieters , Rob CLIN CANCER RES. 200511(8):2974-2980. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia. Stams , Wendy A, Den B, Monique L, Beverloo , Berna H, Kazemier , Karin M, Wering v, Elisabeth R, Janka-Schaub G, Gritta E, Pieters , Rob HAEMATOLOGICA. 200590(12):1697-1699. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. Stams W, Boer d, Monique L, Holleman A, Appel I, Beverloo H, Janka-Schaub G, Elisabeth R, Janka-Schaub G, Evans W, Pieters R BLOOD. 2005105(11):4223-4225. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Udo Z, Schmidt S, Kasper B, Beutel K, Diler A, Henter J, Kabisch H, Schneppenheim R, Nrnberg P, Janka-Schaub G, Hennies H HUM MOL GENET. 200514(6):827-834. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro. Valentiner U, Carlsson M, Erttmann R, Hildebrandt H, Schumacher U TOXICOLOGY. 2005213(1-2):157-168. Identification of the actin-binding domain of Ins(1,4,5)P3 3-kinase isoform B (IP3K-B) Brehm M, Schreiber I, Bertsch U, Wegner A, Mayr G The Biochemical journal. 2004382(Pt 1):353-62. Diagnosis of thrombotic thrombocytopenic purpura Budde U, Angerhaus D, Obser T, Schneppenheim R HAMOSTASEOLOGIE. 200424(1):65-70. Standardisierte Diagnostik des von-Willebrand-Syndroms Budde U, Drewke E, Will K, Schneppenheim R HAMOSTASEOLOGIE. 200424(1):12-26. Diagnose der thrombotisch-thrombozytopenischen Purpura Budde U, Angerhaus D, Obser T, Schneppenheim R HAMOSTASEOLOGIE. 200424(1):65-70. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Du J, Widlund H, Horstmann M, Ramaswamy S, Ross K, Huber W, Nishimura E, Golub T, Fisher D CANCER CELL. 20046(6):565-576. Thrombotic thrombocytopenic purpura in childhood Hassenpflug W, Angerhaus D, Budde U, Obser T, Schneppenheim R HAMOSTASEOLOGIE. 200424(1):71-76. Thrombotisch-thrombozytopenische Purpura im Kindesalter Hassenpflug W, Angerhaus D, Budde U, Obser T, Schneppenheim R HAMOSTASEOLOGIE. 200424(1):71-6. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Haupt R, Nanduri V, Calevo M, Bernstrand C, Braier J, Broadbent V, Rey G, McClain K, Janka-Schaub G, Egeler R PEDIATR BLOOD CANCER. 200442(5):438-444. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Heerema N, Harbott J, Galimberti S, Camitta B, Gaynon P, Janka-Schaub G, Kamps W, Basso G, Pui C, Schrappe M, Auclerc M, Carroll A, Conter V, Harrison C, Pullen J, Raimondi S C, Richards S, Riehm H, Sather H, Shuster J, Silverman L, Valsecchi M, Aric M LEUKEMIA. 200418(4):693-702. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. Holleman A, Cheok M, Boer d, Monique L, Yang W, Veerman A, Kazemier K, Pei D, Cheng C, Pui C, Janka-Schaub G, Janka-Schaub G, Pieters R, Evans W NEW ENGL J MED. 2004351(6):533-542. Modern management of children with haemophagocytic lymphohistiocytosis. Janka-Schaub G, Schneider E BRIT J HAEMATOL. 2004124(1):4-14. Gingivitis as probable source of a thoracic actinomycosis due to Actinomyces israelii and Actinobacillus actinomycetemcomitans. Kordes U, Beutel K, Cachovan G, Schfer H, Helmke K, Sobottka I ARCH DIS CHILD. 200489(10):895. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS) Licht C, Stapenhorst L, Simon T, Budde U, Schneppenheim R, Hoppe B Kidney international. 200466(3):955-8. Molekulare Genetik des von-Willebrand-Syndroms Schneppenheim R HAMOSTASEOLOGIE. 200424(1):37-43. Severe ADAMTS-13 deficiency in childhood. Schneppenheim R, Ulrich B, Hassenpflug W, Obser T SEMIN HEMATOL. 200441(1):83-89. Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization. Schneppenheim R, Lenk H, Obser T, Oldenburg J, Oyen F, Schneppenheim S, Schwaab R, Will K, Ulrich B THROMB HAEMOSTASIS. 200492(1):36-41. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein. Stam , van Den H, Den B, Ebus , Janka-Schaub G, Allen , Pieters R LEUKEMIA. 200418(1):78-83. A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Udo Z, Beutel K, Weber B, Kabisch H, Schneppenheim R, Janka-Schaub G BLOOD. 2004104(6):1910. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Woerden R, Beverloo , Veerman , Camitta , Loonen , Wering v, Slater , Harbott J, Den B, Ludwig , Haas , Janka-Schaub G, Pieters R LEUKEMIA. 200418(3):521-529. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. Den B, Harms , Pieters R, Kazemier , Gobel U, Krholz D, Graubner U, Haas , Jorch N, Spaar , Kaspers , Kamps , Does V, Berg V, Wering V, Janka-Schaub G, Janka-Schaub J CLIN ONCOL. 200321(17):3262-3268. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Du J, Miller A, Widlund H, Horstmann M, Ramaswamy S, Fisher D AM J PATHOL. 2003163(1):333-343. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma Du J, Miller A, Widlund H, Horstmann M, Ramaswamy S, Fisher D The American journal of pathology. 2003163(1):333-43. High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood. Erb N, Haverland U, Harms D, Escherich G, Janka-Schaub G J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI. 2003796(1):87-94. Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis. Ericson K, Fadeel B, Andersson M, Gudmundsson G, Grgey A, Yalman N, Janka-Schaub G, Nordenskjld M, Henter J HUM GENET. 2003112(1):98-99. Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Harms D, Gbel U, Spaar H, Graubner U, Jorch N, Gutjahr P, Janka-Schaub G BLOOD. 2003102(8):2736-2740. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M, Kohne E BLOOD. 2003102(13):4576-4581. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Holleman A, Boer d, Monique L, Janka-Schaub G, Janka-Schaub G, Pieters R BLOOD. 2003102(13):4541-4546. Infantile cobalamin deficiency with cerebral lactate accumulation and sustained choline depletion Horstmann M, Neumaier-Probst E, Lukacs Z, Steinfeld R, Ullrich K, Kohlschtter A NEUROPEDIATRICS. 200334(5):261-4. Infantile cobalamin deficiency with cerebral lactate accumulation and sustained choline depletion. Horstmann M, Neumaier-Probst E, Lukacs Z, Steinfeld R, Ullrich K, Kohlschtter A NEUROPEDIATRICS. 200334(5):261-264. The molecular basis of cryptorchidism Ivell R, Hartung S MOL HUM REPROD. 20039(4):175-81. Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Kaaijk P, Kaspers G, Van Wering E, Broekema G, Loonen A, Hhlen K, Schmiegelow K, Janka-Schaub G, Henze G, Creutzig U, Veerman A BRIT J CANCER. 200388(5):775-781. Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases. Nielsen P, Fischer R, Buggisch P, Janka-Schaub G BRIT J HAEMATOL. 2003123(5):952-953. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Pui C, Chessells J, Camitta B, Baruchel A, Biondi A, Boyett J, Carroll A, Eden O, Evans W, Gadner H, Harbott J, Harms D, Harrison C, Harrison P, Heerema N, Janka-Schaub G, Kamps W, Masera G, Pullen J, Raimondi S C, Richards S, Riehm H, Sallan S, Sather H, Shuster J, Silverman L, Valsecchi M, Vilmer E, Zhou Y, Gaynon P, Schrappe M LEUKEMIA. 200317(4):700-706. Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany. Schilling F, Spix C, Berthold F, Erttmann R, Sander J, Treuner J, Michaelis J CANCER LETT. 2003197(1-2):19-28. Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis Schneider E, Lorenz I, Walther P, Janka-Schaub G J PEDIAT HEMATOL ONC. 200325(9):680-683. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Schneppenheim R, Ulrich B, Oyen F, Angerhaus D, Aumann V, Drewke E, Hassenpflug W, Hberle J, Kentouche K, Kohne E, Kurnik K, Mller-Wiefel D, Obser T, Santer R, Sykora K BLOOD. 2003101(5):1845-1850. Lead-time and overdiagnosis estimation in neuroblastoma screening. Spix C, Michaelis J, Berthold F, Erttmann R, Sander J, Schilling F STAT MED. 200322(18):2877-2892. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Stam R, Boer d, Monique L, Meijerink J, Ebus M, Peters G, Janka-Schaub G, Janka-Schaub G, Armstrong S, Korsmeyer S, Pieters R BLOOD. 2003101(4):1270-1276. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(1221) pediatric ALL. Stams , Wendy A, Den B, Monique L, Beverloo , Berna H, Meijerink , Jules P, Stigter , Rolinda L, Wering v, Elisabeth R, Janka-Schaub G, Gritta E, Slater , Rosalyn , Pieters , Rob BLOOD. 2003101(7):2743-2747. Rapid LightCycler assay for identification of the perforin codon 374 Trp --gt stop mutation in patients and families with hemophagocytic lymphohistiocytosis (HLH). Udo Z, Kabisch H, Janka-Schaub G, Schneider E Med Pediatr Oncol. 200341(1):26-29. 2 Hmophilie-A-Patienten ohne Mutation im FVIII-Gen Uen C, Oldenburg J, Schrder J, Brackmann H, Schramm W, Schwaab R, Schneppenheim R, Graw J HAMOSTASEOLOGIE. 200323(1):1-5. Identification and characterisation of clonal incomplete T-cell-receptor Vdelta2-Ddelta3/Ddelta2-Ddelta3 rearrangements by denaturing high-performance liquid chromatography and subsequent fragment collection zur Stadt U, Eckert C, Rischewski J, Michael K, Golta S, Mller M, Schneppenheim R, Kabisch H J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI. 2003792(2):287-98. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M, Zimmermann M, Ludwig W, Janka-Schaub G, Schrappe M, Harbott J LEUKEMIA. 200216(9):1685-1690. Laboratory diagnosis of congenital von Willebrand disease Budde U, Drewke E, Mainusch K, Schneppenheim R Seminars in thrombosis and hemostasis. 200228(2):173-90. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Fuchs J, Rydzynski J, Dietrich V, Udo B, Hecker H, Weinel P, Brger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H CANCER-AM CANCER SOC. 200295(1):172-182. Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole, iv-immunoglobulin and ATG Graf Finckenstein F, Zabelina T, Drken M, Dahlke J, Krger N, Krger W, Janka-Schaub G, Erttmann R, Zander A, Kabisch H KLIN PADIATR. 2002214(4):206-211. In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37 degrees C, but not with affinity determined at room temperature. Haarman , Kaspers , Pieters R, Rottier , Den B, Janka-Schaub G, Veerman LEUKEMIA. 200216(9):1882-1884. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Henter J, Samuelsson-Horne A, Aric M, Egeler R, Elinder G, Filipovich A, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka-Schaub G BLOOD. 2002100(7):2367-2373. Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma Kentouche K, Budde U, Furlan M, Scharfe V, Schneppenheim R, Zintl F ACTA PAEDIATR. 200291(10):1056-9. 11 hemophilia A patients without mutations in the factor VIII encoding gene Klopp N, Oldenburg J, Uen C, Schneppenheim R, Graw J THROMB HAEMOSTASIS. 200288(2):357-60. Homozygous Factor V Leiden mutation in sickle cell anaemia. Kordes U, Janka-Schaub G, Schneppenheim R BRIT J HAEMATOL. 2002116(1):236. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin. Krger N, Zabelina T, Renges H, Krger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuketang Ayuk F, Erttmann R, Kabisch H, Zander A ANN HEMATOL. 200281(11):627-631. In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors. Krger N, Zabelina T, Krger W, Renges H, Stute N, Rischewski J, Sonnenberg S, Ayuk F, Ayuketang Ayuk F, Schade U, Fiegel H, Erttmann R, Lliger C, Zander A BONE MARROW TRANSPL. 200229(8):683-689. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin Krger N, Zabelina T, Renges H, Krger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuk F, Erttmann R, Kabisch H, Zander A ANN HEMATOL. 200281(11):627-31. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. McGill G, Horstmann M, Widlund H, Du J, Motyckova G, Nishimura E, Lin Y, Ramaswamy S, Avery W, Ding H, Jordan S, Jackson I, Korsmeyer S, Golub T, Fisher D CELL. 2002109(6):707-718. SQUID-biosusceptometry in iron overloaded patients with hematologic diseases Nielsen P, Kordes U, Fischer R, Engelhardt R, Janka-Schaub G KLIN PADIATR. 2002214(4):218-222. In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups. Ramakers-van Woerden N, Pieters R, Hoelzer D, Slater R, den Boer M, Loonen A, Harbott J, Janka-Schaub G, Ludwig W, Ossenkoppele G, van Wering E, Veerman A Med Pediatr Oncol. 200238(6):379-386. Neuroblastoma screening at one year of age. Schilling F, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J NEW ENGL J MED. 2002346(14):1047-1053. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Schneider E, Lorenz I, Mller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub G BLOOD. 2002100(8):2891-2898. Prenatal diagnosis of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHLH). Udo Z, Pruggmayer M, Jung H, Henter J, Schneider M, Kabisch H, Janka-Schaub G PRENATAL DIAG. 200222(1):80-81. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor Widlund H, Horstmann M, Price E, Cui J, Lessnick S, Wu M, He X, Fisher D J CELL BIOL. 2002158(6):1079-87. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Zwaan C, Kaspers G, Pieters R, Hhlen K, Janka-Schaub G, Zantwijk v, Christina H, Huismans D, de Vries E, Rots M, Peters G, Jansen G, Creutzig U, Veerman A BLOOD. 200299(1):245-251. Familial hemophagocytic lymphohistiocytosis: how late can the onset be Allen M, De Fusco C, Legrand F, Clementi R, Conter V, Danesino C, Janka-Schaub G, Aric M HAEMATOLOGICA. 200186(5):499-503. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. Clementi R, Zur Stadt U, Savoldi G, Varoitto S, Conter V, De Fusco C, Notarangelo L, Schneider M, Klersy C, Janka-Schaub G, Danesino C, Aric M J MED GENET. 200138(9):643-646. Bone marrow transplantation in hemophagocytic lymphohistiocytosis. Drken M, Finckenstein F, Janka-Schaub G LEUKEMIA LYMPHOMA. 200141(1-2):89-95. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Gransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, Sderhll C, Samuelsson A, Janka G, Schneider M, Grgey A, Yalman N, Rvsz T, Egeler R, Jahnukainen K, Storm-Mathiesen I, Haraldsson A, Poole J, Janka-Schaub G, Nordenskjld M, Henter J AM J HUM GENET. 200168(3):590-597. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Krger N, Schetelig J, Zabelina T, Krger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander A BONE MARROW TRANSPL. 200128(7):643-647. Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors. Krger N, Zabelina T, Krger W, Renges H, Stute N, Drken M, Graf von Finkenstein F, Erttmann R, Kabisch H, Schafhausen P, Jaburg N, Lliger C, Zander A ANN HEMATOL. 200180(4):209-215. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin. Krger N, Zabelina T, Krger W, Renges H, Stute N, Schrum J, Kabisch H, Schafhausen P, Jaburg N, Lliger C, Schfer P, Hinke A, Zander A BRIT J HAEMATOL. 2001113(4):1060-1071. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin Krger N, Zabelina T, Krger W, Renges H, Stute N, Schrum J, Kabisch H, Schafhausen P, Jaburg N, Lliger C, Schfer P, Hinke A, Zander A BRIT J HAEMATOL. 2001113(4):1060-71. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Motyckova G, Weilbaecher K, Horstmann M, Rieman D, Fisher D, Fisher D P NATL ACAD SCI USA. 200198(10):5798-5803. Linking osteopetrosis and pycnodysostosis Motyckova G, Weilbaecher K, Horstmann M, Rieman D, Fisher D, Fisher D P NATL ACAD SCI USA. 200198(10):5798-803. Familial Williams-Beuren syndrome showing varying clinical expression Pankau R, Siebert R, Kautza M, Schneppenheim R, Gosch A, Wessel A, Partsch C Am J Med Genet. 200198(4):324-9. Localized Ewing tumor of bone: final results of the cooperative Ewings Sarcoma Study CESS 86. Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner G, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Mller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Gbel U, Treuner J, Vote P, Zoubek A, Gadner H, Jrgens H J CLIN ONCOL. 200119(6):1818-1829. In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia. Ramakers-van Woerden N, Pieters R, Slater R, Loonen A, Beverloo H, van Drunen E, Heyman M, Moreno T, Rots M, van Wering E, Kamps W, Janka-Schaub G, Veerman A BRIT J HAEMATOL. 2001112(3):680-690. Screening strategies for a highly polymorphic gene Rischewski J, Schneppenheim R Journal of biochemical and biophysical methods. 200147(1-2):53-64. Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease. Schneppenheim R, Budde U, Obser T, Brassard J, Mainusch K, Ruggeri Z, Schneppenheim S, Schwaab R, Oldenburg J BLOOD. 200197(7):2059-2066. A molecular approach to the classification of von Willebrand disease Schneppenheim R, Budde U, Ruggeri Z BEST PRACT RES CL HA. 200114(2):281-98. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Mnster Group Trial NHL-BFM 90. Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, Drffel W, Zimmermann M, Mann G, Gadner H, Parwaresch R, Riehm H, Reiter A BLOOD. 200197(12):3699-3706. Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry Studt J, Budde U, Schneppenheim R, Eisert R, von Depka Prondzinski M, Ganser A, Barthels M AM J CLIN PATHOL. 2001116(4):567-74. Successful treatment of Pseudomonas aeruginosa respiratory tract infection with a sugar solution--a case report on a lectin based therapeutic principle von Bismarck P, Schneppenheim R, Schumacher U KLIN PADIATR. 2001213(5):285-7. Denaturing HPLC for identification of clonal T-cell receptor gamma rearrangements in newly diagnosed acute lymphoblastic leukemia zur Stadt U, Rischewski J, Schneppenheim R, Kabisch H CLIN CHEM. 200147(11):2003-11. MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen. Zur Stadt U, Harms D, Schlter S, Schrappe M, Goebel U, Spaar H, Janka-Schaub G, Kabisch H LEUKEMIA. 200115(2):283-285. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. Aric M, Valsecchi M, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui C, Masera G NEW ENGL J MED. 2000342(14):998-1006. An additional unique candidate mutation (G2470A M740I) in the original families with von Willebrand disease type 2 M Vicenza and the G3864A (R1205H) mutation Castaman G, Missiaglia E, Federici A, Schneppenheim R, Rodeghiero F THROMB HAEMOSTASIS. 200084(2):350-1. Paraneoplastic cerebellar degeneration in pediatric Hodgkin disease Hahn A, Claviez A, Brinkmann G, Altermatt H, Schneppenheim R, Stephani U NEUROPEDIATRICS. 200031(1):42-4. Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Harms D, Janka-Schaub G LEUKEMIA. 200014(12):2234-2239. Hereditary fructose intolerance and alpha(1) antitrypsin deficiency Hillebrand G, Schneppenheim R, Oldigs H, Santer R Archives of disease in childhood. 200083(1):72-3. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Kordes U, Krappmann D, Heissmeyer V, Ludwig W, Scheidereit C LEUKEMIA. 200014(3):399-402. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Krger N, Zabelina T, Sonnenberg S, Krger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, Del Valle F, Erttmann R, Kabisch H, Zander A BONE MARROW TRANSPL. 200026(7):711-716. Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases. Nielsen P, Engelhardt R, Duerken M, Janka-Schaub G, Fischer R Transfus Sci. 200023(3):257-258. Williams-Beuren syndrome 35 years after the diagnosis in one of the first Beuren patients Pankau R, Partsch C, Gosch A, Siebert R, Schneider M, Schneppenheim R, Winter M, Wessel A Am J Med Genet. 200091(4):322-4. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Ramakers-van Woerden N, Pieters R, Loonen A, Hubeek I, van Drunen E, Beverloo H, Slater R, Harbott J, Seyfarth J, van Wering E, Hhlen K, Schmiegelow K, Janka-Schaub G, Veerman A BLOOD. 200096(3):1094-1099. The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population. Rischewski J, Bismarck P, Kabisch H, Janka-Schaub G, Obser T, Schneppenheim R LEUKEMIA. 200014(8):1528-1529. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy Rischewski J, Clausen H, Leber V, Niemeyer C, Ritter J, Schindler D, Schneppenheim R KLIN PADIATR. 2000212(4):174-6. Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia. Rots M, Pieters R, Peters G, Noordhuis P, Van Zantwijk C, Henze G, Janka-Schaub G, Veerman A, Jansen G BRIT J HAEMATOL. 2000109(3):629-634. Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim results. Schilling F, Berthold F, Erttmann R, Michaelis J, Spix C, Sander J, Schwarz K, Treuner J Med Pediatr Oncol. 200035(6):701-704. Von Willebrand Disease type 2M Vicenza in Italian and German patients Schneppenheim R, Federici A, Budde U, Castaman G, Drewke E, Krey S, Mannucci P, Riesen G, Rodeghiero F, Zieger B, Zimmermann R THROMB HAEMOSTASIS. 200083(1):136-40. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Schrappe M, Camitta B, Pui C, Eden T, Gaynon P, Gustafsson G, Janka-Schaub G, Kamps W, Masera G, Sallan S, Tsuchida M, Vilmer E LEUKEMIA. 200014(12):2193-2194. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Wu M, Hemesath T, Takemoto C, Horstmann M, Wells A, Price E, Fisher D, Fisher D GENE DEV. 200014(3):301-312. Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase Zur Stadt U, Harms D, Schlter S, Jorch N, Spaar H, Nrnberger W, Vlpel S, Gutjahr P, Schrappe M, Janka-Schaub G, Kabisch H KLIN PADIATR. 2000212(4):169-173. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Zwaan C, Kaspers G, Pieters R, Ramakers-Van Woerden N, den Boer M, Wnsche R, Rottier M, Hhlen K, van Wering E, Janka-Schaub G, Creutzig U, Veerman A BLOOD. 200096(8):2879-2886. Intracerebral hemorrhage as a late complication after CNS treatment of childhood lymphoma Claviez A, Neubauer B, Link J, Schneppenheim R KLIN PADIATR. 1999210(6):406-8. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen. David K, Ollert M, Vollmert C, Heiligtag S, Eickhoff B, Erttmann R, Bredehorst R, Vogel C CANCER RES. 199959(15):3768-3775. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance. Den Boer M, Kapaun P, Pieters R, Kazemier K, Janka-Schaub G, Veerman A BRIT J HAEMATOL. 1999105(4):876-882. Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia. Den Boer M, Pieters R, Kazemier K, Janka-Schaub G, Henze G, Creutzig U, Kaspers G, Kearns P, Hall A, Pearson A, Veerman A BRIT J HAEMATOL. 1999104(2):321-327. Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia. Den Boer M, Pieters R, Kazemier K, Janka-Schaub G, Henze G, Veerman A LEUKEMIA. 199913(12):2023-2030. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Dufourcq-Lagelouse R, Jabado N, Le Deist F, Stphan J, Souillet G, Bruin M, Vilmer E, Schneider M, Janka-Schaub G, Fischer A, de Saint Basile G AM J HUM GENET. 199964(1):172-179. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. Drken M, Horstmann M, Bieling P, Erttmann R, Kabisch H, Lliger C, Schneider E, Hellwege H, Krger W, Krger N, Zander A, Janka-Schaub G BRIT J HAEMATOL. 1999106(4):1052-1058. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors Drken M, Horstmann M, Bieling P, Erttmann R, Kabisch H, Lliger C, Schneider E, Hellwege H, Krger W, Krger N, Zander A, Janka G BRIT J HAEMATOL. 1999106(4):1052-8. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Fischer R, Tiemann C, Engelhardt R, Nielsen P, Drken M, Gabbe E, Janka-Schaub G AM J HEMATOL. 199960(4):289-299. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94. Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H KLIN PADIATR. 1999211(4):305-309. In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97 Janka-Schaub G, Harms D, den Boer M, Veerman A, Pieters R KLIN PADIATR. 1999211(4):233-238. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus Jonat S, Santer R, Schneppenheim R, Obser T, Eggert P Archives of disease in childhood. 199981(1):57-9. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Drken B, Scheidereit C ONCOGENE. 199918(4):943-953. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases. Krger W, Rssmann B, Krger N, Salomon C, Ekopf N, Elsner H, Kaulfers P, Mack D, Fuchs N, Drken M, Kabisch H, Erttmann R, Zander A BONE MARROW TRANSPL. 199923(6):589-597. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Niehues T, Kapaun P, Harms D, Burdach S, Kramm C, Krholz D, Janka-Schaub G, Gbel U LEUKEMIA. 199913(4):614-617. Longitudinal evaluation of growth, puberty, and bone maturation in children with Williams syndrome Partsch C, Dreyer G, Gosch A, Winter M, Schneppenheim R, Wessel A, Pankau R J PEDIATR-US. 1999134(1):82-9. A 2-year-old boy with recurrent severe bleeding Rauch R, Budde U, Schneppenheim R, Ries M, Girisch M, Klinge J EUR J PEDIATR. 1999158 Suppl 3:S171-3. Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates. Rots M, Pieters R, Peters G, van Zantwijk C, Mauritz R, Noordhuis P, Willey J, Hhlen K, Creutzig U, Janka-Schaub G, Kaspers G, Veerman A, Jansen G BLOOD. 199994(9):3121-3128. Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial Schmitt C, David K, Hiller J, Schrum J, Bredehorst R, Vogel C, Lliger C, Erttmann R KLIN PADIATR. 1999211(4):314-318. Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow. Zander A, Zabelina T, Krger N, Renges H, Krger W, Lliger C, Drken M, Stockschlder M, de Wit M, Wacker-Backhaus G, Bielack S, Jaburg N, Rssmann B, Erttmann R, Kabisch H BONE MARROW TRANSPL. 199923(9):889-893. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia. den Boer M, Pieters R, Kazemier K, Janka-Schaub G, Henze G, Veerman A LEUKEMIA. 199812(6):912-920. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. den Boer M, Pieters R, Kazemier K, Rottier M, Zwaan C, Kaspers G, Janka-Schaub G, Henze G, Creutzig U, Scheper R, Veerman A BLOOD. 199891(6):2092-2098. Treatment of hemophagocytic lymphohistiocytosis, HLH, with bone marrow transplantation Drken M, Schneider E, Bltters-Sawatzki R, Stollmann-Gibbels B, Janka-Schaub G, Bretz R, Krholz D, Probst E, Holsten-Griffin H, Harps E, Zander A, Janka G KLIN PADIATR. 1998210(4):180-184. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine. Erb N, Harms D, Janka-Schaub G CANCER CHEMOTH PHARM. 199842(4):266-272. 10 years neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE). Erttmann R, Tafese T, Berthold F, Kerbl R, Mann J, Parker L, Schilling F, Ambros P, Christiansen H, Favrot M, Kabisch H, Hero B, Philip T EUR J CANCER. 199834(9):1391-1397. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Fhrer M, Burdach S, Ebell W, Gadner H, Haas R, Harbott J, Janka-Schaub G, Klingebiel T, Kremens B, Niemeyer C, Rampf U, Reiter A, Ritter J, Schulz A, Walther U, Zeidler C, Bender-Gtze C KLIN PADIATR. 1998210(4):173-179. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Henter J, Aric M, Janka-Schaub G, Imashuku S, Janka G HEMATOL ONCOL CLIN N. 199812(2):417-433. Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrands disease Holmberg L, Karpman D, Isaksson C, Kristoffersson A, Lethagen S, Schneppenheim R THROMB HAEMOSTASIS. 199879(4):718-22. Infection - and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Janka G, Imashuku S, Janka-Schaub G, Schneider M, Henter J HEMATOL ONCOL CLIN N. 199812(2):435-444. Treatment and long-term outcome of pineal nongerminomatous germ cell tumors. Knappe U, Bentele K, Horstmann M, Herrmann H PEDIATR NEUROSURG. 199828(5):241-245. Treatment and long-term outcome of pineal nongerminomatous germ cell tumors Knappe U, Bentele K, Horstmann M, Herrmann H PEDIATR NEUROSURG. 199828(5):241-5. Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy. Krger N, Hoffknecht M, Hnel M, Krger W, Zeller W, Stockschlder M, de Wit M, Weh H, Kabisch H, Erttmann R, Zander A BONE MARROW TRANSPL. 199821(12):1171-1175. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Krger N, Krger W, Wacker-Backhaus G, Hegewisch-Becker S, Stockschlder M, Fuchs N, Rssmann B, Renges H, Drken M, Bielack S, de Wit M, Schuch G, Bartels H, Braumann D, Kuse R, Kabisch H, Erttmann R, Zander A BONE MARROW TRANSPL. 199822(11):1029-1033. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants. Pieters R, den Boer M, Durian M, Janka-Schaub G, Schmiegelow K, Kaspers G, van Wering E, Veerman A LEUKEMIA. 199812(9):1344-1348. Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden) Pohl M, Zimmerhackl L, Heinen F, Sutor A, Schneppenheim R, Brandis M J PEDIATR-US. 1998132(1):159-61. alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. Price E, Horstmann M, Wells A, Weilbaecher K, Takemoto C, Landis M, Fisher D J BIOL CHEM. 1998273(49):33042-33047. Detection of hyperdiploid karyotypes (gt50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH). Ritterbach J, Hiddemann W, Beck J, Schrappe M, Janka-Schaub G, Ludwig W, Harbott J, Lampert F LEUKEMIA. 199812(3):427-433. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. Weilbaecher K, Hershey C, Takemoto C, Horstmann M, Hemesath T, Tashjian A, Fisher D J EXP MED. 1998187(5):775-785. Age-resolving osteopetrosis Weilbaecher K, Hershey C, Takemoto C, Horstmann M, Hemesath T, Tashjian A, Fisher D The Journal of experimental medicine. 1998187(5):775-85. Thiopurine biology and pharmacology. Aarbakke J, Janka-Schaub G, Elion G TRENDS PHARMACOL SCI. 199718(1):3-7. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay. Anderegg B, Horstmann M, Ernst M, Kabisch H PEDIATR HEMAT ONCOL. 199714(4):349-358. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines. Anderegg B, Horstmann M, Kabisch H CANCER GENE THER. 19974(2):84-90. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines Anderegg B, Horstmann M, Kabisch H CANCER GENE THER. 19974(2):84-90. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay Anderegg B, Horstmann M, Ernst M, Kabisch H PEDIATR HEMAT ONCOL. 199714(4):349-58. Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid. David K, Ehrhardt A, Ollert M, Erttmann R, Bredehorst R, Vogel C EUR J CANCER. 199733(12):1937-1941. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Favara B, Feller A, Pauli M, Jaffe E, Weiss L, Arico M, Bucsky P, Egeler R, Elinder G, Gadner H, Gresik M, Henter J, Imashuku S, Janka-Schaub G, Jaffe R, Ladisch S, Nezelof C, Pritchard J Med Pediatr Oncol. 199729(3):157-166. Factors influencing haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis. A single-centre experience. Hassan H, Krog C, Stockschlder M, Zeller W, Krger W, Erttmann R, Zander A SUPPORT CARE CANCER. 19975(4):299-306. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience. Hassan H, Krog C, Stockschlder M, Schleimer B, Zeller W, Krger W, Erttmann R, Zander A ANTICANCER RES. 199717(1):589-599. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Henter J, Aric M, Egeler R, Elinder G, Favara B, Filipovich A, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Webb D Med Pediatr Oncol. 199728(5):342-347. Late manifestation of diabetes insipidus in pure cutaneous Langerhans cell histiocytosis. Hoeger P, Janka-Schaub G, Mensing H EUR J PEDIATR. 1997156(7):524-527. Frequent reduction or loss of DCC gene expression in human osteosarcoma Horstmann M, Psl M, Scholz R, Anderegg B, Simon P, Baumgaertl K, Delling G, Kabisch H BRIT J CANCER. 199775(9):1309-17. Frequent reduction or loss of DCC gene expression in human osteosarcoma. Horstmann M, Psl M, Scholz R, Anderegg B, Simon P, Baumgaertl K, Delling G, Kabisch H BRIT J CANCER. 199775(9):1309-1317. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation. Krger W, Stockschlder M, Sobottka I, Betker R, De Wit M, Krger N, Grimm J, Arland M, Fiedler W, Erttmann R, Zander A LEUKEMIA LYMPHOMA. 199724(5-6):491-499. Arginine506 to glutamin mutation in the factor V gene in infancy and childhood: evidence of fibrinolytic impairment Nowak-Gttl U, Vielhaber H, Grohmann J, Schneppenheim R, Koch H EUR J PEDIATR. 1997156(3):195-8. APC resistance in childhood thromboembolism Nowak-Gttl U, Schneppenheim R, Vielhaber H Seminars in thrombosis and hemostasis. 199723(3):253-8. Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM. Ollert M, David K, Vollmert C, Juhl H, Erttmann R, Bredehorst R, Vogel C EUR J CANCER. 199733(12):1942-1948. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. von Schweinitz D, Byrd D, Hecker H, Weinel P, Bode U, Brger D, Erttmann R, Harms D, Mildenberger H EUR J CANCER. 199733(8):1243-1249. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. Zander A, Berger C, Krger N, Stockshlder M, Krger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schnrock P, Kuse R, Braumann D, Illiger H, Fiedler W, de Witt M, Hossfeld K, Weh H CLIN CANCER RES. 19973(12 Pt 2):2671-2675. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Aric M, Janka G, Fischer A, Henter J, Blanche S, Janka-Schaub G, Martinetti M, Rusca M LEUKEMIA. 199610(2):197-203. Prevalence of factor V Leiden in children with thrombo-embolism Aschka I, Aumann V, Bergmann F, Budde U, Eberl W, Eckhof-Donovan S, Krey S, Nowak-Gttl U, Schobess R, Sutor A, Wendisch J, Schneppenheim R EUR J PEDIATR. 1996155(12):1009-14. The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients. Berthold F, Hero B, Breu H, Christiansen H, Erttmann R, Gnekow A, Herrmann F, Klingebiel T, Lampert F, Mller-Weihrich S, Weinel P ANN ONCOL. 19967(2):183-187. Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties Bielack S, Erttmann R, Kempf-Bielack B, Winkler K EUR J CANCER. 199632(10):1652-1660. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Mnster Relapse Study Group. Bhrer C, Hartmann R, Fengler R, Rath B, Schrappe M, Janka-Schaub G, Henze G J CLIN ONCOL. 199614(10):2812-2817. Hepatopathie bei Patienten mit Neuroblastom Stadium 4S Claviez A, Hero B, Schneppenheim R, Berthold F KLIN PADIATR. 1996208(4):221-8. Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans. David K, Ollert M, Juhl H, Vollmert C, Erttmann R, Vogel C, Bredehorst R NAT MED. 19962(6):686-689. Naturally occurring humoral cytotoxicity against neuroblastoma (NB) cells in healthy persons and NB patients. Erttmann R, Schmitt C, Ollert M, David K, Bredehorst R, Vogel C PEDIATR HEMAT ONCOL. 199613(6):545-548. Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group. Favrot M, Ambros P, Schilling F, Frappaz D, Combaret V, Berthold F, Dominici C, Erttmann R, Esteve J, Jenkner A, Kerbl R, Mann J, Mathieu P, Parker L, Powell J, Philip T ANN ONCOL. 19967(6):607-611. Pharmacokinetics of the 5HT3 receptor antagonist tropisetron in children. Gaedicke G, Erttmann R, Henze G, Hartmann W, Drechsler S, Grass P, Faerber L, Kutz K PEDIATR HEMAT ONCOL. 199613(5):405-416. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(111819) Horstmann M, Argyriou-Tirita A, Borkhardt A, Kabisch H, Kapaun P, Winkler K, Haas O CANCER GENET CYTOGEN. 199688(2):103-9. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(111819). Horstmann M, Argyriou-Tirita A, Borkhardt A, Kabisch H, Kapaun P, Winkler K, Haas O CANCER GENET CYTOGEN. 199688(2):103-109. Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation. Horstmann M, Kroschke G, Stockschlder M, Betker R, Krger W, Erttmann R, Kabisch H, Zander A PEDIATR HEMAT ONCOL. 199613(1):45-53. Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood--follow up after 9 years. Coall Study Group. Janka-Schaub G, Harms D, Goebel U, Graubner U, Gutjahr P, Haas R, Juergens H, Spaar H, Winkler K EUR J PEDIATR. 1996155(8):640-648. Induction of multiple melanocytic nevus cell nevi in 2 children with malignant hematologic systemic diseases and chemotherapy-induced immunosuppression Jappe U, Abeck D, Janka-Schaub G, Gross G, Jakob T, Ring J HAUTARZT. 199647(7):537-540. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values. Krger W, Sobottka I, Stockschlder M, Mross K, Hoffknecht M, Rssmann B, Horstmann M, Betker R, Zander A SCAND J INFECT DIS. 199628(3):313-316. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values Krger W, Sobottka I, Stockschlder M, Mross K, Hoffknecht M, Rssmann B, Horstmann M, Betker R, Zander A SCAND J INFECT DIS. 199628(3):313-6. Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism Nowak-Gttl U, Auberger K, Gbel U, Kreuz W, Schneppenheim R, Vielhaber H, Zenz W, Zieger B EUR J PEDIATR. 1996155(11):921-7. Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells. Ollert M, David K, Schmitt C, Hauenschild A, Bredehorst R, Erttmann R, Vogel C P NATL ACAD SCI USA. 199693(9):4498-4503. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen J, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram C, Ludwig W, Riehm H, Lampert F, Harbott J LEUKEMIA. 199610(6):957-963. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1 Schneppenheim R, Budde U, Krey S, Drewke E, Bergmann F, Lechler E, Oldenburg J, Schwaab R THROMB HAEMOSTASIS. 199676(4):598-602. Defective dimerization of von Willebrand factor subunits due to a Cys-gt Arg mutation in type IID von Willebrand disease Schneppenheim R, Brassard J, Krey S, Budde U, Kunicki T, Holmberg L, Ware J, Ruggeri Z P NATL ACAD SCI USA. 199693(8):3581-6. Use of cryopreserved bone marrow in unrelated allogeneic transplantation. Stockschlder M, Krger W, Tom Dieck A, Horstmann M, Altnder M, Lliger C, Fiedler W, Hoffknecht M, Erttmann R, Zander A BONE MARROW TRANSPL. 199617(2):197-199. Geographic distribution and origin of CFTR mutations in Germany Tmmler B, Storrs T, Dziadek V, Drk T, Meitinger T, Golla A, Bertele-Harms R, Harms H, Schrder E, Claass A, Rutjes J, Schneppenheim R, Bauer I, Breuel K, Stuhrmann M, Schmidtke J, Lindner M, Eigel A, Horst J, Kaiser R, Lentze M, Schmidt K, von der Hardt H, Estivill X HUM GENET. 199697(6):727-31. Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance. Bielack S, Kallenbach K, Looft G, Erttmann R, Winkler K ANTICANCER RES. 199515(4):1279-1284. First case of disseminated Mycobacterium avium infection following chemotherapy for childhood acute myeloid leukemia Claass A, Claviez A, Westphal E, Rsch-Gerdes S, Schneppenheim R INFECTION. 199523(5):301-2. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings Horstmann M, Stockschlder M, Krger W, Hoffknecht M, Betker R, Kabisch H, Zander A ANN HEMATOL. 199571(2):77-81. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia transplanted with bone marrow from HLA-identical related donors Horstmann M, Stockschlder M, Kabisch H, Zander A BLOOD. 199585(5):1404-5. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results. Horstmann M, Stockschlder M, Krger W, Hoffknecht M, Betker R, Kabisch H, Zander A ANN HEMATOL. 199571(2):77-81. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation. Krger W, Stockschlder M, Rssmann B, Berger C, Hoffknecht M, Sobottka I, Kohlschtter B, Kroschke G, Krger N, Horstmann M BRIT J HAEMATOL. 199591(3):684-690. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation Krger W, Stockschlder M, Rssmann B, Berger C, Hoffknecht M, Sobottka I, Kohlschtter B, Kroschke G, Krger N, Horstmann M BRIT J HAEMATOL. 199591(3):684-90. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Nielsen P, Fischer R, Engelhardt R, Tondry P, Gabbe E, Janka-Schaub G BRIT J HAEMATOL. 199591(4):827-833. Identification of a candidate missense mutation in a family with von Willebrand disease type IIC Schneppenheim R, Thomas K, Krey S, Budde U, Jessat U, Sutor A, Zieger B HUM GENET. 199595(6):681-6. Von Willebrand disease in childhood Schneppenheim R, Thomas K, Sutor A Seminars in thrombosis and hemostasis. 199521(3):261-75. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89. von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Brger D, Erttmann R, Mildenberger H J PEDIATR SURG. 199530(6):845-852. Intraspinal metastasis of stage I anaplastic Wilms tumor Wiegel T, Grzyska U, Schwarz R, Escherich G STRAHLENTHER ONKOL. 1995171(5):296-299. Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in childhood: guidelines for differential diagnosis--report of the Histiocyte Society. Bucsky P, Favara B, Feller A, Nezelof C, Radzun H, Schlegelberger B, Janka-Schaub G Med Pediatr Oncol. 199422(3):200-203. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkins disease in childhood Claviez A, Tiemann M, Peters J, Kreipe H, Schneppenheim R, Parwaresch R ANN HEMATOL. 199468(2):61-6. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment Horstmann M, Erttmann R, Winkler K Lancet. 1994343(8905):1098-9. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment. Horstmann M, Erttmann R, Winkler K LANCET. 1994343(8905):1098-1099. Screening for neuroblastoma. Schilling F, Erttmann R, Ambros P, Strehl S, Christiansen H, Kovar H, Kabisch H, Treuner J LANCET. 1994344(8930):1157-1158. Genetic heterogeneity of severe von Willebrand disease type III in the German population Schneppenheim R, Krey S, Bergmann F, Bock D, Budde U, Lange M, Linde R, Mittler U, Meili E, Mertes G HUM GENET. 199494(6):640-52. Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol von Schweinitz D, Brger D, Bode U, Weinel P, Erttmann R, Hecker H, Mildenberger H KLIN PADIATR. 1994206(4):282-288. Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort Bielack S, Bieling P, Erttmann R, Winkler K Cancer Treat Res. 199362:85-92. Extracellular purine nucleosides elevated in chronic recidiving central nervous injury by deranged metabolism in phenylketonuria. Clemens P, Prankel B, Halfman E, Erb N, Mller-Wickop J MED HYPOTHESES. 199341(3):287-288. Phenylalanine, other large neutral amino acids and RNA catabolites as markers for protein biosynthesis in phenylketonuria. Clemens P, Burmester J, Wiegand G, Prankel B, Halfmann E, Erb N, Mller-Wickop J METABOLISM. 199342(4):531-532. BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89 Gbel U, Calaminus G, Teske C, Bamberg M, Bkkerink J, Haas R, Holschneider A, Janka-Schaub G, Jrgens H, Mittler U KLIN PADIATR. 1993205(4):231-240. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure Holmberg L, Dent J, Schneppenheim R, Budde U, Ware J, Ruggeri Z J CLIN INVEST. 199391(5):2169-77. Reversal of multidrug resistance in Friend leukemia cells by dexniguldipine-HCl. Reymann A, Looft G, Woermann C, Dietel M, Erttmann R CANCER CHEMOTH PHARM. 199332(1):25-30. Effect of dose intensity and therapy-induced leukocytopenia in intensive therapy on the prognosis of acute lymphatic leukemia in childhood. Results in 213 patients of the COALL-85 study Gobrecht O, Gbel U, Graubner U, Gutjahr P, Schck V, Spaar H, Janka-Schaub G KLIN PADIATR. 1992204(4):230-235. Infectious risks of Broviac catheters in children with neoplastic diseases: a matched pairs analysis. Harms D, Grtitz I, Lambrecht W, Kabisch H, Erttmann R, Janka-Schaub G PEDIATR INFECT DIS J. 199211(12):1014-1018. Treatment of chronic neutropenia of childhood responsive to cyclosporin A in vitro and in vivo. Janka-Schaub G, Raghavachar A, Rister M, Belohradsky B INT J HEMATOL. 199255(2):157-163. Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study Ludwig R, Weirich A, Ptter R, Harms D, Brger D, Michaelis J, Erttmann R, Weinel P, Haas R, Ritter J KLIN PADIATR. 1992204(4):204-213. Early neuroblastoma detection in Germany. On the status of the Hamburg-Stuttgart cooperative pilot study Schilling F, Erttmann R, Dohrmann S, Erb N, Winkler K, Gross U, Treuner J KLIN PADIATR. 1992204(4):282-287. Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trials. Berthold F, Hunneman D, Kser H, Harms D, Bertram U, Erttmann R, Schilling F, Treuner J, Zieschang J Am J Pediatr Hematol Oncol. 199113(1):8-13. Conserved cytostatic activity of aclarubicin in a doxorubicin selected Friend leukaemia cell line with multifactorial multidrug resistance. Erttmann R, Mnchmeyer M, Looft G, Winkler K EUR J CANCER. 199127(8):1064. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H BLOOD. 199178(5):1166-1172. Familial hemophagocytic lymphohistiocytosis Hesse C, Hansmann M, Janka-Schaub G, Rontogianni D, Radzun H, Fischer R Verh Dtsch Ges Pathol. 199175:200-204. Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood. COALL study group Janka-Schaub G, Sthrk H, Kortm B, Graubner U, Jrgens H, Spaar H, Schck V, Dohrn B, Bahr R, Winkler K KLIN PADIATR. 1991203(4):231-235. Discrepant results of different tests for antibodies to hepatitis C in children with malignant diseases and in patients on renal replacement therapy Rautenberg P, Schneppenheim R, Leimenstoll G, Behnke H, Loose G EUR J CLIN MICROBIOL. 199110(11):978-81. Seroprevalence and significance of antibodies to hepatitis C virus in pediatric patients with malignant diseases Schneppenheim R, Rautenberg P, Behnke H, Vietor K KLIN PADIATR. 1991203(4):273-5. Luminography--a new, highly sensitive visualization method for electrophoresis Schneppenheim R, Budde U, Dahlmann N, Rautenberg P ELECTROPHORESIS. 199112(5):367-72. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri Z, Zimmerman T THROMB HAEMOSTASIS. 199063(2):312-5. Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia. Fengler R, Hartmann R, Bode U, Janka-Schaub G, Jrgens H, Riehm H, Henze G Haematol Blood Transfus. 199033:511-515. Cytogenetics of childhood acute lymphoblastic leukemia in multicenter trials. Harbott J, Ritterbach J, Janka-Schaub G, Ludwig W, Reiter A, Riehm H, Lampert F Haematol Blood Transfus. 199033:451-458. Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations. Janka-Schaub G, Goebel U, Graubner U, Haas R, Juergens H, Spaar H, Winkler K Haematol Blood Transfus. 199033:489-493. Therapy of sickle cell crisis Janka-Schaub G DEUT MED WOCHENSCHR. 1990115(42):1611. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Jrgens H, Ritter J, Kusnierz-Glaz C, Erttmann R CANCER-AM CANCER SOC. 199066(8):1703-1710. Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cooperative Osteosarcoma Study Group COSS. Bielack S, Erttmann R, Looft G, Purfrst C, Delling G, Winkler K, Landbeck G CANCER CHEMOTH PHARM. 198924(6):376-380. Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy. Bielack S, Erttmann R, Winkler K, Landbeck G Eur J Cancer Clin Oncol. 198925(5):873-882. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Eife R, Janka-Schaub G, Belohradsky B, Holtmann H PEDIATR HEMAT ONCOL. 19896(3):265-272. Anthracycline transport in sensitive and resistant leukemia cells Erttmann R, Erb N, Forcadell de Dios P, Neurath C, Looft G, Landbeck G KLIN PADIATR. 1989201(1):40-45. An EcoRI polymorphism in the human von Willebrand factor (vWF) gene Ewerhardt B, Ludwig M, Schwaab R, Schneppenheim R, Olek K Nucleic acids research. 198917(13):5416. Intracranial germ cell tumors: analysis of the therapy study MAKEI 83/86 and changes in protocol for the follow-up study Gbel U, Bamberg M, Budach V, Haas R, Janka-Schaub G, Khl J, Lenard H, Rister M, Spaar H KLIN PADIATR. 1989201(4):261-268. Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study Gbel U, Bamberg M, Haas R, Bkkerink J, Brmswig G, Calaminus G, Engert J, Gadner H, Havers W, Janka-Schaub G KLIN PADIATR. 1989201(4):247-260. Familial hemophagocytic lymphohistiocytosis macrophages showing immunohistochemical properties of activated macrophages and T-accessory cells. Hansmann M, Rontogianni D, Janka-Schaub G, Wacker H, Hinkeldey K, Radzun H PEDIATR HEMAT ONCOL. 19896(3):237-246. Familial hemophagocytic lymphohistiocytosis: therapy in the German experience. Janka-Schaub G PEDIATR HEMAT ONCOL. 19896(3):227-231. Familial hemophagocytic lymphohistiocytosis: diagnostic problems and differential diagnosis. Janka-Schaub G PEDIATR HEMAT ONCOL. 19896(3):219-225. Myeloablative chemo - and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma Berthold F, Bender-Gtze C, Dopfer R, Erttmann R, Haas R, Henze G, Krbling M, Riehm H, Rister M, Stollmann B KLIN PADIATR. 1988200(3):221-225. Pharmacokinetics of doxorubicin in man: dose and schedule dependence. Erttmann R, Erb N, Steinhoff A, Landbeck G J CANCER RES CLIN. 1988114(5):509-513. Antineoplastic effectiveness and toxicity of idarubicin (4-demethoxy-daunorubicin) in recurrent acute leukemias in childhood Erttmann R, Bode U, Erb N, Forcadell de Dios P, Gutjahr P, Haas R, Kuhn N, Siewert H, Landbeck G KLIN PADIATR. 1988200(3):200-204. Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling. Hausdorf G, Morf G, Beron G, Erttmann R, Winkler K, Landbeck G, Keck E Br Heart J. 198860(4):309-315. Rapidly rotating combination chemotherapy in childhood acute lymphoblastic leukemia: preliminary results of a randomized comparison with conventional treatment. Janka-Schaub G, Winkler K, Gbel U, Graubner U, Gutjahr P, Haas R, Jrgens H, Spaar J LEUKEMIA. 19882(12):. The COALL-85 cooperative study for risk patients with acute lymphatic leukemia: initial results Janka-Schaub G, Winkler K, Gbel U, Graubner U, Schwenger M, Haas R, Jrgens H, Spaar J KLIN PADIATR. 1988200(3):171-176. Luminography--an alternative assay for detection of von Willebrand factor multimers Schneppenheim R, Plendl H, Budde U THROMB HAEMOSTASIS. 198860(2):133-6. Aplastic crisis caused by parvovirus B19 infection. Schwarz T, Roggendorf M, Janka-Schaub G EUR J CLIN MICROBIOL. 19887(1):87-88. Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study Gadner H, Heitger A, Ritter J, Gbel U, Janka-Schaub G, Khl J, Bode U, Spaar H KLIN PADIATR. 1987199(3):173-182. Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate. Janka-Schaub G, Winkler K, Juergens H, Goebel U Haematol Blood Transfus. 198730:456-460. Detection of neuroblastoma cells in bone marrow by Southern blot and in situ hybridization using a NMYC DNA probe Kabisch H, Heinsohn S, Milde K, Lning T, Bartl S, Erttmann R, Landbeck G MONATSSCHR KINDERH. 1987135(4):210-213. Nachweis von Neuroblastomzellen im Knochenmark durch Southern-Blot und In situ-Hybridisierung mit Hilfe einer NMYC-DNS-Probe Kabisch H, Heinsohn S, Milde-Langosch K, Lning T, Bartl S, Erttmann R, Landbeck G MONATSSCHR KINDERH. 1987135(4):210-3. A luminescence Western blot with enhanced sensitivity for antibodies to human immunodeficiency virus Schneppenheim R, Rautenberg P EUR J CLIN MICROBIOL. 19876(1):49-51. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol. Erb N, Erttmann R, Landbeck G CANCER CHEMOTH PHARM. 198617(1):53-55. Determination of 7-hydroxymethotrexate in human plasma by reversed phase high-performance liquid chromatography. Erttmann R, Bielack S, Landbeck G ONCOLOGY. 198643(2):86-88. The pharmacokinetics of doxorubicin Erttmann R, Grandt M, Erb N, Garbrecht M, Landbeck G KLIN PADIATR. 1986198(3):271-276. Intermediate-dose methotrexate in the treatment of childhood acute lymphocytic leukaemia: lack of benefit during maintenance therapy following intensive induction therapy. Janka-Schaub G, Winkler K, Jrgens H, Goebel U, Gutjahr P, Spaar H EUR J PEDIATR. 1986145(1-2):14-17. Detection of neuroblastoma cells in bone marrow by in situ hybridization. Kabisch H, Heinsohn S, Milde K, Lning T, Bartl S, Erttmann R EUR J PEDIATR. 1986145(4):323-324. Meta-iodobenzylguanidine scintigraphy in neuroblastoma--a comparison with conventional X-ray and ultrasound. Mller-Grtner H, Erttmann R, Helmke K PEDIATR HEMAT ONCOL. 19863(2):97-109. The age dependency of the creatinine-related concentration of ribonucleosides in human urine. Mller-Wickop J, Lorenz H, Winkler K, Erb N J Clin Chem Clin Biochem. 198624(12):993-999. Effect of a local surgical procedure on the incidence of metastases following neoadjuvant chemotherapy of osteosarcoma Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Gbel U Z ORTHOP GRENZGEB. 1986124(1):22-29. 7-Hydroxy-methotrexate and clinical toxicity following high-dose methotrexate therapy. Erttmann R, Bielack S, Landbeck G J CANCER RES CLIN. 1985109(1):86-88. Effect of oral cholestyramine on the elimination of high-dose methotrexate. Erttmann R, Landbeck G J CANCER RES CLIN. 1985110(1):48-50. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy. Erttmann R, Bielack S, Landbeck G CANCER CHEMOTH PHARM. 198515(2):101-104. Clinical significance of non-renal elimination mechanisms of methotrexate (MTX) Erttmann R, Gkanatsas A MONATSSCHR KINDERH. 1985133(8):516-519. The Munich study on the treatment of acute lymphoblastic leukemia in childhood (ALL 77-02) Graubner U, Haas R, Janka G, Janka-Schaub G, Kohne E, Rieber E KLIN PADIATR. 1985197(3):207-214. Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma Mller-Grtner H, Erttmann R, Helmke K NUKLEARMED-NUCL MED. 198524(5-6):222-226. An improved method for the simultaneous analysis of normal and modified urinary nucleosides and nucleobases by high performance liquid chromatography. Sander G, Wieland J, Topp H, Heller-Schch G, Erb N, Schch G CLIN CHIM ACTA. 1985152(3):355-361. In vivo production of childhood acute lymphoblastic leukemia cells in relation to ploidy and immunological subtype. Drmer P, Janka-Schaub G, Lau B, Haas R, Janka G LEUKEMIA RES. 19848(4):587-595. Prolonged methotrexate infusions in children with acute leukemia in relapse and in remission and with medulloblastoma. Pharmacokinetics, toxicity and clinical results. Janka-Schaub G, Mack R, Helmig M, Haas R, Bidlingmaier F ONCOLOGY. 198441(4):225-232. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Gbel U J CLIN ONCOL. 19842(6):617-624. Pancreatic sonography in thalassemia major. Erttmann R, Hausdorf G, Landbeck G KLIN PADIATR. 1983195(2):97-99. Intracranial metastasis in neuroblastoma Erttmann R, Heller M, Veelken N, Landbeck G Z Kinderchir. 198338(5):333-335. Determination of aclacinomycin A by reversed-phase high-performance liquid chromatography. Erttmann R J CHROMATOGR A. 1983277:433-435. Wiskott-Aldrich syndrome Erttmann R, Thne I, Landbeck G MONATSSCHR KINDERH. 1983131(8):524-527. Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology Gbel U, Haas R, Harms D, Janka-Schaub G, Brmswig J, Jrgens H, Weissbach L, Faber P, Mller E KLIN PADIATR. 1983195(3):201-206. Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology Haas R, Brmswig J, Gbel U, Harms D, Janka-Schaub G, Weissbach L KLIN PADIATR. 1983195(3):196-200. Therapy of acute lymphocytic leukemia in childhood with intermediate dose methotrexate and CNS irradiation. A report of the ALL 77-02 study group. Haas R, Janka G, Janka-Schaub G, Kohne E, Netzel B Blut. 198347(6):321-331. Invasive aspergillosis with an intrapulmonary fungus ball in childhood Hausdorf G, Erttmann R KLIN PADIATR. 1983195(2):129-132. Familial hemophagocytic lymphohistiocytosis. Janka-Schaub G EUR J PEDIATR. 1983140(3):221-230. Multivariate analysis of urinary RNA catabolites in malignancies: cross-sectional and longitudinal studies. Mller J, Erb N, Heller-Schch G, Lorenz H, Winkler K, Schch G Recent Results Cancer Res. 198384:317-330. Serological inhibition of graft versus host disease: recent results in 28 patients with leukemia. Rodt H, Thierfelder S, Bender-Gtze C, Dopfer R, Haas F, Janka-Schaub G, Kolb H, Link H, Netzel B, Niethammer D, Schch K, Wilms K Haematol Blood Transfus. 198328:92-96. Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study. Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Gbel U, Havers W, Henze G, Hinderfield L, Hcker P, Jobke A, Jrgens H, Kabisch H, Landbeck G, Preusser P, Prindull G, Ramach W, Ritter J, Sekera J, Treuner J, Wst G J CANCER RES CLIN. 1983106:1-7. COALL-80 therapy in the management of acute lymphoblastic leukemia in childhood--an interim report Winkler K, Beron G, Erttmann R, Jrgens H, Gbel U, Gutjahr P, Kabisch H, Kuhn N, Spaar H, Drescher J, Thomas P, Landbeck G KLIN PADIATR. 1983195(3):161-167. Excretion of methylated nucleosides in the initial therapy phase in a case of anorexia nervosa Clemens P, Schch G, Ziemer G, Altenhoff J, Erb N, Lorenz H, Mller J, Grttner R Padiatr Padol. 198217(2):157-163. So-called histiocytosis X and malignant histiocytosis Haas R, Janka-Schaub G, Helmig M, Meister P ONKOLOGIE. 19825(1):4-12. Improved prognosis in Wilms tumor due to adjuvant combination drug therapy Haas R, Helmig F, Hausner H, Eife R, Devens K, Janka-Schaub G, Helmig M, Lampert F ONKOLOGIE. 19825(2):60-66. Sonographic findings in malignant lymphoblastic T-cell lymphomas in childhood Hausdorf G, Erttmann R, Hbner C, Winkler K ONKOLOGIE. 19825(6):284-288. Medulloblastoma cerebelli in childhood--retrospective evaluation of diagnostic methods and therapy (authors transl) Berthold R, Janka-Schaub G, Lampert F KLIN PADIATR. 1981193(3):189-197. The cyanogenic glycosides of triticum, secale and sorghum. Erb N, Zinsmeister H, Nahrstedt A PLANTA MED. 198141(1):84-89. Infections in children with leukaemia or malignant tumour treated with cytostatic agents: long-term study of 200 cases (authors transl) Goetz O, Peller P, Haas R, Janka-Schaub G DEUT MED WOCHENSCHR. 1981106(14):421-423. All 77-01 therapy study for treatment of acute lymphocytic leukemia in childhood (authors transl) Haas R, Janka-Schaub G, Netzel B, Helmig M KLIN PADIATR. 1981193(3):137-144. Familial lymphohistiocytosis. Janka-Schaub G, Belohradsky B, Dumling S, Mller-Hcker J, Meister P, Haas R Haematol Blood Transfus. 198127:245-253. Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload. Janka-Schaub G, Mhring P, Helmig M, Haas R, Betke K EUR J PEDIATR. 1981137(3):285-290. Microrheological aspects in extreme leukocytotic acute childhood leukemia. Klose H, Kelson S, Janka-Schaub G, Schwarzbach K, Haas R, Betke K Bibl Haematol. 198147:258-263. Initial treatment of acute childhood leukemia with extreme leukocytosis by blood exchange transfusion -- rheological aspects (authors transl) Klose H, Kelson S, Schwarzbach K, Janka-Schaub G, Netzel B, Haas R, Betke K KLIN PADIATR. 1981193(3):172-176. Bone marrow transplantation for aplastic anaemia (authors transl) Kolb H, Wndisch G, Spitzer I, Ochsler H, Stengel-Rutkowski L, Bender-Gtze C, Albert E, Sauer H, Ledderose G, Brehm G, Jehn U, Eckstein R, Mempel W, Wilmanns W, Haas R, Helmig M, Netzel B, Belohradsky B, Janka-Schaub G, Rodt H, GrosseWWilde H, Thiel E, von Lieven H, Roloff R, Krimmel B, Bunde E, Wank R, Schendel D Klin Wochenschr. 198159(7):325-342. Bone marrow transplantation in acute leukemias: antibody treatment for suppression of graft-versus-host disease (authors transl) Rodt H, Netzel B, Kolb H, Haas R, Wilms K, Bender-Gtze C, Wernet P, Janka-Schaub G, Link H, Wilmanns W, Thierfelder S Blut. 198143(2):113-118. Presentation of the cooperative study COALL-80 on treatment of childhood ALL (authors transl) Winkler K, Matzke E, Caspers S, Erttmann R, Grosch-Wrner I, Kabisch H, Mller J, Landbeck G KLIN PADIATR. 1981193(3):155-158. Effects of probenecid on plasma/tissue distribution of 14C-benzylpenicillin in rats. Bergholz H, Erttmann R, Damm K Experientia. 198036(3):333-334. Antibody incubation of human marrow graft for prevention graft versus host disease. Haas R, Janka-Schaub G, Netzel B, Rodt H, Thierfelder S, Helmig M, Eife R, Belohradsky B, Kolb H, Betke K Blut. 198040(6):387-397. Acute juvenile lymphoblastic leukemia Haas R, Janka-Schaub G, Helmig M, Netzel B MMW Munch Med Wochenschr. 1980122(9):301-304. The concept of antileukemic, autologous bone marrow transplantation in acute lymphoblastic leukemia. Netzel B, Rodt H, Haas R, Janka-Schaub G, Thierfelder S Haematol Blood Transfus. 198025:297-307. Wolmans disease: clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcification. Schaub J, Janka G, Christomanou H, Sandhoff K, Permanetter W, Janka-Schaub G, Meister P EUR J PEDIATR. 1980135(1):45-53. Total aganglionosis of the colon and Ondines curse. Stern M, Erttmann R, Hellwege H, Kuhn N LANCET. 19801(8173):877-878. Radiation therapy of the renal tumor in children (authors transl) von Lieven H, Kurz S, Haas R, Janka-Schaub G, Devens K Strahlentherapie. 1980156(6):388-393. Non-Hodgkins lymphoma in children: improved prognosis through aggressive multiple drug combination and irradiation (authors transl) Janka-Schaub G, Lau B, Meister P, Lampert F, Haas R KLIN PADIATR. 1979191(1):40-46. High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (authors transl) Janka-Schaub G, Wiesner H, Bidlingmaier F, Haas R Klin Wochenschr. 197957(8):411-416. Hydrocyanic acid content in cerals and cereal products Lehmann G, Zinsmeister H, Erb N, Neunhoeffer O Z Ernahrungswiss. 197918(1):16-22. Osteosarcoma: histological evaluation and grading. Meister P, Konrad E, Lob G, Janka-Schaub G, Keyl W, Strz H ARCH ORTHOP TRAUM SU. 197994(2):91-98. GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation. Rodt H, Kolb H, Netzel B, Rieder I, Janka-Schaub G, Belohradsky B, Haas R, Thierfelder S TRANSPL P. 197911(1):962-966. Juvenile rhabdomyosarcoma. Diagnosis and new therapeutic possibilities Haas R, Devens K, Helmig M, Janka-Schaub G, Klose H, Lampert F ONKOLOGIE. 19781(4):142-148. Diagnostik significance of cell membrane markers in childhood ALL (authors transl) Haas R, Netzel B, Janka-Schaub G, Rodt H, Thiel E, Thierfelder S KLIN PADIATR. 1978190(5):446-452. Lymphoblast cell size and prognosis in acute lymphoblastic leukemia in childhood. Janka-Schaub G, Teige-Singer S, Haas R, Lau B Blut. 197837(2):89-94. Combination chemotherapy and radiotherapy for Hodgkins disease in children. Janka-Schaub G, Lau B, Haas R, von Lieven H, Lampert F EUR J PEDIATR. 1978127(4):287-292. Malignant juvenile bone tumors Janka-Schaub G MED KLIN. 197873(22):815-818. Abt-Letterer-Siwe disease. Diagnosis and therapy (authors transl) Wolff H, Janka-Schaub G MONATSSCHR KINDERH. 1978126(7):425-430. In vitro functions of lymphoid cells in untreated childhood acute lymphoblastic leukemia. Eife R, Kopecky M, Lau B, Janka-Schaub G, Haas R, Lampert F Haematol Blood Transfus. 197720:209-213. Neuroblastoma: paraneoplastic diseases and late complications (authors transl) Holschneider A, Geiger H, Bolkenius N, Janka-Schaub G, Lampert F MONATSSCHR KINDERH. 1977125(2):69-73. Childhood malignant lymphoma. Favourable outlook with aggressive combination chemotherapy and radiotherapy. Lau B, Janka-Schaub G, Meister P, Lampert F, Haas R EUR J CANCER. 197713(11):1237-1240. Distrubances in glucose metabolism during diphenyhydantoin treatment in childhood Janka G, Toyka K, Janka-Schaub G, Frster C Bibl Psychiatr. 1975151:172-175. Letzte Aktualisierung aus dem FIS: 17.12.2016 - 02:11 Uhr